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1. Bone Tissue Engineering  
The loss and dysfunction of bone tissues lead to trauma, injuries, and diseases that result in a 
variety of socio-economic issues. More than two million patients worldwide undergo a bone 
transplantation every year, with an estimated total cost on the health system of 2.5 million 
dollars in the USA alone. To date, transplantation of autologous bone, i.e. autograft, is the 
gold standard. This procedure involves the use of bone from the same patient, which avoids 
immune and infection-related risks. However, recent studies have reported considerable 
shortcomings associated with autografts, such as the shortage of transplantable bone, the need 
for an additional surgical operation, and high donor site morbidity risks associated with 
bleeding, infection, and pain [1, 2].  
Bone tissue engineering (BTE) has emerged over the last thirty years as promising 
alternative solution to autografts. Starting from the basic understanding of bone structure and 
biology, BTE aims to artificially recapitulate and enhance bone regeneration and bone repair 
mechanisms. Specifically, BTE relies on three key parameters: 1) a 3D biocompatible 
scaffold that mimics as close as possible the extracellular bone matrix, 2) stem cells that are 
able to express osteogenic potential, 3) specific growth factors that can trigger bone 
regeneration and healing [3]. The technically complex challenge of BTE has engaged a wide 
multidisciplinary scientific community consisting of engineers, biologists, surgeons, material 
scientist, etc., each of them focused on a specific aspect of the ultimate goal (e.g. develop 
artificial constructs that can be used for bone repair).  
2. Biomaterials  
One of the crucial aspects of BTE is the use of biologically compatible materials. Specifically, 
an ideal BTE material should be osteoinductive, i.e. able to promote the differentiation of 
stem cells in osteoblastic lineage, and osteoconductive, i.e. able to support bone growth. 
Furthermore, materials that can be degraded by biological systems, i.e. biodegradable, 
potentially can be tuned to ensure low toxic and immunological reactions from the host 
organism, while avoiding revision surgery [4]. The biomaterials used for BTE can be chosen 
from all material categories, i.e. ceramics, (bio)polymers, metals, and hybrid composites [5].  
Ceramic materials have evoked special interest because of their high similarity to the 
calcified phase of mammalian bone, and likewise of dental tissues. For this reason, ceramics 
show remarkable biological, biodegradable and osteoconductive properties. Ceramic materials 
of clinical interest are usually based on calcium phosphate (CaP) salts, e.g. alpha-tricalcium 
phosphate (α-TCP), hydroxyapatite (HA), and bioglasses. New technical advances in ceramic 
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material manufacturing allow to obtain porous materials with injectable properties that can be 
implanted into the body through a minimally invasive surgical operation. Furthermore, the 
combination of ceramics with specific growth factors, gene activator complexes, antibiotics or 
therapeutics has been used to enhance the osteogenic and biological properties [6].  
Polymers can have a natural origin, such as chitosan, silk, and alginate; or a synthetic origin, 
such as polylactic acid (PLA), polyglycolic acid (PGA), and poly-ε-caprolactone (PCL). 
Similar to ceramics, polymeric materials have become popular because of their biocompatible 
and biodegradable features. Main advantages of using polymers are that they can be 
manufactured in strictly controlled ways, through many processing techniques, such as fiber 
meshing, microsphere sintering, and 3D printing. Therefore, polymers can be designed with 
fine precision porosity and interconnectivity according to the specific bone application. 
Furthermore, especially synthetic polymers can be tailored to optimal mechanical strength, 
even suitable for load-bearing sites [7]. 
As usual, both ceramics and polymers are showing advantages and disadvantages. 
Therefore, hybrid composites have been designed using ceramics and different polymers, to 
combine the main material properties requested for BTE. A typical example is the 
combination of α-TCP and HA calcium phosphate-based cement with PLGA microparticles 
[8].  
3. Imaging Challenges in BTE 
For the translation of biomaterials in clinical applications, in vivo models for testing their 
biological properties are demanded [7]. To date, many preclinical BTE studies are based on 
destructive evaluation methods, such as histology and immunochemistry, which are limiting 
the possibility to perform longitudinal volumetric and functional assessments of the implanted 
scaffold. Therefore, there is a strong need of less-invasive imaging strategies with high 
resolution (i.e. ideally at subcellular level) that allow quantitative assessment of the tissue 
engineered constructs behavior once implanted into to a living system [9, 10]. To date, the 
imaging characterization of typical BTE scaffolds is well established only at a pre-
implantation stage (e.g. by using scanning and/or transmission electron microscopy), while it 
is more difficult to visualize the biomaterial degradation in vivo, as well as their interaction 
with cells and tissues [11].  
Traditionally, bone imaging is based on X-ray radiography and X-ray tomography. These 
imaging techniques are widely used to assess bone graft substitutes and their tissue integration 
in vivo [12]. However, in recent studies, also other non-invasive imaging modalities have 
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been applied for BTE imaging. For instance: 1) optical coherence tomography (OCT) was 
used to study the distribution of cells labeled with magnetic beads within 3D polymeric 
scaffolds [13], 2) bioluminescence imaging was applied to follow ectotopic bone formation 
within porous scaffolds by imaging mesenchymal stem cells (MSCs) expressing luciferase 
[14], 3) magnetic resonance microscopy (MRM) and X-ray microtomography (XMT) were 
used to assess newly formed bone and its mineral content within tissue-engineered phalange 
constructs [15], 4) regerneration and revascularization of large bone defects, as created in 
rabbits, were monitored over three months of time by single photon emission computed 
tomography (SPECT) [16], and 5) labeling bone morphogenetic protein-2 (BMP-2) with 
iodine-125 (
125
I) allowed the observation of the BMP-2 release and its subsequent effect on 
the bone formation by SPECT imaging [17]. 
4. Objectives of the Thesis 
In this context, this thesis focused on the development of bone-dedicated biomaterials with 
enhanced MRI and CT imaging properties. Therefore, various types of MRI and CT contrast 
agents (CAs) were incorporated in well-defined bone substituting materials and their 
subsequent behavior was tested in in vitro and in vivo models.  
Specifically, the following research questions were assessed: 
1. What is the current state-of-the-art in MRI sequences for bone and bone-dedicated 
biomaterials? 
2. Is zero echo time (ZTE)- based MR imaging suitable to monitor CPC degradation after 
in vivo implantation in teeth? 
3. Can the combination of CAs and growth factors be used to create a theranostic 
biomaterial for dental applications? 
4. Are perfluorocarbons and gold nanoparticles suitable CAs for the enhancement of the 
MRI and CT signal of CPC? 
5. Can functionalization of CAs with HA-targeting compounds be used to prolong the 
permanence of the CAs into the CPC matrix? 
6. Can hydrogel based scaffolds be used for BTE, and if so, which imaging modality 
needs to be used for their in vivo follow-up? 
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1. Introduction 
Magnetic resonance imaging (MRI) is a non-invasive screening technology that creates three-
dimensional (3D) tomographic reconstructions of the body organs with high spatial resolution 
(< 1 mm). The primary advantage of MRI is to allow for obtaining cross-sectional anatomical 
information of the organs due to an excellent soft tissue contrast and no-depth penetration 
limits. At the same time, MRI offers functional information based on many tissues properties, 
such as proton density, temperature, biochemical content, oxygen level and pH [1, 2].  
Since the introduction of MRI in clinical practice in the early 1980`s, the number of MR 
examinations has tremendously increased especially for pathologies related to brain, spine, 
abdomen, cardiovascular and muscular systems [3, 4]. To date, the state-of-art of MRI include 
many advanced technologies, such as: 1) MR spectroscopy (MRS) and chemical shift imaging 
(CSI), which permit the identification and classification of tumors through the assessment of 
the chemical metabolism of a specific area of the body, 2) functional MRI (fMRI), which is 
able to image the neuronal activity through the detection of the blood oxygenation level-
dependent (BOLD) changes occurring in the brain, and 3) MR elastography (MRE), which 
can be used for the characterization of the biomechanical properties of soft tissues by the 
visualization of propagating shear waves [5-7].  
Despite the wide and rapid use of MRI as a diagnostic tool for soft tissues, its application 
for hard tissues (i.e. bone and teeth) has been always challenging. The water content in such 
tissues is very low (< 20 % v/v) and mainly trapped in a solid phase leading to a very short 
relaxation profile. Therefore, the signal as created by conventional clinical MRI pulse 
sequences decays very rapidly, which results in a dark and undefined image [8]. Over the last 
decade, new ultrafast MRI sequences that are able to image tissues with very low water 
content have been developed. The most promising sequences are known as ultrashort echo 
time (UTE), zero echo time (ZTE) and sweep imaging with Fourier transformation (SWIFT). 
These ultrafast MRI sequences demand specific high-speed imaging hardware; therefore, their 
clinical translation has been limited thus far. Still, many small but significant steps have been 
made to allow the application of such sequences in the clinic. Thus, after a general 
introduction to the basic theory behind MRI, bone-specific MRI sequences, and the related 
strength and weakness, this review will focus on the basic description of the anatomical and 
chemical composition of the hard tissues, and all progresses that have been made on ultrashort 
MRI acquisition of such tissues in terms of sequences development and possible clinical 
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translations. Finally, an exotic but fast-growing application for such MRI sequences, i.e. 
acquisition and monitoring of biomaterials, is also reviewed.  
2. Basic principles of MRI  
MR imaging evolved from the basic physical principles of nuclear magnetic resonance 
(NMR). Typically, MRI is used to detect the nucleus of hydrogen (H
+
), i.e. the single proton, 
in the water molecules as present in the body. Protons are positively charged subatomic 
particles that are constantly rotating along their axis. The motion of rotation of protons in an 
atom gives rise to a quantum-mechanic atomic property that is called spin. Only unpaired 
protons exhibit spin, which is the case of atoms with an odd number of protons and neutrons, 
whereas atoms with an equal number of protons and neutrons exhibit a null overall spin. The 
spinning motion of an electric charge generates a magnetic field, hence each proton can be 
considered as a small bar magnet and described as a vectorial force, named magnetic moment, 
with random orientation (Figure 1a). When an external magnetic field (B0) is applied to a 
proton, its magnetic moment will align to the direction of B0 and have only two possible 
orientations, i.e. parallel to B0 (spin = 1/2), and antiparallel to B0 (i.e. spin = -1/2). The speed 
of the precession movement of the proton is described by the Larmor frequency (ω) and 
depends on the strength of the applied B0 and on gyromagnetic ratio (γ) according to the 
following formula ω = γ B0, where γ is a constant describing each atom species (e.g. for the 
hydrogen proton γ = 42.75 MHz/T). If to the static B0 a second alternating magnetic field (B1) 
is applied in the orthogonal direction, it is possible to disturb the magnetic moment of the 
proton from the B0 direction. The alternating magnetic field B1 is usually referred as radio 
frequency (RF) and must have the same Larmor frequency as the investigated nucleus. In this 
way, the applied RF is able to induce a transfer of energy to the protons and a shift in 
direction of 90° (Figure 1a). When the RF is switched off, the protons tend to return to their 
original position in a process known as relaxation.  
During relaxation, protons lose energy according to two processes known as longitudinal 
relaxation (T1) and transverse relaxation (T2) (Figure 1b, c). The longitudinal relaxation 
describes the process whereby the adsorbed energy is released to the surrounding nuclei, 
inducing an increase of vibration within the lattice that results in an increase of thermal 
energy. Hence, longitudinal relaxation is also named spin-lattice relaxation, while T1 
relaxation refers to the time needed by the protons to reach 63% of the original position 
(Figure 1b, d). Transverse relaxation describes the process whereby the adsorbed energy is 
released by spins as consequence of random mutual interference between each other, hence 
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also known as spin-spin relaxation. The T2 relaxation refers to the time needed by the proton 
to have a reduction of the 37% of its original value (Figure 1c, e). Pure T2 decay is happening 
theoretically only with a completely homogeneous B0. However, this is never the case, as 
tissues with different susceptibility properties can affect the homogeneity of the magnetic 
field. These inhomogeneities are fixed in phase and time, while the random interactions 
between spins are time-depending. The sum of fixed and random effects is described by a T2
*
 
constant (Figure 1e). As tissues have different relaxation properties, an image can be 
generated based on the differences in T1 (i.e. T1-weighted image, Figure 1d) and in T2 (i.e. T2-
weighted image, Figure 1e) relaxation properties [1, 8, 9]. 
The position of the spins into the space can be defined based on the frequency analysis of 
the measured MRI signal, which is performed through a mathematical algorithm known as 
Fourier transform (FT). Specifically, FT is able to convert the frequency data (in Hz) in 
spatial information (in mm) that are collected in the so-called k-space. In a 2D acquisition, the 
k-space consists of a two-dimensional matrix with Kx and Ky coordinates corresponding to 
the x- and y-axis, respectively. Therefore, the location of the spins can be defined based on 
their spatial frequency in the Kx and Ky directions of the k-space [10, 11]. 
Tissues with a high free water content, such as blood, brain, skeletal muscle, and spinal 
cord, show long T2 and T1 relaxation, which can generate a very strong signal in MRI [12]. By 
contrast, in tissues with low water content where the protons are trapped in a rigid crystal 
phase, such as bone and teeth, the signal decays really quickly, resulting to a dark image with 
no discernible structured contrast (Table 1) [13, 14]. This review will focus on the tissues with 
short T2 relaxation that are commonly classified as tissue with short (i.e. T2 = 1-10 ms), 
ultrashort (i.e. T2 = 0.1-1 ms), and supershort relaxation (i.e. T2 < 0.1 ms) [15].  
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Figure 1. Schematic representation of the basic principles of MRI. In (a) protons are represented as red balls 
spinning around their own axis. When an external magnetic field B0 (orange arrow) is applied, protons tend to 
align with the direction of B0 and have only two possible orientation, spin-up and spin-down. The difference 
between the protons aligned parallel and antiparallel to B0 (blue ball) represents the protons that are responsible 
for the MRI signal. The sum of these protons can be described by a magnetization vector (M0, blue arrow). If a 
second magnetic field (B1) orthogonal to B0 is applied, it is possible to tilt M0 of 90° along the x-y direction (Mxy, 
green arrow). When B1 is switched off Mxy returns to the equilibrium through two processes: T1 and T2 
relaxation. In (b) and (c) the schematic representation T1 and T2 relaxation are shown respectively. T1 relaxation 
is defined as the time needed to achieve the 63% of the original longitudinal magnetization (d). Blue curve and 
the green curve represent tissues with short and long T1 values, respectively. T2 relaxation is defined as the time 
to dephase up to 37% of the original value (e). Blue curve and the green curve represent tissues with short and 
long T2 values, respectively. Adapted from [8] and [9]. 
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2.1. Basic principle of ultrashort echo time 
UTE refers to MRI sequences that can be used to image tissues that have a T2 shorter than 10 
ms. The basic 2D-UTE basic sequence uses two short half RF pulses and acquires data as 
soon the excitation finishes. The first half RF pulse is collected by a negative slice selection 
gradient, while for the second half RF pulse the gradient is reversed (Figure 2a) [13, 14, 16]. 
The detected data are added together to provide one line into the k-space that starts from the 
center of the k-space and proceeds radially. This process, known as radial mapping of the k-
space, is repeated through all 360°, typically in 128-512 steps (Figure 2b). The data are then 
interpolated onto a rectangular matrix, e.g. 512 x 512, and transformed into an image through 
a two-dimensional FT [17, 18].  
 
Figure 2. Schematic representation of a basic 2D UTE sequence. In (a) the pulse diagram is reported. Note that 
the half RF pulse is applied firstly with a negative and then with a positive slice selection (Gslice). When the RF 
is switched off the radial gradients Gxy are applied and the acquisition starts. The acquired data give a line in the 
k-space (b). Each spoke represents the k-space trajectories due to the readout gradients. The small dots in the 
center are sampled during the gradient ramp; the big dots are sampled while the gradient reaches the plateau. For 
a typical acquisition are used 128-512 spokes and 256-512 point each spoke. Adapted from [13]. 
 
As for the imaging of ultrashort T2 components the signal has to be acquired as soon the 
signal excitation ends, fast transmit/receiving switching coils and dedicated hardware are 
demanded to minimize the signal decay. An optimal UTE acquisition does not necessarily 
imply to use a strong B0. Still, high field strength for high signal-to-noise (SNR) is necessary 
when X-nuclei with lower signal sensitivity than 
1
H, such as phosphorous and sodium, have 
to be detected. Surely, the performance of the gradient, in terms of slew rate and amplitude, 
needs to be as high as possible, as it is necessary to ramp down the gradient really quickly 
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after the RF. Also, a high RF receiver system is demanded to quickly recover the signal 
without losing any data [18].  
Starting from conventional CSI sequences, a UTE-CSI sequence that is sensitive to 
ultrashort T2 components and that can be used for the detection of sodium and phosphorous 
nuclei has been developed. The use of a gradient with high performance (i.e. peak 40 mT/m 
and slew rate of 200 T/m/s) and a short RF pulse (i.e. 200 µs) allowed the reduction of the 
echo time (i.e. the time between the application of the RF and the acquisition of the signal in 
the coil, typically referred as TE) to 170 µs, which is much lower compared to the TE used in 
the conventional CSI (i.e. 2.3 ms). Nevertheless, only low resolution images have been 
achieved thus far [19]. 
Safety concerns, mainly about tissue heating, are limiting the possibility to use stronger 
gradients or RF [20]. Recently, Grodzki et al. [21] proposed a new method of filling the k-
space based on a combination of radial mapping and Cartesian single point acquisition, also 
known as pointwise encoding time reduction with a radial acquisition (PETRA). In this way, 
the gap in the middle of the k-space is filled with the exact value obtained from the single 
point acquisition. Therefore, every point in the k-space can be measured with the smallest 
encoding time. Afterwards, Lee et al. compared the conventional UTE sequence with the 
PETRA-based UTE method confirming the superiority of the latter approach. Currently, the 
only sequences clinically used on 3T MRI systems by UTE are based on PETRA acquisition 
[21, 22]. 
2.2. Basic principle of zero echo time 
With the ZTE technique, the encoding gradient is switched on before the RF pulse excitation, 
hence resulting in an actual zero TE. This ZTE acquisition method uses a short hard-pulse 
excitation and small flip angle, while the gradients in the three directions are gradually 
reoriented (Figure 3a). Therefore, ZTE sequences have more restrictions in flip angles and 
readout bandwidths compared to the UTE. However, the fact that the gradient does not need 
to be switched off permits, at least virtually, an acquisition without any acoustic noise. The k-
space is filled through a 3D radial center-out method and then transformed into an image by 
FT, as also is done for the UTE acquisitions. In reality, after the RF excitation, the acquisition 
starts with a delay (δ) that is determined by the time needed for the transmit/receive 
switching. This gap of information can be filled by acquisition oversampling, which is a linear 
algebra-based imaging reconstruction scheme (Figure 3b). However, large oversampling 
increases the amount of data that a computer has to process and the memory requirements [23, 
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24]. The development of the RF switching techniques and the demand for strong hardware 
that can handle the enormous amount of generated data stands as one of the technical 
challenges for the application of ZTE sequences in humans. Recently, Weiger et al. [25] 
implemented the ZTE method for imaging in humans by using a custom console, including 
the spectrometer and the pulse generator that allowed the reduction of the excitation pulse to 3 
µs and the transmit/receive switching to 471 µs. The custom-built console was based on a 
packaged analog-to-digital converter (ACD) and a field-programmable gate array (FPGA) 
combined with 1 terabyte (TB) redundant array of independent disks (RAID) for real-time 
data storage. However, a large excitation bandwidth with associated high specific absorption 
rate (SAR) and imaging artifacts were found to be the major concern [25]. A suitable solution 
to this problem was proposed by Li et al. [26] who initially combined the PETRA into the 
ZTE for the correction of imaging artifacts, allowing to operate with longer RF pulse and 
lower peak power. Furthermore, short amplitude-modulated and frequency-modulated pulses 
for high bandwidth RF excitation and long T2 suppression methods were also optimized for 
ZTE leading to significantly improved sequences suitable for clinical use [27, 28].   
 
Figure 3. Schematic representation of a basic ZTE sequence. In (a) the pulse diagram is reported. Note that the 
gradient in a given direction is ramped up and followed by and hard RF pulse. Signal acquisition starts 
immediately resulting in a TE = zero. In reality the acquisition starts after a delay (δ). The acquired data give a 
line in the k-space shown in (b). Big black dots and small empty dots represent the data points required for a 
complete projection. The small empty dots represent the points that are missed because of delay (δ). Gray dots 
indicate the additional point achieved through oversampling. Adapted from [23]. 
 
2.3. Basic principle of sweep imaging with Fourier transformation 
The SWIFT method was firstly developed by Idiyatullin et al. [29, 30] SWIFT can be 
considered as a combination of all three basic NMR techniques, i.e. continuous wave (CW), 
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pulsed, and stochastic. Specifically, SWIFT is based on a swept RF excitation, similar to CW 
NMR but with a faster rate, where the signal is acquired as the function of the time, as in the 
pulsed NMR, and extracted by using the correlation method as done in the stochastic NMR 
[31, 32]. This method leads to an MRI sequence that allows a nearly simultaneous excitation 
and acquisition scheme, hence suitable for the detection of ultrashort T2 components. The 
scheme for SWIFT uses sequences of RF pulses with a specific (Tp) duration in the order of 
milliseconds. Each pulse is divided into N segments, having the RF pulse on for a τp duration 
after a delay with the RF off. The acquisition is performed at τa after the pulse segment 
(Figure 4). In this way, the full set of frequency-encoding projections are firstly acquired and 
then reconstructed by using a 3D back-projection algorithm or gridding. The imaging process 
is then performed by using a cross-correlation method. However, this time-shared method, or 
gapped method, is limited by the time needed for the intermediate passage between each N 
segment. Such restriction compromises the SNR and resolution of the images [30]. Several 
improvements of the SWIFT sequence have been already proposed by Idiyatullin et al., such 
as a continuous SWIFT acquisition mode (cSWIFT), a multiple excitation bands approach 
(MB-SWIFT), and a gradient-modulated SWIFT (GM-SWIFT) which are able to overcome 
the hardware limitations and to reduce the SAR and the acquisition time [33-36].  
 
 
Figure 4. Schematic representation of a basic SWIFT sequence. Note that SWIFT uses sequences of RF pulses 
each of them having Tp duration in the range of milliseconds. The pulse is divided into N segments reported on 
the left of the figure. Data sampling is performed at τa time after each segment. Adapted from [31]. 
 
3. Anatomical considerations of the hard tissues 
Hard tissues comprise all the tissues that show a mineralized component in their extracellular 
matrix, such as bone and teeth. The ratio of the mineral phase is not only different for each 
tissue but can vary with age, sex, gender, and site [37]. Such tissue heterogeneity results in 
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different T2 properties according to the amount of available free water (Table 1). In the 
following paragraphs, a general overview of the specific chemical components of bone and 
teeth is provided. 
Table 1.  T1 and T2 of tissues and tissue components measured at 1.5 T  
Adapted from [13] and [14].  
Tissue T1 T2 
Blood   1441 ms 290 ms 
Gray matter                   1124 ms 95 ms 
Skeletal muscle             1008 ms 44 ms 
Heart                              1030 ms 40 ms 
White matter                   884 ms 72 ms 
Spinal cord                      745 ms 74 ms 
Kidney                             690 ms 55 ms 
Ligaments                                           - 4-10 ms 
Knee menisci                                     - 5-8 ms 
Periosteum                                     - 5-11 ms 
Cortical bone                   398 ms 0.4-0.5 ms 
Dentin                                            - 0.15 ms 
Dental enamel                                     - 70 µs 
Protons in proteins                               - 10 µs 
 
3.1. Bone 
Bone is a mineralized tissue that performs several functions in the body. Bone protects the 
vital organs, provides sites for muscle attachment to allow for motion and locomotion, 
produces the blood cells, and serves as a reservoir for several important ions (e.g. calcium, 
phosphate and others). The adult human skeleton consists of two main components: compact 
bone (~80% - also called cortical bone) and trabecular bone (~20% - also called cancellous 
or spongy bone). The ratio of cortical and trabecular bone is different depending on the 
different locations in the skeleton. As the name implies, compact bone shows a dense 
structure that is almost solid (i.e. 10% or less in porosity) and consists of parallel cylindrical 
units called osteons (or Haversian systems). Compact bone is present at the outer areas of 
long bone like femur and tibia, small bones like wrist and ankle, and flat bones like skull vault 
and other irregular bones. Trabecular bone is less dense than cortical bone, presents higher 
porosity usually between 50-90%, and is located near the ends of long and small bones and in 
between the surfaces of flat bones. The outer surface of the bone is covered by a connective 
Chapter 2 
 
31 
 
tissue, named the periosteum, which plays an important role in the skeletal development and 
bone healing (Figure 5) [38-40].  
The mineral component of the bone consists of hydroxyapatite (HA). Depending on the site, 
the mineral component of most bones represents the 60% to 70% of the total dry weight, with 
the exception of the ossicles in the ear that show up to 98% mineral content. The remaining 
component of the bone consists of an organic phase (20-30%) and water (10-15 %). The main 
component of the organic phase is collagen type I (about 90%), which is stiffened with the 
mineral phase, while non-collagenous proteins, lipids, and water are present in minor amount, 
i.e. 5%, 3%, and 2% respectively [41-43]. 
Water content into the bone is found to be in three different forms. First, water can be 
associated with the mineral phase; second water can be associated with the organic collagen 
phase; and finally there is free bulk water located in the pores of the mineral phase [44, 45]. 
Naturally, the occurrence of both freely and tightly bound water results in two major 
relaxation components, which decay at different rate. Protons associated with the mineral 
phase and the organic phase are decaying quickly (i.e. T2
 
< 11,7 µs, and T2
 
= 320 µs, 
respectively), while bulk water decays slowly (T2
 
= 2.28 ms) when measured on a 3 T MRI 
system [46-48]. 
 
 
 
Figure 5. Schematic representation of long bone 
morphology. From the outside towards the inside it is 
possible to distinguish  periosteum, cortical bone 
(that consists of osteons) and the trabecular bone. 
Note that each tissue has different T2 values 
according to his composition. T2 values reported in 
the figure are measured on a 1.5 T MRI system. 
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3.2. Teeth 
Mammalian teeth consist of four main tissues: enamel, dentin, cementum, and pulp. Enamel, 
dentin, and cementum represent three differently mineralized tissues that are tightly attached 
to each other, while the pulp is the only soft tissue of the tooth (Figure 6). The enamel is a 
highly mineralized structure (up to 96%) forming the outer shell of the crown and is 
mechanically the hardest substance in the body. The remaining 4% consists of water and other 
organic proteins called amelogenin, ameloblastins, and enamelins. The dentin is formed by 
70% mineral phase, 20% of organic phase, mainly collagen type I, and 10% water. The 
cementum is a thin layer present between dental root and the periodontium. The thickness of 
the cementum is raging from 50 to 1500 µm depending on different location and tooth. 
Cementum consists of 45-50% of HA as inorganic phase, 50-55% organic phase (mainly 
collagen type I), and for the rest of water [49-54]. Because of the very low water content 
relaxation values for dentin and enamel are very low, i.e. T2 < 1 ms and 70 µs, respectively 
(data measured on a 1.5 T system) [55].  
 
 
 
Figure 6. Schematic representation of human 
molar anatomy. From the outside to the inside 
it is possible to distinguish enamel, dentin, and 
dental pulp. T2 values reported in the figure are 
measured on a 1.5 T MRI system. Adapted 
from www.charlesfamilydental.com 
 
 
4. Ultrashort echo time sequences for bone imaging 
UTE-based MR sequences were firstly used to image human osseous tissues (e.g. periosteum, 
knee, lumbar spine, cortical bone in the tibia) by Bydder’s group [56, 57]. Aiming for a wider 
use of such sequences for clinical applications the authors tested a conventional UTE (CUTE) 
sequence as well as modified and optimized UTE sequences (see Table 2) [56]. 
Implementations of the CUTE sequence were based on two different methods: reduction of 
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the signal from long-T2 components, and on fat suppression. Reduction of long-T2 components 
can be used to increase the conspicuity of the short-T2 components in relation to normal 
tissues, while fat suppression can result in a reduction of the background signal. Based on 
these modifications of the UTE basic sequence, the authors developed a long-T2 suppression 
UTE (LUTE), a fat suppressed UTE (FUTE), short inversion time (TI) with UTE (STUTE), 
and medium TI with UTE (MUTE) (Table 2). Among them, FUTE was found to be the most 
promising as this sequence was able to show the tibial periosteum and cortex in healthy 
patients. However, the signal from the cortical bone, which was associated to the collagen 
type I and the bound water, was decreasing with the increase of the distance from the coil 
[57].  
Thereafter, through the subtraction of the images acquired by CUTE to the images acquired 
by FUTE it was possible to obtain in human volunteers high signal images of the periosteum 
and of the bone healthy condition at different locations (e.g. tibia, fibula, and spine). The 
thickness of the periosteum obtained from MRI was reported being consistent with the 
standard anatomical descriptions. Moreover, it was possible to show that the periosteum 
thickness is higher in case of patients with midtibial fracture when compared to healthy 
patients [58]. A similar approach based on the difference of images was also used to obtain a 
positive signal from the cortical bone with higher conspicuity. FUTE sequence was used to 
show callus formation in a fractured tibia of a 22-year-old male patient three weeks after the 
injury. Moreover, FUTE was able to show the difference in cortical bone density between 
healthy and osteoporotic patients. On the other hand, CUTE showed new bone formation 
occurring in 32-year-old female patients after four years from a tibia injury [59]. However, 
these modified UTE sequences were subject to susceptibility and gradient distortion artifacts. 
Du et al. combined off-resonance saturation contrast to UTE acquisition (UTE-OSC) in order 
to suppress signals from long-T2 and fat components and to create a high contrast for cortical 
bone (Table 2) [60]. Afterwards, the same authors developed an UTE spectroscopic imaging 
method (UTE) based on highly undersampled interleaved projection reconstructions with 
multiecho sequences (Table 2) [61, 62]. Through the UTESI sequence, it was possible to 
achieve high spatial resolution spectroscopic images of the cortical bone (Table 2). The 
success of this spectroscopic technique arises from three main factors: 1) a minimal TE of 8 
µs that was achieved through the combination of a variable-rate selective excitation (VERSE), 
a radial ramp selection, and a fast transmit/receive switch; 2) an interleaved variable TE UTE 
acquisition that significantly improved the spatial resolution; 3) suppression of long T2 
components from muscle and fat. The feasibility to quantify mobile proton density by 
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pursuing the UTESI approach opened a new scenario for MRI as a possible screening tool 
that could be used to detect bone disease related to bone pore size and water content changes, 
like in osteoporosis [62].  
Preclinical studies were performed on an ovariectomized rat model that resulted in estrogen 
deficient and thus osteoporotic animals. After daily subcutaneous injection of alendronate, 
which was used as inhibitor of the bone resorption, bone mineral density was measured based 
on 
31
P and 
1
H UTE MRI and compared with the assessments performed by NMR and micro 
computed tomography (µCT, i.e. gold standard bone screening tool). The outcomes of this 
study proved the feasibility to use UTE-based MRI for the assessment of the water and 
mineral content in femora of ovariectomized rat, and to relate such findings to antiresorptive 
treatments. Phosphorous densities measured through 
31
P UTE MRI showed a positive 
correlation to the values obtained through 
31
P NMR, while water content measured through 
1
H UTE MRI showed a negative correlation with the µCT-based bone density [63].  
Once the potential for bone screening by the use of UTE sequences became consolidated in 
the scientific community, further improvements of such imaging methods followed. Firstly, a 
dual adiabatic inversion recovery UTE sequence (DIR-UTE) was released and tested for 
cortical bone (Table 2). DIR-UTE was able to suppress long-T2 component and the signal 
from the surrounding fat and muscle, displaying the distal tibia of healthy volunteer with high 
contrast. However, DIR-UTE is a 2D technique, hence subject to partial-volume effect when 
tiny structures (< 0.1 mm) need to be acquired [64]. Finally, an adiabatic inversion recovery 
UTE sequence (IR-UTE) was developed. The IR-UTE provided excellent qualitative and 
quantitative depiction of the bone in vitro and in vivo, based on a robust long-T2 species 
suppression achieved through the use of the inversion recovery and a short TR (Table 2). In 
comparison with standard UTE sequence, IR-UTE provided lower SNR and higher CNR [65].  
However, despite the continuous improvements of the UTE sequences, the real translation 
towards clinical use was only possible after the introduction of the UTE-PETRA acquisition 
method, which combined radial and Cartesian filling of the k-space. Such a method was able 
to give 1 mm resolution images and high SNR with much shorter TA when compared to the 
conventional UTE, making ultrashort MRI sequences useful in orthopedic clinical 
applications (Table 2). Furthermore, UTE-PETRA was not sensitive to gradient imperfections 
and delay, and had low demand for fast gradient switching and ramping. Since its 
introduction, UTE-PETRA has been used for the imaging of knee, ankle, head and wrist in 
human patients [21, 22].  
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It is known that a deficit of bone mineral content is related to an increase in water content. 
Moreover, increase in free bulk porous water corresponds to increased bone porosity, while 
tightly-bound water is related to the mineral content. Gravimetric studies, 
1
H NMR, and three-
point bending test performed on tibiae harvested from healthy and phosphorous-deficient 
rabbits, has proven that bound water is associated with bone strength and toughness, while 
free water is associated with the elasticity modulus of bone. Therefore, mineral features, and 
thus water content, can be associated to the bone biomechanical properties, and to the risk of 
bone fractures [66]. The importance of understanding the water content in bone lead to many 
studies where UTE-based approaches were used for the detection in vivo of the bound and 
free water. Chang et al. [67] combined the UTE sequence with magnetization transfer (MT) 
imaging, an indirect method that allows the performance of a quantitative and qualitative 
assessment of protons with extremely fast relaxation. They observed that UTE-MT provided 
accurate information about cortical bone tissue properties by using a whole-body clinical 3T 
MRI scanner in only two minutes acquisition time. Specifically, the off-resonance saturation 
ratio (OSR) measured through UTE-MT on human cadaveric femora and tibia correlates with 
the bone porosity measured via µCT and the mechanical properties, such as Young’s modulus 
and yield stress, measured through a four-point bending test. This study showed a moderate 
negative correlation between the OSR and the cortical porosity (R
2
 = 0.51), and a positive 
correlation between OSR and both Young’s modulus (R2 = 0.12) and yield stress (R2 = 0.30). 
Although the correlation of the OSR and mechanical properties was low, UTE-MT appeared 
to be superior to the conventional UTE as it was able to detect the tightly-bound water 
components of the mineral bone phase on a clinical scanner [67]. Horch et al. [68] associated 
a preexisting UTE pulses with a double adiabatic full passage (DAFP) sequence and an 
adiabatic inversion recovery (AIR) for the detection of the pore and bound water, 
respectively. These sequences were used to acquire human cadaveric femora on a 4.7 T 
system. The estimated water content was correlated to the mechanical properties, such as 
Young’s modulus, yield stress, peak stress, and toughness to failure measured through three-
point bending tests. Pearson’s correlation values between DAFP- and AIR-UTE and the 
various mechanical properties were ranging between 0.35 and 0.69, hence providing the 
proof-of-concept that this UTE based strategy can be used for the prediction of bone fractures 
[68]. Afterwards, the same authors translated in vivo the DAFP and AIR UTE protocols for 
the quantitative mapping of bound and porous water in radius and tibia of six healthy 
volunteers on a 3 T MRI clinical system. The outcomes of the study showed that the bound 
water concentration was approximately 28 and 35 mol 
1
H/liter of bone, while the porous 
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water was 7 and 6 mol 
1
H/liter of bone, for tibia and radius, respectively. These findings 
corroborated with the values reported in previous observations in femoral specimens [69]. 
Recently, few more UTE-based methods to detect water content in vivo with more accuracy 
and precision have been proposed, such as IR-UTE, 3D IR-UTE, UTE sequence associated 
with a numerical-based algorithm [70-72]. However, the correlation of these methodologies 
with the mechanical properties remains unexplored. Furthermore, water molecules bound to 
the collagen matrix or to the crystal phase are decaying really fast (< 10 µs) and their 
detection is still challenging even by using the most advanced UTE sequence. 
The feasibility to use 3D UTE-MRI for the quantification of the mandibular condyle 
morphology, which is indicative of degenerative joint diseases, was investigated on human 
cadaveric specimens and compared with measurements performed via µCT. UTE-MRI was 
able to show the contour of the condyle cortical bone and the associated cartilage, which was 
not visible on µCT acquisitions. MRI resulted to give accurate information, with an isotropic 
voxel size of 100 µm, about joint surface curvature, incongruity, as well as on cartilage 
thickness [73]. In 2014, Serai et al. [74] proved the technical pediatric feasibility of 
musculoskeletal MRI using UTE sequences in a clinical 1.5 T system with less than 5 min 
TA, supporting its beneficial use for the evaluation of bone pathology, such as irregular 
ossification at the weight-bearing site of the femoral condyle.  
As HA is the main component of bone, MRI imaging based on 
31
P detection gained 
attention to obtain information about the bone mineral density. However, 
31
P-MR imaging of 
cortical bone is challenged by the fact that T2
*
 of the cortical bone is very short (i.e. 179 µs at 
1.5 T) and the T1 is very long (i.e. 10.1 s ant 1.5 T). The first UTE MRI of 
31
P was performed 
in 2004 by Robson et al. [75] on seven healthy patients. The authors reported a 
31
P-based 
image of the tibial cortical bone with pixel dimension of 0.3 mm that corresponded to 2.9 mm 
true resolution. T2
* 
and T1 for the cortical bone were measured and resulted to be 207 ± 12 µs 
and 8.6 ± 3.0 s, respectively. Trabecular bone 
31
P-based visualization was achieved as well, 
although with a reduced SNR due to the lower 
31
P concentration per unit [75]. Afterwards, a 
31
P quadrature low-pass birdcage coil, which was able to provide 10 µs hard pulses for a 10° 
flip angle, was build and tested to image human wrist on a 3 T clinical system. The delay of 
transmit/receive switch was implemented through technical modifications of the circuit diode 
that lead to a switching speed in the order of nanoseconds. In this way, 3D 
31
P-based images 
of the human wrist with a resolution of 3.5 mm and with improved SNR were achieved in 37 
min acquisition time [76].  
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5. Zero echo time (ZTE) sequences for bone imaging 
Simultaneously with the development of UTE methods, ZTE sequences were also tested and 
improved for the MR imaging of bone. The first implementation of ZTE methods for humans 
was described in 2013 by Weiger et al. (Table 2 and paragraph 2.2) [25]. The authors reported 
the first 3D ZTE images of the human head, wrist, knee, and ankle on a 7 T human whole-
body MRI system. The acquired images showed fine anatomical details with a well delineated 
bone-tissue interface, high SNR, and isotropic spatial resolution of 0.83 mm [25]. Also, these 
authors proved the feasibility of ZTE sequences to image trabecular microstructures in bovine 
bone samples, by comparing the µMRI images with the µCT acquisitions. By using imaging 
resolutions of 56 µm and 14.8 µm, respectively for the µMRI and µCT acquisitions, the 
trabecular micro-architecture was shown with excellent agreement on both modalities. 
Furthermore, the assessment of the bone volume fraction resulted in similar values, i.e. 0.34 
and 0.36, for both µMRI and µCT [77]. However, because of the nonuniformity of the B1, 
smooth intensity variations were observed in the head. This limitation was overcome by a 
combination of ZTE and a rotating ultrafast imaging sequence (RUFIS), which consisted of a 
nonselective hard pulse excitation followed by a 3D center-out radial sampling (Table 2). 
Image acquisition was started immediately at full speed leading to a nominal TE equal to 
zero. Furthermore, by using minimal gradient switching in between repetitions and short RF 
pulses, a robust and fast method with more efficient SNR was achieved. Such ZTE-based 
method provided high-resolution pictures of the cranium, facial skeleton, and cervical 
vertebrae of human volunteers. MRI acquisitions depicted anatomical details equivalent to the 
CT acquisitions obtained through a PET/CT scanner [78].  
Similarly, to what was done for the UTE sequence, ZTE was associated to a PETRA 
acquisition method for the correction of the imaging artifacts within the current limits of the 
clinical scanner hardware (Table 2) [26]. Afterward, ZTE was associated with a MT method 
and tested for the assessment of the cortical bone composition in mice on a 4.7 T system 
(Table 2). Relaxation time properties of the femoral diaphysis were based on MT-ZTE and 
reported higher values when compared to previous studies. Specifically, T1, T2, and T2
* 
resulted to be 1107 ± 203 ms, 12.5 ± 2.0 µs, and 563 ± 75 µs, respectively. These differences 
were not only ascribed to a difference in magnetic field strength when compared to other 
studies, but also to the higher sensitivity of the MT-based approach [79].  
Assessment of the mineral bone composition was also assessed through a 
31
P-ZTE-PETRA 
acquisition of human cadaveric tibia specimens. The mean of the bone mineral 
31
P content 
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was 6.7 ± 1.2 mol/l, and the values were positively correlated to the bone density measured by 
µCT (R
2
 = 0.46). Furthermore, 
31
P T1 relaxation time assessments showed a positive 
correlation with the bone density measured via µCT (R
2
 = 0.62) and a negative correlation 
with the porosity (R
2 
= 0.45) calculated from the water content. Based on these data, the 
authors proved that a decrease in 
31
P T1 is associated with an increase in bone porosity. These 
findings can be explained by the fact that an increase in porosity results in a loss of minerals 
from the bone matrix. Therefore, the remaining 
31
P nucleus can interact with a greater number 
of protons that results in a reduction of the 
31
P T1 value [80]. Recently, the same 
31
P-ZTE-
PETRA method was used to acquire in vivo the tibia of healthy volunteers. Bone mineral 
content estimated through 
31
P-MRI showed a strong positive correlation with bone mineral 
content assessed through high-resolution peripheral quantitative CT (R
2
 = 0.96) [81].  
Larson et al. compared UTE and ZTE methods in vivo on a 7 T system [82]. After MRI 
acquisition of the bone in the brain, ankle, and knee of human volunteers the results dealing 
with the imaging quality, resolution capabilities, and off-resonance sensitivity were compared 
to each other. This study showed no differences in resolution capabilities and comparable 
image contrast and SNR for both UTE and ZTE sequence. Only subtle differences were found 
in the off-resonance response, due to the difference in k-space sampling for the two MRI 
techniques. ZTE acquisitions showed increased blurring around the skull, as well as signal 
dropout artifacts in proximity of the edge of the field of view, while UTE showed more 
flexibility in imaging volume selection resulting more adequate for clinical applications [82]. 
 
Table 2. Ultrashort MRI sequences for bone 
Name of the sequence 
 
MRI settings 
 
CUTE (Conventional UTE) 
 
 
 
 
 
FUTE (Fat-suppressed UTE) 
 
 
 
 
 
STUTE (Short inversion time UTE) 
 
 
 
 
 
 
FOV = 26 – 38 cm, section thickness = 4 – 8 mm  
TR = 500 ms, TE = 80 µs 
Second TE = 2.87, 5.66, 11.08, 17.70 ms 
RF pulse = 0.4 – 0.6 ms, FA = 30°– 80° 
TA = 8.5 – 17 min. [56, 57] 
 
FOV = 26 – 38 cm, section thickness = 4 – 8 mm  
TR = 500 ms, TE = 80 µs 
Second TE = 2.87, 5.66, 11.08, 17.70 ms  
RF pulse = 10 ms, FA = 30°– 80° 
TA = 8.5 – 17 min. [56, 57] 
 
FOV = 26 – 38 cm, section thickness =  4 – 8 mm  
TR = 2200 ms, TE = 80 µs 
Second TE = 2.87, 5.66, 11.08, 17.70 ms 
RF pulse = 0.4 – 0.6 ms, FA = 45° or 80° 
Inversion pulse = 4 ms, TI = 360 or 380 ms 
TA = 8.5 – 17 min. [56, 57] 
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MUTE (Medium inversion time UTE) 
 
 
 
 
 
 
UTE-OSC 
(Off-resonance saturation contrast UTE) 
 
 
 
 
 
UTESI (UTE spectroscopy imaging) 
 
 
 
 
 
 
 
DIR-UTE (UTE with dual inversion-
recovery) 
FOV = 26 – 38 cm,  section thickness =  4 – 8 mm,  
TR = 2500 ms, TE = 80 µs 
Second TE = 2.87, 5.66, 11.08, 17.70 ms 
RF pulse = 0.4 – 0.6 ms, FA = 45° or 80° 
Inversion pulse = 4 ms, TI = 750 ms 
TA = 8.5 – 17 min. [56, 57] 
 
FOV = 10 cm, section thickness =  2 – 3 mm 
Gradient amplitude = 40 mT/m 
Slew rate = 150 mT/m/ms, Bandwidth = 62.5 kHz 
TR = 200 – 300 ms, TE = 8 µs 
Fermi pulse = 16 ms/ Hard pulse = 10 ms 
TA = 4 – 10 min [60] 
 
FOV = 10 cm, section thickness = 8 mm 
Gradient amplitude = 40 mT/m 
Slew rate = 150 mT/m/ms, Bandwidth = 62.5 kHz 
TR = 75 ms, TE = 8 µs, Second TE = 80 µs, 
FA = 60°, RF pulse = 90° x 8 ms 
Spatial resolution = 0.78 x 0.78 mm
2
  
TA = 5 min. [62] 
 
FOV = 10 cm, section thickness = 2 mm  
TR = 300 ms, TE = 8 µs 
Number of projections = 51, bandwidth = 62.4 kHz 
TA = ~ 5 min. [64]  
 
IR-UTE (inversion recovery UTE) 
 
 
 
 
 
 
 
UTE-PETRA (UTE-pointwise encoding 
time reduction with radial acquisition) 
 
 
 
 
 
 
MT-UTE (magnetization transfer UTE) 
 
 
 
 
 
 
 
ZTE 
 
 
 
 
 
 
 
 
 
FOV = 10 cm, section thickness = 6 mm 
Gradient amplitude = 40 mT/m 
Slew rate = 150 mT/m/ms, Bandwidth = 125 kHz 
TR = 300 ms, TE = 8 µs 
Second TE = 4400 µs, TI = 80, 100, 120, 140, 160 ms 
FA = 60°, Spatial resolution = 0.2 x 0.2 x 6 mm
3
 TA = 9 min. 
[65] 
 
FOV = 200 mm, section thickness = 22 mm 
Gradient amplitude = 8 – 15 mT/m 
Slew rate = 100 mT/m/ms, Bandwidth = 86 kHz 
TR = 2 – 5 ms, TE = 70 – 50 µs 
Second TE = 4.6 ms, FA = 4° – 9°  
Spatial resolution = 1.3 – 1.04 mm 
TA = 5 – 10 min. [21] 
 
FOV = 4 mm, slice thickness = 3 mm 
Gradient amplitude = 40 mT/m 
Slew rate = 150 mT/m/s, Bandwidth = 62.5 kHz 
TR = 100 ms, TE = 8 µs, FA = 60°,  
Spatial resolution = 1.35 x 1.35 x 1.35 mm
3
 
MT = Fermi pulse 8 ms, Spectral bandwidth = 0.8 kHz  
TA = 12 min. [67] 
 
FOV = 530 – 240 mm, slice thickness = 2 – 3 mm 
Gradient amplitude = 22.2 – 24.5 mT/m  
Slew rate = 200 mT/m/ms, Bandwidth = 500 – 250 kHz 
TR = 471 – 793 ms, TE = 0 
FA = 2.2°, RF hard pulse = 3 µs 
Isotropic spatial resolution = 1.66 – 0.83 mm  
TA = 2.31 – 3.12 min. [25] 
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ZTE-RUFIS (rotating ultrafast imaging 
sequence) 
 
 
 
 
ZTE-PETRA (ZTE-pointwise encoding 
time reduction with radial acquisition) 
 
                                                           
                                                                  
MT-ZTE (magnetization transfer ZTE)                       
                                                                        
 
 
 
 
 
FOV = 220 – 260 mm 
TR = 10 ms, TE = 0 
FA = 1.2°, Bandwidth = 62.5 kHz  
Isotropic spatial resolution = 1.35 – 0.85 mm3 
TA = 2.53 –  6.12 min. [78]  
 
TR = 10 ms, TE = 85 µs 
FA = 5°, RF pulse = 20 µs 
Spatial resolution = 1.17 x 1.17 x 1.17 mm
3
 
Bandwidth = 62.6 kHz (= 5 µs dwell time) [26]    
 
FOV = 45 mm, Isotropic spatial resolution = 0.35 mm
3
 
Gradient amplitude = 370 mT/m  
Slew rate = 3375 T/m/ms, Bandwidth = 178 kHz 
TR = 1 ms, TE = 0 µs, FA = 3.7°,  
MT = Gaussian pulse 10 ms,  
TA = 3.16 min. [79]   
  
 
6. Ultrashort MR sequences imaging of teeth 
Dental tissues show the shortest relaxation profile of any tissue, and therefore their imaging 
represents the toughest challenge in MRI. Still, the use of MRI in dentistry is continuously 
increasing. The first UTE-MR image of teeth was shown by Boujraf et al. in 2009 [83]. 
Human volunteers were scanned using a whole-body 3 T system with a total scanning time of 
10 min. The sagittal slice of the jaw acquired by using UTE sequences with TE = 50 µs 
provided a clear view of all the dental structures including enamel (Table 3). Subsequently, 
Bracher et al. [84, 85] imaged not only teeth by using 3D-UTE but also estimated and 
correlated T2 values with the presence of dental caries. The mineral breakdown caused by 
caries was found to lead to a gradual increase in T2 value depending on the extension of the 
lesion, therefore suggesting UTE based MRI as a feasible screening tool for the early 
detection of dental caries. Idiyatullin et al. [86] proposed a SWIFT sequence, which was able 
to give simultaneous acquisition in vivo of both soft and hard dental tissues with high 
resolution and short acquisition time (Table 3). SWIFT-MRI acquisitions were performed 
with a 4 T system and with a custom-made one-side shielded coil, which was located between 
the cheek and the teeth. The shielded coil minimized the signal from the surrounding soft 
tissue. To reduce artifacts associated with the patient motion, “rigid body” motions were also 
achieved by comparing 16 low resolution images. High-resolution ZTE images of extracted 
teeth (i.e. incisors, canine, molars, and wisdom teeth) was made ex vivo using an 11.7 T MRI 
system. Teeth showed various dental caries and dental fillers, including amalgam and ceramic 
materials. Three-dimensional ZTE images with 148x148x188 µm resolution were acquired in 
6.55 min and compared with UTE-MRI and µCT acquisitions. ZTE-based MRI indicated 
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slight differences in dentin composition that were only barely or not recognizable at all by 
µCT. Furthermore, ZTE-MRI showed signal variation around the pulp, which was not visible 
in µCT. Dental fillings presented imaging artifacts in both modalities depending on their 
composition. In case of amalgam filling, which was used in a molar after endodontic 
treatment, a strong beam-hardening artifact was compromising the µCT image, while in ZTE 
images the artifact was reduced and confined to the filling location, which allowed better 
diagnosis. A strong blurring artifact was observed in the ZTE acquisition of a molar treated 
with an unknown filling. Despite the strong imaging artifact, local signal changes in the 
enamel and dentin were still detectable. However, µCT was superior to the ZTE-MRI and 
showed better signal from the enamel and the calculus as present on the tooth surface. UTE- 
and ZTE-based images were comparable, still ZTE was showing a better contrast of both 
dentin and enamel. These findings were confirmed by the quantification of the SNR for each 
imaging modalities [87, 88]. 
Information about the mineral density of the teeth and of their major component (i.e. HA) 
was obtained by quantification of the phosphorous content. Extracted human molars were 
scanned on a 9.4 T system with a home-build double resonance (
31
P and 
1
H) probe through a 
31
P-SWIFT and 
31
P-ZTE sequence. These methods provided 
31
P-based images, which made it 
possible to distinguish the enamel from the dentin structures with a resolution of 0.5 mm. 
When comparing the two MRI methods, the 
31
P MRI images obtained through 
31
P-ZTR 
showed better SNR (>28 %) with respect to 
31
P-SWIFT [89].  
However, the lack of coils and powerful gradient in a whole-body MRI system is hampering 
the translation of ZTE sequences in the clinic. Furthermore, ZTE sequences have to be 
optimized also for their use on 3 T and 7 T MRI systems [90]. An intraoral MRI coil that can 
be placed between the maxillary and mandibular teeth has recently been proposed by 
Idiyatullin et al. [91]. The coil consisted of a single loop of 10 mm width covered with sticky 
foam and suitable to fit in the adult maxillary arch. Such a coil was used for MRI acquisition 
of a human volunteer with a 4 T MRI scanner through a 3D radial SWIFT sequence. The 
intraoral coil showed high SNR and spatial resolution (0.3 mm
3
) compared to an extraoral 
coil. However, the main limitation of the intraoral coil was the lower SNR in proximity of the 
cusps of the teeth [91]. Ludwig et al. [92] developed a wireless inductively-coupled intraoral 
coil consisting of two coaxial loops of 1.5 and 2 cm diameter covered with a dental resin and 
adapted to the human mouth anatomy by a home-made dental cast. The coil was used firstly 
ex vivo on a porcine mandible and then in vivo in a human volunteer using a 3 T MRI system. 
However, instead of an ultrashort TE sequence, a high-resolution 3D-FLASH was used for the 
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images acquisitions. The coil showed improved SNR when compared to other dental coils 
described in the literature, and displayed relevant anatomical details with an isotropic voxel 
size of 350 µm. The authors suggested the optimization and combination of the coil with 
ultrashort echo time sequences for further improvement of the image quality [92].  
 
Table 3. Ultrashort MRI sequences dental tissues 
 
7. Ultrashort MR sequences for hard tissue substitutes and biomaterials 
The development of MRI sequences that can detect really sort T2 components, widens the use 
of MRI also to the imaging of artificial materials, as used in orthopedic and dental 
applications, like bone fillers and restorative materials [93]. Materials that are used for bone 
and dental application can be distinguished based on their degradation properties in 
degradable and non-degradable materials. Degradable materials, such as ceramics and certain 
polymers, have the property to be removed from the body through in vivo degradation, while 
non-degradable materials, such as metals and resins, are biologically compatible but mostly 
need to be removed from the body with an additional operation (e.g. metallic fracture 
stabilization plate) or left in situ (e.g. permanent dental fillers) [94, 95].  
In 2011 Springer et al. [96] proposed a modified Ernst equation and variable flip-angle 
method combined with a 3D-UTE sequence to visualize polymeric materials with a 3 T 
whole-body MRI scanner. The variable flip-angle method allowed for the T1 quantification of 
the polymeric material within a reduced acquisition time. Although the exact material 
composition was not described, the authors were able to estimate its relaxation properties, i.e. 
Name of the sequence 
 
MRI settings 
 
First UTE in teeth  
 
 
 
 
 
 
SWITF 
 
 
 
 
High resolution ZTE 
 
 
FOV = 80 mm
3
 
Gradient amplitude = 40 mT/m  
Slew rate = 200 T/m/ms, Bandwidth = 357 kHz 
TR = 9.4 ms, TE = 50 µs  
Isotropic spatial resolution = 250 µm
3
 
FA = 10°, TA = 10 min. [83] 
 
FOV = 110 mm, TR = 2.5 ms  
Isotropic spatial resolution = 430 µm
3
 
RF pulse = 2 ms, Bandwidth = 62 kHz 
FA = 8°, TA = 10 min. [86] 
 
FOV = 1.9 x 1.9 x 2.4 mm  
TR = 1.0 ms, TE = 0, FA = 3° 
Isotropic spatial resolution = 148 x 148 x 188 µm 
Bandwidth = 200 kHz 
RF pulse = 1 µs, T/R switching = 4.5 µs 
TA = 6.55 min. [87] 
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T1 = 223.1 ms and T2
*
 = 0.295 ms [96]. Dental restoration materials, such as amalgam and 
ceramic inlays, inserted in human molars could be imaged through high-resolution ZTE [87]. 
Grosse et al. [97] used a 3D-UTE sequence with specific optimized parameters to image 
several of the most common dental restoration materials, such as methacrylate resins 
(DETAX, Ettlingen, Germany), 2,2 bis [4-(2-hydroxy-3-methacryloyloxypropoxy)-phenyl] 
propane (VOCO, Hamburg, Germany), methacrylate-based cement (MAGNEDENTAL, 
Büdingen, Germany), zinc phosphate cement (Harvard Dental International, Hoppegarten, 
Germany), etc.. A great variety of dental restoration materials was visible using UTE-MRI, 
and for all these materials the relaxation profiles were quantified (Table 4). The reported T1 
and T2 values of each dental restoration material now are available for further optimization of 
MRI sequences [97].  
           Table 4.  T1 and T2
*
 of most common dental fillers measured at 3 T.  
#
 means T2
*
 measure at 1.5 T, 
†
 measured on a 11.7T.  Adapted from [13], [97-99] 
Material T1 T2
*
 
Methacrylate resins 207 ms 235 µs 
Triethylene glycol dimethacrylate 28 ms 180 µs 
Methacrylate-based cement 214 ms 106 µs 
Zinc phosphate cement                           30 ms 40 µs 
2,2 bis [4-(2-hydroxy-3-
methacryloyloxypropoxy)-phenyl] 
              
159 ms 96 µs 
Urethandimethacrylat 227 ms 337 µs 
Eugenol-free Polycyarboxylate-based 
Cement 
 
190 ms 113 µs 
Hydroethyl dimethacrylate 295 ms 178 µs 
Resin-reinforced, chemically curing  
glaspolyalkenoate cement 
 
153 ms 600 µs 
Hydroxyapatite - ~ 1 µs
#
 
CPC compositions 520-1000 ms
†
 270-450 µs
†
 
 
Biodegradable calcium phosphate-based (CPC) compositions have also been imaged by 
MRI. Sun et al. [98] investigated the MRI visual properties of a specific injectable CPC 
composition consisting of a mix of 68% alpha-tricalcium phosphate (α-TCP), 8% dicalcium 
phosphate dehydrate, 4% HA, and 20% poly(lactic-co-glycolic acid) (PLGA). The CPC was 
first injected in vitro in a cylindrical defect created in bone blocks and subsequently implanted 
in vivo in cylindrical defects made in rat femora. The assessments were performed on an 11.7 
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T scanner with both UTE and ZTE sequence. Relaxation estimation for the CPC composition 
based on a 3D-UTE sequence showed a T2
* 
equal to 442 µs. This value was very close to the 
T2
* 
relaxation of the pig cortical bone (i.e. 597 µs), resulting in a similar MRI signal with both 
UTE and ZTE acquisition. This similarity in relaxation profiles hampered the identification of 
the CPC after implantation either in vitro or in vivo, which makes the use of MRI contrast 
agents the only solution for the enhancement of the CPC signal [98]. For example, Ventura et 
al. [99] combined already CPC with a dedicated dual contrast agent (DCA) that consisted of 
superparamagnetic iron oxide (SPIO) particles with a mean size of 200 nm, and gold 
nanoparticles (AuNPs) with a mean size of 4 nm as MRI and CT contrast agent, respectively. 
In vivo imaging by ZTE-MRI and CT of the CPC-DCA material after installation in rat 
femoral defects, revealed that ZTE-MRI allowed the identification of the implanted CPC until 
8 weeks post-implantation, while the CT contrast of the CPC was lost 4 week after 
implantation. However, because of the strong susceptibility properties of the SPIO particles, a 
strong imaging artifact (i.e. blooming effect) was observed on the ZTE-MRI acquisitions. 
Although such a blooming effect leads to an easy identification and localization of the 
implanted CPC, it hampers proper analysis of the material [99]. The use of different type of 
MRI contrast agents is a possible solution to imaging artifact-related drawbacks. Therefore, 
CPC was combined with a fluorine-based MRI contrast agent (i.e. perfluoro-15-crown-5-
ether) and gold nanoparticles, respectively for 
19
F-MRI and CT imaging [100]. Fluorine-based 
ZTE-MRI of the labeled CPC implanted in rat femora permitted the fine visualization of the 
CPC shape and made it possible to follow the material degradation longitudinally and to 
compare such findings with the CT images [100]. 
Another CPC composition, consisting of 59.1% α-TCP, 1,5% carboxymethylcellulose 
(CMC), and 39.4% cryo-grinded PLGA, was used as dental pulp capping agent in extracted 
human molars. The specimens were scanned on an 11.7 T scanner through a 3D-UTE and 
ZTE sequence. This specific CPC reported a T2
* 
equal to 273 µs, which was lower than the 
T2
* 
from human dentin (i.e. T2
* 
= 476 µs). Therefore, such a CPC can be distinguished from 
dentin on the ZTE acquisition (Figure 7). Also, the authors investigated the possibility to use 
MRI to follow CPC degradation after in vivo implantation in goat incisors. Relaxation studies 
were performed on the CPC before and after 7 weeks implantation. A lower T1 value was 
found for the CPC composition after the implantation in vivo, i.e. 742 ms versus 1008 ms after 
and before the in vivo study, respectively. These results suggested the feasibility to use the 
relaxation properties of the CPC to follow its degradation in vivo [101].  
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Figure 7. ZTE-based MR image of human lower 
wisdom molar, which underwent pulp capping 
treatment with CPC. The following setting were 
used for the acquisition: TR=2 ms, TE=0, FA=3°, 
FOV=4cm, Matrix = 256x256x256, TA=13.46 min. 
Blue arrow indicates the applied CPC, while green 
arrow indicates glass ionomer restoration material. 
Image provided by the authors 
 
8. Conclusions 
Currently, MRI sequences for the imaging of hard tissue (e.g. bone and teeth) and of 
biomaterials used for restoration of such tissues are becoming more and more advanced. The 
huge potential of ultrashort TE MRI is evident, not only for the morphological high-resolution 
3D reconstruction of bone and dental structures, but also for the early detection of bone 
diseases. By using ultrashort TE MRI it is possible to obtain information about the status of a 
pathological condition. Moreover, MRI is considered a very promising screening tool in 
dentistry not only because of the lack of radiation, but also because of the simultaneous 
multiplanar imaging of soft and hard tissue, the lack of artifacts generated by the presence of 
dental restoration materials fillers, as well as the ability to detect demineralization and dental 
caries [102].  
However, many challenges still need to be solved before such MRI methods will be 
accessible to a wider patient population. While issues with hardware systems and fast 
transmit/receive switches can be solved in a relatively easy way, the need for high gradient 
performance remains still a challenge. Furthermore, the requirement of appropriate software, 
which allows for qualitative and quantitative analysis, also needs to be taken into account, as 
not all the MRI companies are updated with these recently developed sequences [16]. Finally, 
the extensive costs for MRI machines and their maintenance still hamper a global spreading 
of such imaging tools, especially in dentistry. The development of a relatively “cheap” MRI 
system is necessary. This review reported many studies that can be used as a proof-of-concept 
for the translation of MRI to dentistry. Therefore, the next step will be the refinement of the 
MR IMAGING OF HARD TISSUES 
46 
 
available technologies to make them suitable for dental applications, while the use of short-
bore systems and of low magnetic fields relying on the pre-polarization MRI concept can be 
suggested as a possible solution to reduce the manufacturing costs [103, 104]. 
In summary, ultrashort TE sequences represent an applicable MRI tool that allows 
quantitative and qualitative assessment of bone, teeth and solid-like biomaterials. Their 
clinical translation is an ongoing occurring process especially in the orthopedic field, while 
still many efforts have to be made in dental MR imaging. The use of biomaterials for bone 
and dental repair is well established in the clinic, which warrants the investigation of MRI 
sequences for their screening.  
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1. Introduction 
For non-invasive imaging at high spatial resolution of hard tissues, such as bone and teeth, 
magnetic resonance imaging (MRI) is an attractive technique compared to X-ray or computer 
tomography (CT), as it does not make use of ionizing radiation, offers different options for 
contrast and simultaneously can provide information of soft tissues [1-3]. Due to the limited 
water content in these tissues and the very short T2
*
 of their protons [3-8], only sequences 
sensitive to ultra-short T2
*
 relaxation can be used to acquire images at high signal-to-noise 
ratio (SNR), such as ultra-short echo time (UTE), zero echo time (ZTE) or sweep imaging 
with Fourier Transform (SWIFT) [9-12]. These sequences have been applied in bone imaging 
for qualitative and quantitative analysis of cortical bone and direct depiction of bone 
microstructure [13,14]. Also, they have been applied in dental imaging to identify different 
tooth components,
 
including the detection of caries lesions [3,15,16].   
Calcium phosphate cement (CPC) is an injectable, biocompatible and biodegradable 
material with a high similarity to hard tissues and therefore commonly used for bone or tooth 
restoration [17-23]. To monitor CPC and its degradation in bone longitudinally, different 
imaging techniques like CT and MRI have been used, but none has been applied to CPC in 
teeth yet. Previously, we did not find differences in the MR relaxation properties between a 
CPC material and bone, necessitating the use of contrast agents for MR visualization of the 
CPC [24-26].           
In this study, we aimed to examine the potential of ZTE MR imaging at high field to 
visualize a new CPC formulation for dental restorations that is designed for hard tissue 
formation with fast bio-degradation [27]. It is unknown if this CPC formulation has relaxation 
properties by which it can be distinguished by MRI from the surrounding dental components 
enamel and dentin after implantation in human teeth. Therefore, we first determined the T1 
and T2
*
 relaxation times of this new CPC material and of enamel and dentin, to optimize MR 
measurement parameters for the best image contrast of CPC in restored human teeth. As we 
encountered non-exponential T2
*
 decay, we applied the recently proposed Gaussian 
augmentation of mono-exponential (GAME) decay model for fitting T2
* 
[28]. This model 
assumes a Gaussian rather than a Lorentzian intra-voxel frequency distribution, and provides 
both T2
*
 and T2 values. Subsequently, we tested if the relaxation optimized ZTE sequence 
could be used to assess the in vivo degradation of CPC in dental tissues. For this purpose CPC 
material was implanted into freshly extracted goat teeth, and into teeth of goats in vivo, which 
were extracted after seven weeks. Of the CPC implanted in vivo in the latter teeth, the MRI 
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properties, including T1 and T2
*
 values, were estimated and compared with those of CPC 
implanted in the freshly extracted goat teeth.   
2. Materials and Methods 
2.1. CPC preparation  
The calcium phosphate cement investigated in this study consisted of 59.1 weight percentage 
(wt%) alpha-tricalcium phosphate, 1.5 wt% carboxymethylcellulose (CAM bioceramics, 
Leiden, The Netherlands) and 39.4 wt% cryo-grinded poly-lactic-co-glycolic acid particles 
(PURASOB 5002A, Purac, Gorinchem, the Netherlands). The CPC powder was mixed in a 2 
ml end-closed syringe and sterilized by 25 KGy of gamma irradiation (isotron B.V., Ede, The 
Netherlands).  
All CPC materials were prepared by an experienced researcher who had received an 
extensive training in CPC preparation. To minimize the material variability all CPC materials 
applied in human and goat teeth were selected from the same batch. 
2.2. Human teeth  
Three extracted human teeth (molars) were applied for CPC implantation. They were selected 
as waste tissues and disconnected from any subject-indentifying data to allow their use 
exempt under the institutional review board. A vertical hole (diameter: 3 mm; length: 3 mm) 
was drilled in the occlusal surface of each tooth by using a dental drill, and filled with CPC 
paste (~20 mm
3
) which was obtained after mixing the powder with a sodium phosphate based 
setting solution (4% NaH2PO4•2H2O). The teeth were then separately stored in three 15 ml 
falcon tubes, embedded in 5% gelatin type A (Sigma Aldrich, Saint Louis, USA). The applied 
gelatin solution prevented the teeth from drying out and also allowed for an easy localization 
of these samples on gradient-echo “localizer” images at the beginning of each MR 
experiment. 
2.3.  Goat teeth 
Three healthy 1.5 years old Habsi male goats (weight: 40-50 kg) were included in this study. 
All in vivo experiments were performed after the animal protocol was approved (approval 
number: FR0263) by the animal ethical committee of King Saud University, College of 
Dentistry Research Center, Riyadh, Saudi Arabia. National guidelines for care and use of 
laboratory animals were obeyed. 
All dental operations were performed under general anesthesia and sterile conditions. An 
intramuscular injection of ketamine hydrochloride (5 mg/kg) and diazepam (1 mg/kg) was 
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used to sedate the animals before the operations. To reduce the risk of perioperative infection, 
the goats received antibiotics pre-operatively (10 mg/kg intravenously; Amoxicillin®, 
Centrafarm, Etten-Leur, The Netherlands), and post-operatively at days 1 and 3 (50 mg/kg 
intramuscularly; Albipen®, Intervet BV, Boxmeer, The Netherlands). The analgesic 
Finadyne® (1 mg/kg, three times a day, Intervet BV, Boxmeer, The Netherlands) was 
administered for two days after the operation.  
In total six teeth (lower incisors) were randomly selected from the goats for dental surgery 
involving CPC implantation. Three of these were subjected to this implantation after they 
were extracted from the animals. Because of the size difference between human molars and 
goat incisors, CPC material was implanted into smaller defects in goat teeth. A small 
cylindrical hole (diameter: 1 mm; length: 2 mm) was drilled on the labial surface of each 
tooth by a dental drill and immediately filled with the above mentioned CPC paste (~1.5 
mm
3
), which are further denoted to be obtained at time point (TP) 1. The other three incisors 
were subjected to the same dental procedure but applied in vivo. At seven-week post-surgery, 
they were extracted from the goats for ex vivo MRI experiments (TP2). All goats were 
euthanized by an overdose of Nembuta® (Apharmo, Arnhem, The Netherlands). Each goat 
tooth was stored in a 15 ml falcon tube, embedded also in 5% gelatin type A (Sigma Aldrich, 
Saint Louis, USA). 
2.4.  MRI measurement 
A 3D UTE sequence was used to investigate the MR relaxation properties and a ZTE 
sequence for imaging of the CPC restored teeth. While both sequences are able to detect 
tissues with very short transverse relaxation times at high SNR, their respective intrinsic 
features make them suitable for different purposes [13-16]. The selection of TE values in UTE 
enables to acquire images with T2
*
 contrast and also to suppress signals from materials with 
extremely fast decay like components of the RF coil. Moreover, UTE images at serial TEs can 
be used to evaluate the (very) short T2
*
 relaxation times of (semi-)solid tissues. For ZTE, the 
zero echo time results in images with higher SNR relative to the UTE images obtained at 
finite echo time. Additionally, the constant encoding gradients with maximal strength in ZTE, 
compared to the ones in UTE in which the maximum value is reached after the gradient ramp, 
allows faster k-space filling, resulting in images with higher resolution and less influence 
from local susceptibility gradients [15].         
MRI measurements were performed on an 11.7T MR-system (BioSpec, Bruker, Germany) 
using a quadrature proton (
1
H) volume coil (Bruker, Germany) with 40 mm inner diameter.  
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Each tooth sample was positioned parallel to the applied magnetic field. No signal 
contribution from the RF coil was seen in UTE and ZTE images likely because of the limited 
amount of protons in the coil materials and their ultra-short T2
*
 relaxation times. 
A 3D UTE sequence (TE= 8 µs, repetition time (TR)= 8 ms, image resolution= 0.3 mm
3
, 2 
averages, gradient ramp duration=106 µs, bandwidth (BW)= 200 kHz, number of radial 
spokes= 51360 and TRF (the length of applied pulse)= 4 μs) was applied for T1 estimation 
with 7 flip angles (FAs) from 3°-15° with 2° as an increment. Total scan time was about 1 
hour 32 minutes. A similarly parameterized 3D UTE sequence was used for T2
*
 evaluation but 
with TR= 10 ms, FA= 7° and 16 TEs (18, 28, 38, 48, 58, 78, 98, 128, 158, 188, 228, 268, 308, 
358, 408 and 608 µs). The corresponding total acquisition time was approximately 4 hours 52 
minutes. 
All human and goat teeth were imaged by a ZTE sequence with the scan parameters of TR= 
2 ms, FA= 3°, image resolution= 0.16 mm
3
, 4 averages, BW= 200 kHz and TRF = 1 μs. The 
resultant dead time is 6.6 μs, and each scan took about 27 minutes. The applied FA of 3° was 
calculated based on the estimated T1 values to achieve near-optimal steady-state 
magnetization at TR of 2 ms. 
2.5. Gravimetric analysis 
Five blot-dried CPC cylinders (diameter: 4.5 mm; length: 9 mm) were dried in an incubator at 
37 °C for 24 hours in order to remove pore water and subsequently oven-dried at 1300 °C for 
6 hours to remove bound water, similar to the method applied in Chen et al. [29]. The 
cylinders were weighed before and after each drying step. The pore and the bound water 
content were calculated as follows: 
                                                                                                            (1) 
and 
                                                                                                      (2) 
where Winitial, Wincubator-dried, Woven-dried represent the original weight, the weight of one CPC 
cylinder after incubator-drying and oven-drying respectively, and Vcpc is the volume of one 
CPC cylinder and ρwater is the water density. 
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2.6. Data analysis  
A custom-built program written in MATLAB R2014b (Math-Works, Natick, MA, USA) was 
used to calculate the T1 and T2
* 
relaxation times of CPC as well as of human and goat teeth. 
From the multi-FA UTE data, T1 was calculated from the slope of e p (  TR/T1) in the 
equation [25, 30, 31] 
 
        
    
             
   
  
  
     
                
   
  
                
              (3) 
where S(FA) represents the image intensity at a specific FA and M0 is the net magnetization at 
thermal equilibrium. The slope was obtained by a linear regression between S(FA)/sin(FA) 
and S(FA)/tan(FA).  
With the multi-TE UTE data, the T2
*
 values of fresh CPC, i.e., restored in human teeth and 
goat teeth at TP1 as well as the corresponding dental components (enamel and dentin) were 
estimated by using the mono-exponential (ME) model 
                                                                     
   
  
                                                   (4)                 
and the GAME model [28, 32, 33] 
                                                                         
                                  (5) 
where S0 is the pseudo-spin density and ~2.35σ represents the full-width-at-half-maximum 
(FWHM) of the Gaussian frequency distribution responsible for the reversible transverse 
relaxation rate [28].  
As for a Lorentzian underlying frequency distribution with FWHM of 2R2
’
, the T2
*
 was 
defined as     
    
    , the corresponding T2
*
 under a Gaussian distribution with FWHM 
of ~2.35σ was calculated using the following equation to keep the definition consistent: 
                                                 
      
                                                                                  (6)  
The T2
*
 values of CPC and dentin in goat teeth at TP2 were obtained with the bi-exponential 
(BE) model 
                                                  
                    
                       (7) 
where S0 is the pseudo-spin density, T2,1
*
 and T2,2
*
 are the effective transverse relaxation times 
of two different water components, and p is the fraction of the first water component. 
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The background noise Snoise for each dataset was estimated from a region of interest (ROI) 
selected in a homogeneous area completely outside the object without any visible artifact. A 
quadratic noise correction [31] was used to correct the noise effect on each dataset using the 
following equation: 
                                                                                                                        (8) 
in which Suncorr and Scorr represent the signal intensities before and after noise correction.  
The noise corrected signal intensities Scorr were used for T1 and T2
*
 estimation. The fits in 
ME, GAME and BE models were with unconstrained nonlinear optimization [34]. 
To evaluate the reproducibility of estimating the relaxation times for CPC as well as for 
enamel and dentin, coefficients of variation (CVs), defined as SDs/mean values across three 
tooth samples, were calculated using the correspondingly averaged e.g., T1 and T2
*
 values, 
across two or three consecutive slices in each tooth. 
From the ZTE images, the SNR of ROI x and the contrast-to-noise-ratio (CNR) between 
ROIs x and y were calculated according to  
                                                                           / s                                            (9) 
and  
                                                                             / s                                               (10) 
where Sx, Sy and Sbackground represent the mean signal intensities of ROIs x, y and background 
respectively and s is the standard deviation (SD) of the noise.  
To assess the signal homogeneity of the CPC regions in three goat teeth at TP1 and three at 
TP2 on ZTE images, the CVs of signal intensities in each CPC regions, defined by SDs/mean 
levels of signal intensities, were respectively calculated. The used signal intensities in CPC 
regions were corrected for noise effect by using Eq.8. A higher CV value for larger signal 
deviation represents a less homogeneous signal distribution. The corresponding mean CV 
levels were calculated across three consecutive slices of each goat teeth.    
All ROIs were manually outlined on UTE and ZTE tooth images using MRIcro software 
[35]. The mean signal intensities for different ROIs were obtained. 
3. Results 
3.1. Human teeth  
The relaxation times for CPC, dentin and enamel in all three human teeth were obtained for 
selected areas as indicated on the UTE MR images in Figures 1A and 1B. The signal 
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intensities recorded by the UTE sequence as a function of TE were fitted using the ME model 
to obtain T2
*
 relaxation times and were also fitted using the GAME model to obtain the 
irreversible relaxation times (T2) and reversible rela ation times (1/ ) for CPC, dentin and 
enamel respectively (Figures 1C, D, E). The GAME model showed better fitting than the ME 
model as reflected in higher R
2
 values for goodness of fit (mean: 0.994 vs 0.955). In the 
example shown in Figure 1, the GAME fits (red), compared to the ME fits (blue), performed 
significantly better in the CPC region (GAME: T2= 1155 µs, 1/ = 367 µs, T2
*
= 247 µs, R
2
= 
0.997; ME: T2
*
= 430 µs, R
2
= 0.884), and slightly better in the enamel region (GAME: T2= 
1168 µs, 1/ = 752 µs, T2
*
= 415 µs, R
2
= 0.992; ME: T2
*
= 771 µs, R
2
= 0.962) and in the dentin 
region (GAME: T2= 651 µs, 1/  = 702 µs, T2
*
= 312 µs, R
2
= 0.990; ME: T2
*
= 508 µs, R
2
= 
0.966).  
 
Figure 1. MR images of human 
tooth with CPC obtained with 
UTE at TE= 18 µs. A) transversal 
view. B) coronal view along the 
slice noted by a blue line in (A). 
Regions of interest (ROIs) with 
identical size of 3 by 3 voxels 
were selected in (B) with pink 
color in CPC, enamel and dentin 
regions, respectively. C) A 
Gaussian augmentation mono-
exponential (GAME) model (red) 
and a mono-exponential (ME) 
model (blue) fit of the multi-TE 
UTE data (*) using a semi-log 
plot for the ROI in CPC. D) Idem 
for a region in enamel. E) Idem 
for a region in dentin. 
 
Using the GAME model for fitting, the mean T2, 1/  and T2
*
 values of similarly selected 
areas with the same size across three consecutive slices of each tooth were then calculated 
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(Figures. 2A, B, C). The averaged 1/  values for enamel in tooth 1 as well as for dentin in 
teeth 1 and 2 were not shown because of 1/  >> 1000 µs, resulting in a comparable fitting 
performance by GAME and ME models. 
The mean values across three teeth obtained for CPC were: T2= 1234±27 µs, 1/ = 412±38 
µs and T2
*
= 273±19 µs; for enamel: T2= 963±151 µs and T2
*
= 562±221 µs; for dentin: T2= 
577±41 µs and T2
*
= 476±147 µs. The T2, 1/  and T2
*
 values for CPC, enamel and dentin 
showed high inter-reproducibility across the three teeth with low CVs (T2: 2.2% for CPC, 
15.6% for enamel and 7.0% for dentin; 1/ : 9.2% for CPC; T2
*
: 7.0% for CPC).  
The T1 relaxation times of CPC and human tooth tissues were also estimated. Respective 
mean values were calculated across three consecutive slices for each tooth (Figure 2D). The 
mean T1 values were: 1065±45 ms for CPC; 972±40 ms for enamel and 903±7 ms for dentin. 
Reproducible T1 values were observed across the three teeth in each of CPC, enamel and 
dentin regions, indicated by low CVs (CPC: 4.3%; enamel: 4.2%; dentin: 0.8%).  
      
Figure 2. Mean T2, 1/ , T2
*
 and T1 relaxation times of CPC and dental components in human teeth. A) mean T2 
(µs); B) 1/  (µs); C) T2
* 
(µs); D) T1 (ms) with error bars indicating ± 1 standard deviation (SD) of CPC, enamel 
and dentin across three consecutive slices for three human tooth samples. Mean 1/  levels of dentin in teeth 1 
and 2 as well as of enamel in tooth 1 are not shown because of 1/ mean >> 1000 µs. 
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T1, T2 and T2
*
 values were also estimated for each voxel in the selected ROIs to construct 
histograms of their distributions for CPC, enamel and dentin. The median values were also 
shown and comparable to the obtained mean levels (Supplementary Material, Figures S1-S3). 
On ZTE images, acquired with optimized FA of 3° at TR of 2 ms based on these T1 values, 
CPC has a much higher SNR compared to enamel and dentin (Figure 3). Across three 
consecutive slices over all three teeth, mean SNR values of 26.7±1.6, 10.9±0.8 and 19.3±1.3 
were calculated for CPC, enamel and dentin respectively (Figure 4). Additionally, a strong 
image contrast for CPC is seen as reflected by high CNRs between CPC and surrounding 
enamel or dentin (mean: 15.7±1.2 or 7.4±0.4; Figure 4).  
 
Figure 3. MR images of human tooth 
with CPC obtained with ZTE. A) coronal 
view; B) transversal view. The 
corresponding signal-to-noise-ratios 
(SNRs) of CPC, enamel and dentin are 
27.6, 11.1 and 20. The contrast-to-noise-
ratios (CNRs) are thus 16.5 between CPC 
and enamel and 7.6 between CPC and 
dentin. 
 
 
 
Figure 4. Mean SNRs of CPC, enamel, 
and dentin and mean CNRs of CPC to 
enamel and to dentin in ZTE images 
across three consecutive slices over three 
human teeth. Error bars indicate ± 1 SD. 
3.2. Goat teeth 
The goat teeth were imaged ex vivo by ZTE at TP1 (with CPC implantation immediately after 
the extraction of teeth) and at TP2 (teeth extracted seven weeks after CPC implantation). 
Similar to the CPC in human teeth, the CPC in goat teeth also showed a hyperintense signal 
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and a strong image contrast compared to dentin at TPs 1 and 2 (Figures. 5 and 6; mean: 
SNRcpc= 25.6±1.1 and CNRcpc-dentin= 10.7±0.8 at TP1; mean: SNRcpc= 26.4±1.2 and CNRcpc-
dentin= 11.3±1.3 at TP2). Comparing the goat teeth at TP1 and TP2, the SNRs for dentin were 
not different (mean: 14.9±0.6 vs 15.1±0.7; Figure 6). However, on ZTE images the CPC in 
teeth extracted at TP2 was less homogeneous (Figure 5), reflected by a larger range of signal 
intensities than the CPC implanted after extracting these teeth at TP1 in all three slices over 
all teeth (mean CVs: 14.9±1% vs 10.5±2%). The SNRs of enamel and CNRs between CPC 
and enamel were not calculated since enamel in goat teeth is thin and therefore it is difficult to 
select a representative ROI for analysis (Figure 5). 
The T1 and T2 values of fresh CPC in restored goat teeth at TP1 were also estimated to 
determine how comparable they are with those of CPC in human teeth. Robust T2 fitting was 
obtained with the GAME model, indicated by high R
2
 values (mean: 0.991±0.008). The mean 
levels of T2 and also T1 values were calculated across two consecutive slices over three goat 
teeth. The resultant values were comparable to those of fresh CPC in human teeth (T2: 
1271±335 µs vs 1234±27 µs; T1: 1008±277 ms vs 1065±45 ms). As the estimated reversible 
rela ation times (1/ ) >> 1000 µs, the corresponding mean T2
*
 of fresh CPC in goat teeth at 
TP1 was also 1271±335 µs.  
 
 
Figure 5. MR images of goat teeth obtained 
with ZTE. A) coronal view and B) 
transversal view at time point (TP) 1 with 
SNRCPC=24.8, SNRdentin= 14, CNRCPC-dentin= 
10.8 and CV= 12.6% for the signal 
intensities in CPC region. C) coronal view 
and D) transversal view at TP2 with 
SNRCPC= 26.9, SNRdentin= 14.9, CNRCPC-
dentin= 12 and CV= 16.4% for the signal 
intensities in CPC region. 
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Figure 6. SNRs of CPC and dentin and 
CNRs of CPC to dentin in ZTE images of 
goat teeth.  Across three consecutive slices 
over three goat teeth at TP1 and three at 
TP2, mean SNRs of CPC and dentin as well 
as mean CNRs of CPC to dentin. Error bars 
indicate ± 1 SD. 
A BE model was used for T2
*
 estimations in the CPC and dentin regions for all three goat 
teeth at TP2. A robust fit was achieved with a high goodness of fit (mean R
2
: 0.99; Figure 7).  
Two components with distinctly different T2
*
 and fraction values were found for CPC and 
dentin by using the BE model. The mean T2
*
 values for both components and the mean 
fraction values of the long T2
*
 components were calculated for CPC and dentin in each tooth 
across two (for CPC) and three (for dentin) consecutive slices (Figures. 8A, B, C). The mean 
T2
*
 values across all three teeth for CPC were 1110±280 µs and 94±38 µs (with CVs 25.2% 
and 40.4%), and for dentin these were 2211±180 µs and 91±2 µs (with CVs 8.1% and 1.7%). 
The mean fraction percentage for the long T2
*
 component for CPC was 55.5±5.4% (CV: 
9.8%), and for dentin this was 66.9±1.6% (CV: 2.5%). 
The mean T1 values in each goat tooth at TP2 were also estimated for CPC and dentin 
across two (for CPC) and three (for dentin) consecutive slices (Figure 8D). The average T1 
values and the corresponding CV values over all three teeth were: 742±103 ms and 13.9% for 
CPC, and 930±57 ms and 5.0% for dentin. Compared to freshly applied CPC in goat teeth at 
TP1, much lower T1 values were found in the CPC region at TP2 (742 ms vs 1008 ms).   
3.3. Water content  
Pore and bound water volume percentages of all five CPC cylinders were calculated. The 
mean value for pore water over all CPCs was 24.8±2.7%, and for bound water this was 
10.4±0.8%. 
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Figure 7. MR images of goat 
teeth obtained with UTE at TE= 
18 µs. A) coronal view at TP2. 
ROIs (pink) with identical size of 
3 by 2 voxels were selected in 
CPC and dentin regions, 
respectively. A bi-exponential 
(BE) model fit the multi-TE UTE 
data (*) using a semi-log plot for 
the ROIs in CPC (B) and dentin 
(C) regions, which (blue) 
achieved high goodness of fit: R
2
 
= 0.99 (CPC: T2.1
*
= 1310 µs 
(fraction: 53.2%), T2.2
*
= 114 µs; 
dentin: T2.1
*
= 2208 µs (fraction: 
68.5%), T2.2
*
= 88 µs). 
 
 
Figure 8. Mean levels of the T2
*
 values in the long T2
*
 component (A) with its fraction (B), the T2
*
 values in the 
short T2
*
 component (C) and T1 values (D) of the CPC and dentin across two (for CPC) or three (for dentin) 
consecutive slices for three goat tooth samples at TP2, indicated with error bars ± 1 SD. 
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4. Discussion  
In this paper we present high field proton MR properties of a new CPC material as applied in 
the restoration of teeth. This includes T1 and T2
*
 relaxation times of this material implanted in 
teeth and of the enamel and dentin tissues in these teeth. Because of the very short T2
*
 
relaxation times of CPC and dental tissues, we used a ZTE sequence to obtain high SNR 
images of CPC restored teeth. In these images, CPC is hyperintense and has a strong image 
contrast with respect to dentin and enamel. In addition, we demonstrate that seven weeks after 
implantation in goat teeth CPC exhibits a less homogeneous signal distribution, a decreased 
T1, and a change in T2
*
 values, implying a certain CPC degradation over time.  
Previously, the T2
*
 value of a comparable CPC was reported, although the ME model used 
to analyze the multi-TE data in that study did not result in a satisfactory fit [36]. Because non-
exponential behavior was also observed for the T2
*
 relaxation of the CPC investigated in this 
study, we applied the GAME model to fit our gradient-echo data [28]. This model assumes 
that the intra-voxel frequency distribution responsible for the reversible relaxation component 
is Gaussian- rather than Lorentzian- shaped, which is particularly relevant at higher field 
when this component becomes more prominent in T2
*
 relaxation. It has been successfully 
used for T2
*
 determinations from gradient-echo measurements of human brain and prostate 
and gynecologic cancers at 3T [28,32,33]. In this study it was applied for the first time to 
estimate the T2
*
 values of teeth and engineered tissue.   
Unlike the ME model that gives a single T2
*
 value from fitting the signals of a multiple TE 
gradient-echo measurement, the GAME model provides both the irreversible relaxation time 
(T2) and reversible rela ation time (1/ ) from such a measurement. As the reversible 
relaxation reflects local inhomogeneities, the relatively high CV (about 10%) that we obtained 
for the 1/  times of CPC across three human tooth samples indicates differences in 
microstructures such as small (air) cavities in the material and at the interface of CPC with 
tooth tissues, which may cause complex susceptibility gradients. Fitting with the GAME 
model also appeared valuable for T2
*
 estimations of dentin and enamel. While T2 relaxation 
dominates their T2
*
 rela ation times, the effect of 1/  on T2
*
 of these tissues is not negligible 
in some teeth (Figures 1 and 2).  
Previously, relaxation times for enamel and dentin have been investigated at 1T [7,37]. 
These studies determined for a semi-liquid component in enamel a T2
*
 of about 240 μs, a T2 
of 10 ms and a T1 in the order of 300 ms. For dentin a T2
*
 of below 1000 μs and T2 of 38 ms 
were reported. A study performed at 1.5T reported T2 (T2*) values for dentin and enamel in 
adult teeth of 150 μs and 70 μs respectively [38]. At 3T human teeth were measured ex vivo 
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and in vivo using a UTE sequence with multiple TEs [31,39]. Fitting by a standard ME model, 
the T1 and T2
*
 relaxation times of dentin tissue ex vivo were 545 ms and 478 μs and the T2
*
 
time of dentin in vivo was 324 μs, which are closer to the results we have obtained in the 
present study, than to those in any of the other previous studies. The discrepancies between 
the reported tooth relaxation properties of these studies might be because of the use of 
different field strengths, different MR sequences and different analysis and fitting methods, as 
well as of variations between the conditions of the tooth samples used in each examination.   
Because of their very short T2
*
 relaxation times and limited water content, ZTE is a favorite 
sequence to record high SNR images of teeth [8,15]. As CPC, dentin and enamel appeared to 
have comparable T1 values, a FA (3°) for near-optimum steady state magnetization at a TR of 
2 ms could be applied in the ZTE sequence for tooth imaging, which essentially produces 
proton density weighted images. The observed hyperintense signal in CPC and strong image 
contrast to surrounding tissues can therefore only be explained by its higher water content 
relative to dentin and enamel. To confirm this assumption, a gravimetric analysis was 
performed to quantify water content in CPC. Two water components, namely, pore water and 
bound water, were found with a much higher water volume percentage (about 25 and 10% 
respectively) than that reported for enamel and dentin (4 and 10% respectively) [8]. As CPC 
thus has at least two water compartments, a bi-exponential T2
*
 decay may have been expected 
that would not have been possible to fit by the GAME model. A plausible reason that this is 
not observed is that the bound water probably has an ultra-short T2
*
. A T2
*
 value of 100 μs has 
been reported for collagen-bound water in cortical bone at 3 T [29]. Together with the 
substantial contribution from local field inhomogeneities, which follows from the GAME fit, 
the T2
*
 of bound water in CPC matrices is expected to be significantly shorter at 11.7 T. Also, 
considering the lower volume percentage of this bound water it is expected that in the UTE 
examinations for T2
*
 fitting, bound water contributed little to the recorded signal.  
To investigate if CPC degradation in teeth can be monitored over time, we separately 
implanted CPC into three goat teeth ex vivo and three in vivo. While the fresh CPC implanted 
in teeth ex vivo was scanned immediately (TP1), the CPC injected in teeth in vivo was 
measured at seven weeks post-surgery (TP2). With respect to the CPC at TP1, we observed a 
less homogeneous signal distribution in ZTE images for the CPC component at TP2. We also 
compared their relaxation properties and found a decreased T1 time and T2
*
 separated into two 
components (Figure. 9). Based on these findings, we infer that the CPC at TP2 had undergone 
compositional changes. The observed less homogeneous structure might indicate that a certain 
degree of CPC dissolution had occurred at TP2, giving rise to a different phase cement 
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composition. The degradation of included PLGA particles in acidic monomers (i.e., lactic and 
glycolic acid) is expected to induce an initial dissolution of CPC with increased porosity. This 
porous structure is less rigid and could explain the decrease of T1 in CPC at TP2. Moreover, 
the increased porosity could also allow more fluid flow through the implant and recruitment 
of odontoblast-like cells, which are responsible for reparative dentin deposition [40-41]. The 
newly emerging dentin component in CPC can explain why a bi-exponential model performed 
a robust fit for the CPC at TP2. This is also the reason that the short T2
*
 parts of CPC and 
dentin at TP2 were found comparable (mean: 94 μs vs 91 μs). Thus, these changes in 
relaxation properties may help to understand and monitor the interaction of CPC and dental 
tissues in vivo. Further histological analyses are required to assess the micro-structural 
alterations in the CPC area from TP 1 to 2. 
 
Figure 9. Comparison of T2
*
 and T1 values between freshly applied CPC at TP1 and CPC at TP2. Mean levels of 
T2
*
 (A) and T1 (B) relaxation times of CPC across two consecutive slices over three goat teeth at TP1 and three 
at TP2. Error bars indicate ± 1 SD. 
 
It is striking that the human molars show a convex shape for the T2
*
 signal decay as a 
function of TE and the goat incisors a concave shape. This could be due to differences in 
chemical composition of these teeth. It is known that the chemical composition of human and 
animal teeth can vary widely [43]. In particular the calcium, phosphorous and magnesium 
content is not the same in teeth of different species, in different types of teeth of the same 
animal (molar and incisor) and in different tissues in the same tooth (enamel and dentin).   
The images in our study were measured at high magnetic field strength and with rather 
lengthy acquisitions to obtain optimal SNR. However, it has been demonstrated that excellent 
MR images of teeth can be obtained at lower clinical field strengths with turbo spin echo 
(TSE), UTE or SWIFT sequences at relatively short acquisition times, including the detection 
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of bisphosphonate-induced necrosis, caries lesions, periodontitis and micro-cracks 
[8,16,39,44,45]. Therefore, we anticipate that our finding that the investigated CPC has T1 and 
T2 relaxation properties different from that of the host dental tissue also will provide useful 
image contrast of this material at lower field strength and shorter acquisition times. ZTE is 
now also available on clinical 3T MR systems and its applicability in dental imaging in vivo 
can be explored. 
5. Conclusions 
For the assessment of T2
*
 relaxation times in MRI of human teeth a Gaussian instead of a 
Lorentzian exponential model provides the best fit to the T2
*
 signal decays of CPC, dentin and 
enamel. Due to a high water content, excellent images of CPC in teeth can be obtained with 
ZTE at high field, showing high SNR and strong image contrast. Relaxation times and MR 
image properties of the regions filled with CPC in vivo were significantly altered after seven 
weeks, indicating that material decomposition, and possibly dentin formation, can be followed 
by MRI.   
6. References 
1.  Seifert, A.C.; Wehrli, F.W., Solid-State Quantitative (1)H and (31)P MRI of Cortical Bone 
in Humans. Current Osteoporosis Reports 2016, 14 (3), 77-86. 
2. Wehrli, F.W., Magnetic resonance of calcified tissues. Journal of Magnetic Resonance 
2013, 229, 35-48. 
3. Idiyatullin, D.; Corum, C.; Moeller. S.; Prasad, H.S.; Garwood, M.; Nixdorf, D.R., Dental 
Magnetic Resonance Imaging: Making the Invisible Visible. Journal of Endodontics 2011, 
37, 745–752. 
4. Wehrli, F.W.; Fernández-Seara, M.A., Nuclear magnetic resonance studies of bone water. 
Annals Biomededical Engineering 2005, 33, 79-86. 
5. Pasteris, J.D.; Wopenka, B.; Valsami-Jones, E., Bone and Tooth Mineralization: Why 
Apatite?. Elements 2008, 4, 97–104. 
6. Chandra, S.; Chandra, S.; Chandra, M.; Chandra, N., Textbook of dental, oral histology 
and embryology with multiple choice questions. Jaypee Brothers Medical Publishers Ltd 
2007, 353. 
7. Schreiner, L.; Cameron, I.; Funduk, N.; Miljković, L.; Pintar, M.; Kydon, D., Proton NMR 
spin grouping and exchange in dentin. Biophysical Journal 1991, 59, 629–639. 
8. Hövener, J.B.; Zwick, S.; Leupold, J.; Eisenbeiβ, A.K.; Scheifele, C.; Schellenberger, F.; 
Hennig, J.; Elverfeldt, D.V.; Ludwig, U., Dental MRI: Imaging of soft and solid 
Chapter 3 
 
75 
 
components without ionizing radiation. Journal of Magnetic Resonance Imaging 2012, 36, 
841–846. 
9. Robson, M.D.; Gatehouse, P.D.; Bydder, M.; Bydder, G.M., Magnetic resonance: an 
introduction to ultrashort TE (UTE) imaging. Journal of Computer Assisted Tomography 
2003, 27 (6), 825-846. 
10. Hafner, S., Fast imaging in liquids and solids with the Back-projection Low Angle ShoT 
(BLAST) technique. Magnetic of Resonance Imaging 1994, 12 (7), 1047–1051. 
11. Madio, D.P.; Lowe, I.J., Ultra-fast imaging using low flip angles and FIDs. Magnetic 
Resonance Medicine 1995, 34 (4), 525–529. 
12. Idiyatullin, D.; Corum, C.; Park, J.Y.; Garwood, M., Fast and quiet MRI using a swept 
radiofrequency. Journal of Magnetic Resonance 2006, 181 (2), 342–349. 
13. Du, J.; Carl, M.; Bydder, M.; Takahashi, A.; Chung, C.B.; Bydder, G.M., Qualitative and 
quantitative ultrashort echo time (UTE) imaging of cortical bone. Journal of Magnetic 
Resonance 2010, 207 (2), 304–311. 
14. Weiger, M.; Stampanoni, M.; Pruessmann, K.P., Direct depiction of bone microstructure 
using MRI with zero echo time. Bone 2013, 54 (1), 44–47. 
15. Weiger, M.; Pruessmann, K.P.; Bracher, A.K.; Kӧhler, S.; Lehmann, V.; Wolfram, U.; 
Hennel, F.; Rasche, V., High-resolution ZTE imaging of human teeth. NMR in 
Biomedicine 2012, 25, 1144–1151. 
16. Bracher, A.K.; Hofmann, C.; Bornstedt, A.; Hell, E.; Janke, F.; Ulrici, J.; Haller, B.; 
Geibel, M.A.; Rasche, V., Ultrashort echo time (UTE) MRI for the assessment of caries 
lesions. Dentomaxillofacial Radiology 2013, 42 (6), 20120321. 
17. Barrere, F.; van Blitterswijk, C.A.’; de Groot, K., Bone regeneration: molecular and 
cellular interactions with calcium phosphate ceramics. International Journal of 
Nanomedicine 2006, 1 (3), 317–332. 
18. Klijn, R.J.; van den Beucken, J.J.; Félix Lanao, R.P.; Veldhuis, G.; Leeuwenburgh, S.C.; 
Wolke, J.G.; Meijer, G.J.; Jansen, J.A., Three Different Strategies to Obtain Porous 
Calcium Phosphate Cements: Comparison of Performance in a Rat Skull Bone 
Augmentation Model. Tissue Engineering Part A 2012, 18, 1171–1182. 
19. Félix Lanao, R.P.; Hoekstra, J.W.; Wolke, J.G.; Leeuwenburgh, S.C.; Plachokova, A.S.; 
Boerman, O.C.; van den Beucken, J.J.; Jansen, J.A.; Porous calcium phosphate cement for 
alveolar bone regeneration. Journal of Tissue Engineering and Regenerative Medicine 
2014, 8, 473–482. 
VISUALIZATION OF CPC BY ZTE MRI 
76 
 
20. Hoekstra, J.W.; Klijn, R.J.; Meijer, G.J.; van den Beucken, J.J.; Jansen, J.A. Maxillary 
sinus floor augmentation with injectable calcium phosphate cements: a pre-clinical study 
in sheep. Clinical Oral Implants Research 2013, 24, 210–216. 
21. van de Watering, F.C.; van den Beucken, J.J.; Walboomers, X.F.; Jansen, J.A., Calcium 
phosphate/poly(d,l-lactic-co-glycolic acid) composite bone substitute materials: evaluation 
of temporal degradation and bone ingrowth in a rat critical-sized cranial defect. Clinocal 
Oral Implants Research 2012, 23, 151–159. 
22. Al-Sanabani, J.S.; Madfa, A.A.; Al-Sanabani, F.A., Application of calcium phosphate 
materials in dentistry. International Journal of Biomaterials 2013, 876132. 
23. Peters, M.C.; Bresciani, E.; Barata, T.J.; Fagundes, T.C.; Navarro, R.L.; Navarro, M.F.; 
Dickens, S.H., In vivo dentin remineralization by calcium-phosphate cement. Journal of 
Dental Research 2010, 89 (3), 286-291. 
24. Ventura, M.; Sun, Y.; Rusu, V.; Laverman, P.; Borm, P.; Heerschap, A.; Oosterwijk, E.; 
Boerman, O. C.; Jansen, J. A.; Walboomers, X. F., Dual contrast agent for computed 
tomography and magnetic resonance hard tissue imaging. Tissue Engineering Part C: 
Methods 2013, 19 (6), 405-16. 
25. Sun, Y.; Ventura, M.; Oosterwijk, E.; Jansen, J. A.; Walboomers, X. F.; Heerschap, A., 
Zero echo time magnetic resonance imaging of contrast-agent-enhanced calcium 
phosphate bone defect fillers. Tissue Engineering Part C: Methods 2013, 19 (4), 281-7. 
26. Ventura, M.; Sun, Y.; Cremers, S.; Borm, P.; Birgani, Z. T.; Habibovic, P.; Heerschap, A.; 
van der Kraan, P. M.; Jansen, J. A.; Walboomers, X. F., A theranostic agent to enhance 
osteogenic and magnetic resonance imaging properties of calcium phosphate cements. 
Biomaterials 2014, 35 (7), 2227-33. 
27. An, J.; Liao, H.; Kucko, N. W.; Herber, R. P.; Wolke, J. G.; van den Beucken, J. J.; 
Jansen, J. A.; Leeuwenburgh, S. C., Long-term evaluation of the degradation behavior of 
three apatite-forming calcium phosphate cements. Journal of biomedical materials 
research. Part A 2016, 104 (5), 1072-81. 
28. Mulkern, R.V.; Balasubramanian, M.; Mitsouras, D., On the lorentzian versus Gaussian 
character of time-domain spin-echo signals from the brain as sampled by means of 
gradient-echoes: Implications for quantitative transverse relaxation studies. Magnetic 
Resonance Medicine 2015, 74, 51–62. 
29. Chen, J.; Grogan, S.P.; Shao, H.; D'Lima, D.; Bydder, G.M.; Wu1, Z.; Du, J., Evaluation 
of bound and pore water in cortical bone using ultrashort-TE MRI. NMR in Biomedicine 
2015, 28, 1754–1762. 
Chapter 3 
 
77 
 
30. Fram, E.K.; Herfkens, R.J.; Johnson, G.A.; Glover, G.H.; Karis, J.P.; Shimakawa, A.; 
Perkins, T.G.; Pelc, N.J., Rapid calculation of T1 using variable flip angle gradient 
refocused imaging. Magnetic Resonance Imaging 1987, 5, 201–208. 
31. Grosse, U.; Syha, R.; Papanikolaou, D.; Martirosian, P.; Grözinger, G.; Schabel, C.; 
Schick, F.; Springer, F., Magnetic resonance imaging of solid dental restoration materials 
using 3D UTE sequences: visualization and relaxometry of various compounds. Magnetic 
Resonance Materials in Physics, Biology and Medicine 2013, 26 (6), 555–564. 
32. Ciris, P.A.; Mulkern, R.V.; Balasubramanian, M.; Seethamraju, R.T.; Fairhurst, J.; 
Tokuda, J.; Scalera, J.; Penzkofer, T.; Fennessy, F.; Jolesz, F.A.; Tempany, C.M.; 
Schmidt, E.J.; Tuncali, K., Gradient echo signal decays in healthy and cancerous prostate 
at 3T require a Gaussian augmentation of the mono-exponential (GAME) model. In 
ISMRM 2015, Toronto, Canada, 2888. 
33. Ciris, P.A.; Balasubramanian, M.; Damato, A.L.; Seethamraju, R.T.; Tempany, C.M.; 
Mulkern, R.V.; Viswanathan, A.N., Characterizing gradient echo signal decays in 
gynecologic cancers at 3T using a Gaussian augmentation of the monoexponential 
(GAME) model. Journal of Magnetic Resonance Imaging 2016, 44 (4), 1020–1030.  
34. Lagarias, J.C.; Reeds, J.A.; Wright, M.H.; Wright, P.E., Convergence Properties of the 
Nelder-Mead Simplex Method in Low Dimensions. SIAM Journal of optimization 1998, 9, 
112–147. 
35. Rorden, C.; Brett, M., Stereotaxic display of brain lesions. Behavioural Neurology 2000, 
12 (4), 191–200. 
36. Dou, W.; Mastrogiacomo, S.; Veltien, A.; Walboomers, X.F.; Heerschap, A., ZTE MR 
Imaging of calcium phosphate cement at 11.7T. In ESMRMB 2015, Edinburgh, United 
Kingdom. 150. 
37. Funduk, N.; Kydon, D.W.; Schreiner, L.J.; Peemoeller, H.; Miljkovic, L.; Pintar, M.M., 
Composition and relaxation of the proton magnetization of human enamel and its 
contribution to the tooth NMR image. Magnetic Resonance in Medicine 1984, 1, 66-75. 
38. Holmes, J.E.; Bydder, G.M., MR imaging with ultrashort TE (UTE) pulse sequence: Basic 
Principles. Radiography 2005, 11, 163–174. 
39. Bracher, A.K.; Hofmann, C.; Bornstedt, A.; Boujraf, S.; Hell, E.; Ulrici, J.; Spahr, A.; 
Haller, B.; Rasche, V., Feasibility of ultra-short echo time (UTE) magnetic resonance 
imaging for identification of carious lesions. Magnetic Resonance in Medicine 2011, 66, 
538–545. 
VISUALIZATION OF CPC BY ZTE MRI 
78 
 
40. Felix Lanao, R.P.; Leeuwenburgh, S.C.; Wolke, J.G.; Jansen, J.A., Bone response to fast-
degrading, injectable calcium phosphate cements containing PLGA microparticles. 
Biomaterials 2011, 32 (34), 8839–8847. 
41. Kanter, B.; Geffers, M.; Ignatius, A.; Gbureck, U., Control of in vivo mineral bone cement 
degradation. Acta Biomaterialia 2014,10 (7), 3279–3287. 
42. AbdulQader, S.T.; Rahman, I.A.; Thirumulu, K.P.; Ismail, H.; Mahmood, Z., Effect of 
biphasic calcium phosphate scaffold porosities on odontogenic differentiation of human 
dental pulp cells. Journal of Biomaterials Application 2016, 30 (9), 1300–1311. 
43. Murray, M.M., The Chemical composition of teeth. IV. The calcium, magnesium and 
phosphorus contents of the teeth of different animals. A brief consideration of the 
mechanism of calcification. Biochemical Journal 1936, 30 (9), 1567–1571. 
44. Geibel, M.A.; Schreiber, E.S.; Bracher, A.K.; Hell, E.; Ulrici, J.; Sailer, L.K.; Ozpeynirci, 
Y.; Rasche, V., Assessment of Apical Periodontitis by MRI: A Feasibility Study. 
Fortschritte Röntgenstrahlen 2015, 187, 269-275. 
45. Idiyatullin, D.; Garwood, M.; Gaalaas, L.; Nixdorf, D.R., Role of MRI for detecting micro 
cracks in teeth. Dentomaxillofacial Radiology 2016, 45 (7), 20160150.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
79 
 
7. Supplementary Information 
 
Figure S1. Histograms of T1 (A), T2 (B) and T2
*
 (C) distributions of CPC regions in three human teeth. The T1, 
T2, and T2
*
 estimations were performed voxel by voxel using Eqs. 3, 5 and 6 for 9 regions of interest with an 
identical size of 3 by 3 voxels selected in the CPC regions across three consecutive slices over three human 
teeth. The T1 values in 81 voxels, and the T2 and T2
*
 values in 75 out of 81 voxels were used for their 
distributions. Six voxels were excluded for T2 and T2
*
 analysis because their R
2
 values for goodness of fit were 
less than 0.90. Additionally, their median values are presented, which are comparable to the corresponding mean 
levels. 
 
Figure S2. Similar to Figure S1, histograms for T1 (A), T2 (B) and T2
*
 (C) distributions of enamel regions in 
three human teeth are shown. In total 81 voxels were evaluated for T1, T2, and T2
*
 values. Their corresponding 
median values and mean levels are also presented and appear to be comparable. 
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Figure S3. Histograms, representing T1 (A), T2 (B) and T2
*
 (C) distributions of dentin regions in three human 
teeth, are shown. T1, T2, and T2
*
 values were estimated in total 81 voxels. In addition, the median and mean 
levels of T1, T2 and T2
*
 values are presented and appear to be comparable. 
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1. Introduction 
The healthy state of dental pulp can be compromised after exposed to an extended caries or 
traumatic injury [1]. Different strategies for vital pulp treatment, such as direct and indirect 
pulp capping and partial pulpotomy, are performed to maintain the integrity and the vitality of 
the tooth. A capping material can serve to protect the exposed pulp and to promote dental pulp 
stem cells to differentiate into odontoblasts, which subsequently produce tertiary dentin (i.e. 
the “dentin bridge”) [2,3]. Based on the intensity of the external stimulus, tertiary dentin can 
be distinguished in reactionary dentin and reparative dentin [4]. The deposition of reactionary 
dentin occurs in the case of mild stimuli and is guided by post-natal odontoblasts that have 
survived to the initial damage. Reparative dentin is secreted in the case of severe external 
stimuli and is guided by newly formed odontoblast-like cells [5,6]. 
An ideal material for vital pulp therapy needs to be biocompatible, have optimal handling 
properties, show imaging contrast, and induce dentin deposition. Historically, calcium 
hydroxide has been widely used for this specific application especially because of its 
antimicrobial and reparative properties [7,8]. Therefore, calcium hydroxide is considered as 
gold standard. However, some limitations, such as lack of pulp sealing, high solubility and 
the formation of “tunnel defects”, reduce calcium hydro ide capability to fulfill optimal 
clinical requirements [9,10]. Among many others compositions that have been investigated 
over the last years, calcium phosphate cement (CPC) appears to be a valid candidate as it 
shows biocompatibility, biodegradability, injectable and self-setting properties [11-13]. 
Moreover, it has been proven that CPC can also induce dentin mineralization and inhibit 
caries [14,15]. The combination of CPCs with specific growth factors (e.g. transforming 
growth factor beta, TGF-β, bone morphogenetic protein 2, BMP-2) can further improve the 
biological properties of the final material resulting in enhancement of tissue formation [16-
18].  
Another important consideration in the development of a pulp capping biomaterial is the 
capacity for imaging, necessary to assess the quality of the filling proximal to the pulp [1]. 
Although X-ray based technologies are widely implemented, concerns about the use of 
ionizing radiations [19] have led to investigations of other imaging techniques, like magnetic 
resonance imaging (MRI), as a suitable alternative in dental screening. MRI is not only 
radiation free, but also allows for the simultaneous anatomical and functional tridimensional 
imaging of both soft and hard tissues [20,21]. Traditionally, the low presence of protons in 
bone and teeth results in a very short T2 relaxation (i.e. 500 µs for cortical bone and 250 µs 
for enamel, respectively) hampering their visualization. However, the newly developed MRI 
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sequences with high sensitivity to ultra-short T2* relaxation (i.e. ultrashort echo time, UTE, 
and zero echo time, ZTE), have opened new scenarios for MRI in dental imaging with the 
improved visibility of bone and dental tissues [22-26].  
In this study, a defined CPC composition - previously tested favorably for bone application 
[27] - was used for direct pulp capping in an in vivo animal model (i.e. goat incisors). 
Specifically, we aimed to produce a theranostic biomaterial, which combined a dedicated dual 
contrast agent (DCA) and BMP-2. The DCA consisted of core-shell superparamagnetic iron 
oxide (SPIO)/colloidal gold nanoparticles respectively as MRI and CT contrast agent, while 
BMP-2 was used to trigger dentin regeneration. Imaging performances of the cement were 
monitored seven weeks’ post-surgery by µCT and MRI. Finally, the biological response, new 
dentin formation, and cement degradation were assessed. 
2. Material and methods 
2.1. CPC composition 
Calcium phosphate cement (CPC) consisted of a weight/weight (wt/wt) mixture of 59.1% 
alpha-tricalcium phosphate (α-TCP; CAM Bioceramics BV, Leiden, the Netherlands), 1.5 % 
carboxymethylcellulose (CMC; CAM Bioceramics) and 39.4% cryo-grinded poly-(DL-
Lactic-co-Glycolic acid) particles (<200 µm) with a 50:50 ratio of lactic to glycolic acid 
(PURASOB 5002A, Purac, Gorinchem, the Netherlands) [28].  
2.2. Core-shell dual contrast agent (csDCA) preparation 
Core-shell structured dual contrast agent (csDCA) particles were provided by Nano4Imaging 
GmbH (Aachen, Germany) and used without further purification. Briefly, superparamagnetic 
iron oxide (SPIO) nanoparticles (200 nm) were firstly synthesized according to the literature 
[29] and then coated with gold colloid. Through in situ reduction of suitable gold (III) salts a 
gold layer was deposited on SPIOs to form core-shell structures with a final SPIO/gold ratio 
equal to 3:1 (v/v). Afterward, an inverse emulsion approach was used in order to embed 
SPIO/gold nanoparticles within a silica matrix. Particles were treated with polyethylene 
glycol (PEG-400) and tetraethyl orthosilicate (TEOS) to introduce mesoporous silica matrix 
with a final concentration of 40% (wt/wt). Lastly, all particles were coated with an additional 
apatite-like layer in order to increase the affinity within the CPC phase. All csDCA particles 
had a heterogeneous size with a diameter ranging between 1 µm and 2 µm.  
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2.3. Theranostic dental pulp capping material (CPC/csDCA/BMP-2) preparation  
CPC powders were combined with 5% (wt/wt) csDCA into an exit-closed 2 mL plastic 
syringe (Terumo Europe N.V., Leuven, Belgium). Syringes with pre-mixed components were 
sterilized by using 25kGy of gamma radiation (Synergy Health BV, Ede, the Netherlands). To 
improve biological properties, BMP-2 (R&D Systems, Tocris and Novus Biologicals, 
Abingdon, UK) was added to the powders through resuspension into the setting solution [30]. 
Briefly, BMP-2 was first resuspended in 4 mM HCl containing 0.1% bovine serum albumin 
(BSA, Sigma-Aldrich, St Louis, MO). Right before the in vivo interventions, 10 µg of BMP-2 
were mixed with the setting solution and added to the syringe. For 100 mg of CPC powders, 
60 l of 4% NaH2PO4•2H2O were used. Finally, all components were mixed vigorously for 30 
seconds with a dental shaker machine (Silamat Mixing apparatus, Vivadent, Schaan, 
Liechtenstein).  As control CPC powders were prepared exactly in the same way, but without 
the addition of csDCA and BMP-2. 
2.4. Morphological characterization of the material 
Morphological assessment of the single CPC components, of the csDCA particles and of the 
final theranostic pulp capping agent was performed by scanning electron microscopy (SEM, 
JEOL 6310, Jeol, Tokyo, Japan). Energy dispersive x-ray spectrometry (EDS, Bruker, Kalkar, 
Germany) was used for the investigation of the csDCA particle distribution into the cement 
matrix. Morphology of the csDCA particles was further investigated by transmission electron 
microscopy (TEM, JEOL TEM1010). Briefly, particles were first embedded in a cold-setting 
embedding resin (Epofix
TM 
Kit, Struers, Maassluis, the Netherlands). After polymerization, 
ultrathin sections (between 50 and 100 nm in thickness) were cut on a Leica Reichert Ultracut 
S microtome (Leica Microsystem B.V., Eindhoven, the Netherlands) equipped with a 
diamond knife (Drukker International B.V., Cuijk, the Netherlands) and collected on 100 
mesh copper grids (Sigma-Aldrich).  
2.5. Mechanical and handling properties characterization  
To investigate the effect of csDCA particle incorporation into the CPC phase, mechanical and 
handling properties were assessed. Specifically, initial and final setting times were estimated 
using Gillmore needles (ASTM C266) [28]. Times were recorded after injection of CPC 
formulations in a brass mold (6 mm in diameter, 12 mm in height) immersed in a water bath 
kept at 37°C. Compressive strength and E-modulus were obtained from compression tests. 
Briefly, cylindrical blocks (4.5 mm in diameter, 9 mm in height) were prepared and placed 
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vertically in a testing bench machine (858 MiniBionixII, MTS, Eden Prairie, MN). A final 
loading force of 2.5 kN and constant speed of 0.5 mm/min was applied. Injectability 
properties were investigated by using the same testing bench machine (858 MiniBionixII) set 
in compression mode, with a custom made metallic cage fixture. Briefly, after mixing 500 mg 
of cement with 300 µl of setting liquid for 30 seconds, the syringe (orifice diameter 1.7 mm) 
was placed in the cage and then a compression force of 100 N (i.e. ~maximum force 
applicable by human operator) with a constant speed of 20 mm/min was applied until all 
material was extruded from the syringe (33 ± 2 s). The extrusion curve was calculated as 
applied force (N) by the time (sec) [31]. All cements extruded from the syringes were 
collected in 10 ml of PBS at 37°C and cohesive properties were qualitatively assessed, by 
counting the number of separate pieces.  
2.6. Ex vivo direct pulp capping in human molars and goat incisors   
To investigate the right type/concentration of DCA to be used for the enhancement of the CT 
and MRI contrast in respect of the natural dentin phase, ex vivo direct pulp capping was 
performed on both human molars and goat incisors. Human molars were provided by the 
Department Oral and Maxillofacial Surgery of RadboudUMC Nijmegen, The Netherlands. 
Goat incisors were collected at the College of Dentistry, King Saud University, Riyadh, Saudi 
Arabia from surplus cadavers from non-related prior experiments. Intact teeth were chosen 
and stored in ethanol 70% at room temperature until their use.  
Briefly, on the occlusal surface of human molars and on the buccal surface of goat incisors a 
cylindrical defect (about 3 mm in diameter) was made through the enamel until the dentin was 
reached. Subsequently, a smaller cavity (about 1 mm in diameter) was made in the dentin to 
reach the pulp. Thereafter, a direct pulp capping procedure was performed using CPC with 
and without csDCA. Finally, the cavities were filled with light cured (LC) glass ionomer 
cement (GC Fuji II LC
®
 CAPSULE, Cavex, Haarlem, the Netherlands). All samples were 
prepared in triplicate.  
2.7. In vivo direct pulp capping in goat incisors 
For the in vivo assay, animals involved in a non-related experiment were chosen (i.e. 
reduction of animal use). The work-protocol of the animal experiment was conducted using 
the facility and support of the College of Dentistry, King Saud University, Riyadh, Saudi 
Arabia, with the ethical reference number (PR0038). The animal study was not registered as a 
clinical trial. The in vivo experiment was requested to address three experimental hypothesis: 
1) is csDCA able to give MRI and CT signal after 7 weeks implantation in vivo; 2) is 
Chapter 4 
 
89 
 
CPC/csDCA/BMP-2 able to induce more dentin formation when compared to the control 
groups; 3) is CPC/csDCA/BMP-2 degrading faster when compared to the control groups. The 
needed sample size was calculated through G*Power software (Erdfelder, Faul, & Buchner, 
1996) [32] by using a significance level of 0.05 and 80% power. A standard deviation (SD) of 
25% and effect size (d) of 40% were defined based on previous studies related to dentin 
regeneration [33, 34]. A split-mouth design was used [35]. This usually enhances the power of 
the study, but the extent of that increase could not be readily estimated. Therefore, the number 
of animals used was the one obtained in the conservative power calculation. The lower four 
incisors of each animal were distributed to the four experimental groups (i.e. empty defect, 
pulp capping with CPC, pulp capping with CPC/csDCA and pulp capping with 
CPC/csDCA/BMP-2) through a block randomization approach (n = 6 for all the experimental 
groups, see Table 1). Allocation of the animals to each split-mouth group was also performed 
through a simple randomization method (i.e. the first animal picked was named as Animal 1, 
etc.). The study population, used for in vivo direct pulp capping, consisted of 6 healthy, 18 
months old, Habsi male goats. At this age the four lower goat incisors are all erupted and have 
a similar morphology, reducing the inter-group variability [36]. Pulp capping was performed 
by a single expert operator that was trained in the standardization of the surgical procedure 
according to previous work [33]. All procedures were performed under general anesthesia 
induced by intramuscular (IM) injection of ketamine hydrochloride (5 mg/kg) and diazepam 
(1 mg/kg). To reduce the risk of infection, animals were receiving antibiotics pre-operatively 
(10 mg/kg intravenously; Amoxicillin
®
), and post-operatively, at day 1 and day 3 (50 mg/kg 
intramuscularly; Albipen
®
). To alleviate pain analgesic Finadyne
® 
(1mg/kg) was given three 
times a day. Animals were immobilized in a ventral position. The oral tissues were disinfected 
with 10% Povidone-iodine. Afterward, local anesthesia (Lidocaine 2% with 1:100,000 
Epinephrine) was injected around the lower incisors. A cavity was drilled on the vestibular 
surface of the lower incisor by using a sterile round-shaped bur (1 mm in diameter) mounted 
on conventional dental handpiece with an appropriate speed and irrigation (Supplementary 
Information, Figure S1b). A cylindrical defect (about 1 mm in diameter and 2 mm in length) 
was prepared through the full enamel, dentin and pulp cavity until the dentin on the lingual 
side was reached (Figure S1c). In this way, pulp tissue along the direction of the defect was 
also ripped out from the pulp canal (i.e. partial pulpotomy). During the dental procedure, a 
sterile 0.9% saline solution was used to cool down the drill and to remove the debris. A cotton 
pellet was placed over the defect for 2-3 minutes to control the pulp hemorrhage until the 
bleeding was completely controlled.  
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Pulp capping was performed using one of the experimental cement pastes inserted in the 
prepared cavity with a passive application by means of a Dycal
®
 placement instrument 
(Dentsply Sirona, York, PA). Light pressure was applied using a wet cotton pellet to ensure 
that the paste would reach the deepest part of the cavity. Also, one group was included 
leaving the cavities empty (n=6). Due to the chosen experimental groups, the main operator 
was only partially blinded. Although the cement pastes were prepared by another assistant 
operator, the difference in color between the pastes (i.e. white color for the CPC and brown 
color for the CPC/csDCA and the CPC/csDCA/BMP-2) hindered a completely blinded 
procedure. Still, the main operator was not able to recognize CPC/csDCA from 
CPC/csDCA/BMP-2 pastes. Two primary outcomes were evaluated during the surgical 
procedure, i.e. the ability to handle the prepared paste with a specific dental instrument 
(Dycal
®
 placement instrument), and the ability of the paste to seal the defect. A defined score 
(i.e. very poor, poor, good, and very good) was attributed by the operator to each specimen. 
After material placement, all cavities were filled with light cured (LC) glass ionomer cement 
(GC Fuji II LC
®
 CAPSULE, Cavex) (Figure S1e and S1f). Animals were housed together on 
a goat farm. Seven weeks post-surgery animals were euthanized by an overdose of 
Nembutal® (Apharmo, Arnhem, the Netherlands). Lower incisors were extracted and cleaned 
from the soft tissue. The apical part of the incisors was removed to allow fixative (i.e. 10% 
Formalin for one week) to flow through the tissues.  
2.8. Ex vivo µCT 
All specimens (i.e. human and goat teeth from ex vivo study and goat incisors from in vivo 
study) were wrapped in Parafilm® (SERVA Electrophoresis GmbH, Heidelberg, Germany) 
and scanned vertically along the direction of the X-ray beam by means of a micro-computer 
tomography imaging system (Skyscan 1072, Kontich, Belgium). The following parameters 
were used to get a two-dimensional (2D) reconstruction: X-ray source 100 kV/98 µA, 
exposure time 3.9 s and 1 mm Aluminium filter. Human molars were scanned using X15 
magnification (pixel resolution = 18,88 µm). Goat incisors magnification was set at X25 
(pixel resolution = 11,10 µm). Gray values of a defined volume of interest (VOI) were 
analyzed by CTAnalyser software (version 1.10.1.0, Skyscan) while two-dimensional 
reconstruction was obtained by DataViewer software (Skyscan 1.5.2.4). 
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Table 1. Randomization scheme of the implanted experimental groups and illustration of the 
goat lower incisors with individual tooth number. 
 
New dentin formation and cement degradation were both quantified based on µCT 
acquisitions by using CTAnalyser software (Skyscan). Discrimination between reactionary 
and reparative dentin was not possible from µCT acquisitions because of imaging resolution 
limits. Therefore, both kinds of dentin were considered together. Briefly, a cylinder of 1 mm 
in diameter and 2 mm in height was selected and located in the proximity of the formed dentin 
cap. Relative volume was independently quantified using a standardized gray value threshold 
and expressed in percentage. For the cement degradation, a cylinder of 2.5 mm in diameter 
and 1.5 mm in height was selected and placed in proximity of the performed defect. After 
applying a standardized threshold relative volume was quantified and expressed in 
percentage. To exclude bias from possible dentin debris left in the defect area after drilling 
values were normalized by the mean of the dentin-like components volume present in the 
empty defect group.  
2.9. Ex vivo MRI 
Prior to the MRI examination, all human and goat teeth specimens (i.e. from ex vivo and in 
vivo studies) were embedded in gelatin type A (Sigma-Aldrich) dissolved in MilliQ water 
with a final concentration of 5% (wt/v). Thereafter, samples were imaged on an 11.7 Tesla (T) 
MRI system (Biospec, Bruker) equipped with a proton quadrature volume coil. A zero echo 
time (ZTE) sequence was employed for the image acquisition. The corresponding scan 
parameters were repetition time (TR) = 2 ms, flip angle (FA) = 3°, averages = 3, acquisition 
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time (TA) = 27.34 minutes, matrix size = 256 x 256 x 256 and image resolution = 0.16 mm
3
. 
The acquired images were analyzed using OsiriX software (Pixmeo, Bernex, Switzerland). 
Qualitative evaluation of the MR images was performed to assess signal enhancement, pulp 
tissue integrity and new dentin formation.  
2.10. Histological analysis  
After fixation, goat incisors from the in vivo study were dehydrated in a graded series of 
ethanol (70-100%) and embedded in poly(methyl methacrylate) resin. Cross-sections of 
approximately 10 µm were prepared along the sagittal direction of the tooth. At least three 
sections per sample were obtained and stained with Methylene Blue and Basic Fuchsin. 
Images were acquired using a light microscope (A io Imager Z1, Zeiss, Gӧttingen, Germany) 
equipped with a digital camera (AxioCam MRc5, Zeiss). Micrographs were obtained at X1, 
X10 and X20 magnification. Qualitative evaluation of the acquired micrographs was executed 
independently by three different operators. Tertiary dentin was classified as reactionary dentin 
or reparative dentin as described elsewhere [6]. Briefly, dentin showing tubular structures in 
continuity with the pre-existing secondary dentin was classified as reactionary dentin, while 
atubular calcified scar tissues were classified as reparative dentin.  
2.11. Statistical analysis  
Statistical analysis was performed by using IBM SPSS Statistic 22.0 software (IBM 
Corporation, Armonk, NY). Data were reported as mean ± standard deviation. Statistical 
significant differences in the mechanical properties were investigated by using a Student-t-test 
with Welch’s correction. Differences in setting times, in gray values, by one-way analysis of 
variance (ANOVA) with Tukey post hoc test. Differences in dentin formation and cement 
degradation were analyzed by using a Friedman`s analysis of variance by ranks. All 
differences were considered significant at p-values <0.05. 
3. Results 
3.1.  Morphological characterization  
Scanning electron micrographs of the CPC components (i.e. α-TCP, CMC and PLGA) are 
reported in the supplementary information (Figure S2). Core-shell DCA particles are shown in 
Figure 1a. On the external surface of the particles, it was possible to identify apatite-like 
structures as result of the coating step during the manufacturing process. TEM section images 
of the csDCA showed finest details on the complex structure of the particles. Specifically, a 
shell was distinguishable as a dark ring on the external side of the particles, which 
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corresponded to the apatite-like coated layer. The external shell was surrounding core-shell 
nanoparticles (i.e. SPIO/gold), which appeared homogeneously distributed in a bright phase 
(i.e. silica matrix) (Figure 1b). Visual inspection of the CPC/csDCA composition, after 
mixing with the setting solution, showed a uniform brown colored paste, indicating a 
homogeneous distribution of particles in the cement phase (Figure 2f). SEM micrographs and 
EDS analysis based on silicium detection confirmed that csDCA particles were evenly 
distributed over the CPC matrix (Figure 1c). Finally, connective apatite-like junctions 
between particles themselves and between particles and CPC phase were also identified 
(Figure 3d).  
 
Figure 1. Morphological characterization. In (a) Scanning electron micrograph of csDCA particles at X10000 
magnification; in (b) Transmission electron micrograph of the cross-section of a csDCA particle. It is possible to 
identify the apatite-like layer (i.e. dark ring), the core-shell structures (i.e. dark spots) and the silica matrix (i.e. 
bright phase). Magnification X4000. In (c) overlapping between SEM image and EDS spatial resolution map 
based on Silicium (magnification X1000). In (d) SEM image of csDCA particles entrapped in the CPC phase 
(magnification X1000). Yellow arrows indicate junctions between particle/particle and particle/cement. 
 
3.2. Mechanical and handling properties  
Assessment of the primary outcomes, related to the handling and sealing features of the 
cement pastes during the surgical procedure, showed no differences between CPC, 
CPC/csDCA, and CPC/csDCA/BMP-2 groups. All the pastes showed good consistency and 
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could be inserted in the defect in a relatively easy manner. The pulp bleeding could be 
stopped after pastes insertion suggesting good sealing properties for all the prepared CPC 
compositions.    
Evaluation of the setting times showed a small (< 3 min) but statistically significant increase 
in the initial and final setting for the CPC/csDCA composite and for the theranostic 
CPC/csDCA/BMP-2 agent when compared to the CPC control (i.e. without csDCA and BMP-
2; Figure 2a). Measurement from the compression tests reported no statistical differences in 
compressive strength and in E-modulus between the CPC with or without csDCA (Figure 2c 
and 2d). Extrusion curves from the injectability tests (Figure 2b) showed a similar behavior 
between CPC and CPC/csDCA, while qualitative evaluation of the cohesion reported a 
highest score for the CPC control when compared to the CPC/csDCA (Figure 2e, 2f, and S3). 
Finally, during the material preparation and implantation, no other differences were found in 
handling the CPC composition with and without csDCA.  
3.3. Visual properties of CPC/csDCA implanted ex vivo in human molars and goat incisors 
A ZTE sequence was used to image CPC restored human molars (Figure 3a) and goat incisors 
(Figure 3b) ex vivo. On the ZTE images teeth implanted only with CPC, showed a 
hyperintensity for this material compared to surrounding dental tissues (Figures 3c, 3d). 
However, for the teeth filled with CPC/csDCA, a stronger effect (i.e. “blooming effect”) on 
the MR signal is observed resulting in hypointensity for the CPC regions on the ZTE images 
(Figure 3e and 3f). Because of the blooming effect, which extends the contrast effect on the 
MR signal, the identification of the cement was easier for the CPC/csDCA composite when 
compared to the CPC alone. Glass ionomer filler was identified as a hypointense area (i.e. 
dark area; Figure 3). 
Micro-CT reconstructions of the teeth showed a clear difference in contrast between the 
specimens treated with CPC/csDCA and the samples treated with only CPC (Figure 4a, 4b, 4d 
and 4e). Specifically, CPC/csDCA was clearly distinguished from the surrounding dental 
tissues in both kinds of specimens (i.e. human molar and goat incisors). Differently, the CPC 
control showed similar contrast to the dentin, hence the CPC was barely recognizable. 
Quantitative assessment of the mean level of the gray values distribution showed an increased 
frequency for CPC compositions with csDCA when compared to CPC alone (for both human 
and goat specimens). Moreover, the CPC/csDCA formulations showed a leftward shift of gray 
values curve. Beside such shift, no overlapping between gray values curve of the CPC/csDCA 
Chapter 4 
 
95 
 
and of the natural dentin occurred (Figure 4c and 4f). In all specimens, glass ionomer filler 
showed the highest CT attenuation features resulting in a completely dark area (Figure 4).  
 
Figure 2. Mechano-physical properties. In (a) initial and final setting times from Gillmore test (n=3) for the 
CPC (in red), the CPC/csDCA (in blue) and the CPC/csDCA/BMP-2 (in green) composite. In (b) 
extrusion curves from injectability test (n=3), in (c) E-Modulus and in (d) compressive strength (n=8) for 
the CPC (in red) and the CPC/csDCA (in blue) are shown. In (e) and (f) representative pictures from 
CPC and CPC/csDCA from the cohesion tests (n=3) are reported. 
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3.4.  Visual properties of CPC/csDCA implanted in vivo in goat incisors 
After surgery, all animals appeared to be in good health condition throughout the entire 
experimental period. No visual damage or trauma was found in the treated incisors.  
Using ZTE MRI to acquire these goat incisors (Figure 5), differences were found between 
different groups. While a dark region was found on the images for the incisors with no filling 
(Figure 5a), teeth filled with CPC control (Figure 5b) showed a brighter signal when 
compared to the surrounding dentin tissue. A blooming artifact was found on the ZTE images 
for the teeth filled with either CPC/csDCA and CPC/csDCA/BMP-2 (Figures 5c and 5d). 
Interestingly, a visually stronger blooming effect was observed on the CPC/csDCA samples 
when compared to the ones treated with CPC/csDCA/BMP-2. ZTE MR images were also 
used to identify newly formed dentin (Figure S4).  
Micro-CT 2D reconstructions showed that differences in contrast between samples with and 
without contrast agent vanished at 7 weeks post-surgery (Figure 5). These outcomes were 
confirmed by gray value quantification, which reported a reduced shift of the gray value curve 
for teeth treated with CPC/csDCA when compared to teeth treated with only CPC (Figure 6). 
Interestingly, samples treated with BMP-2 showed higher frequency intensity when compared 
to the other compositions, suggesting a higher radiodensity. Finally, the comparison between 
the CPCs implanted ex vivo (i.e. fresh paste) and in vivo (i.e. after 7 weeks degradation) was 
also performed (Figure S5). Our outcomes reported a higher CT contrast enhancement for the 
cements implanted ex vivo when compared to the same composition implanted in vivo 
resulting in a weaker material signal enhancement. These findings are in line with the 
obtained MRI data. 
Similarly to the in vitro outcomes, glass ionomer filler was always identified as a 
hypointense area in the MR images and as a dark area in the µCT reconstructions respectively 
(Figure 5). 
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Figure 3. ZTE MR images of human molars (coronal view) and goat incisors (sagittal view) after ex vivo pulp 
capping. In (a) and (b) an overview of a human molar and a goat incisor are shown respectively. In figures (c) 
and (d) teeth treated with CPC, while in (e) and (f) teeth treated with CPC/csDCA are shown respectively. Blue 
and yellow arrows indicate the applied ceramic material and the glass ionomer respectively. A strong blooming 
effect is noticed on the images only when csDCA was used. 
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Figure 4. µCT characterization of human molar (coronal view) and goat incisor (along with the sagittal view) 
after ex vivo pulp capping. Respectively in (a) human molars treated with CPC, in (b) human molar treated with 
CPC/csDCA, in (d) goat incisor treated with CPC and in (e) goat incisor treated with CPC/csDCA. Blue arrows 
indicate the installed ceramic material. Yellow arrows indicate the glass ionomer. In (c) and (f) are reported the 
graphs from gray value distribution assessment for human and goat teeth respectively (n=3). The curves of the 
gray values based on a defined VOI are shown respectively in red for CPC, in blue for CPC/csDCA and in green 
for dentin. 
 
Figure 5. Goat incisors after the in vivo direct pulp capping. On the top MRI acquisitions, while on the bottom 
µCT reconstructions are reported respectively (sagittal view). Respectively, from the right to the left the same 
incisor from empty defect, CPC, CPC/csDCA and CPC/csDCA/BMP-2 group is reported. In the empty defect 
specimen the white region indicates the empty space. Blue arrows point out the cylindrical defect with or without 
implanted material, while yellow arrows indicate a thin layer corresponding to the glass ionomer filler. 
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3.5. Dentin and cement quantification 
New dentin formation and cement degradation were quantified by µCT. Quantification of 
relative new dentin formation reported a statistically significant increase of the dentin 
deposition for the incisors treated with the theranostic CPC/csDCA/BMP-2 when compared to 
the empty defect group (Figure 7a). When looking at the same data clustered for each animal, 
the incisors treated with CPC/csDCA/BMP-2 were showing more dentin deposition when 
compared to the other experimental groups over all the studied population (Figure S6a).  
Quantification of the relative volume of the cement left in the defect after 7 weeks from the in 
vivo installation reported statistically higher values for the groups treated with CPC and 
CPC/csDCA when compared to the theranostic CPC/csDCA/BMP-2 agent (Figure 7b). After 
plotting the same data clustered as function of the single animals all the incisors receiving 
CPC/csDCA/BMP-2 showed less cement volume percentage when compared to the other 
experimental groups over all the studied animals (Figure S6b). 
 
Figure 7. Quantitative evaluation of (a) the tertiary dentin formation and of (b) the cement degradation 
calculated based on µCT acquisitions (n=6). # means p<0.05. 
 
Figure 6. Gray value distribution of cement 
compositions after installation in vivo in goat 
incisors (n=6). Gray value curves from CPC 
composite doped with csDCA (i.e. blue 
curve) and csDCA/BMP-2 (i.e. green curve) 
showed a leftward shift compared with the 
CPC control (i.e. red curve) due to the 
presence of the contrast agent. 
CPC/csDCA/BMP-2 is also showing and 
increased radio-density. No overlapping with 
the gray value curve from the dentin phase 
(i.e. dark gray curve) was observed. 
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3.6. Histology 
Histological qualitative inspection showed that the defect was drilled through the full enamel, 
dentin and root canal until the dentin on the lingual side of the incisor was touched (Figure 8). 
Defects were homogeneous in size and shape and only sporadically were slightly downwards 
inclined (Figure 8a). All defects appeared still filled with the applied glass ionomer filler and 
with the cement (i.e. except for the empty defect group). All cement types showed a 
homogeneously distributed porosity and occasionally some micro cracks along the cement 
phase. These cracks were mainly located in the cement part, which was close to the root canal, 
while the cement far from the canal appeared to be always intact (Figure 8b, 8c, 8d). In all 
specimens, signs of inflammatory response were identified in the pulp canal in the proximity 
of the applied cement resulting in a violet stained area. Such area resulted visually wider in 
five out of six samples treated with BMP-2. In some cases, cement was found also in the pulp 
cavity in the proximity of the defect. In all samples, intact pulp tissue was found only in the 
lower part of the tooth (i.e. below the defect), while the upper part of the pulp cavity appeared 
completely or partially empty (i.e. partial pulpotomy). Dentin debris was always identified in 
the pulp cavity, right above and beneath the defect. Noticeably, all the samples were showing 
tertiary dentin formation. Newly formed dentin was clearly demarcated from the adjacent 
secondary dentin by a difference in color in the histological section from a dark to a brighter 
pink tint. The new dentin located into the lower part of the canal was forming a sealing cap 
between the defect and the underneath pulp. Such dentin showed an amorphous morphology 
as well as a lack of tubular structures, hence classified as reparative-like dentin. Reparative-
like dentin was also visually identified around pre-existing debris of secondary dentin 
originated during the drilling. In such circumstances, new dentin was holding together all pre-
existing pieces of dentin and forming a sealing layer that appeared as a dark circular region 
(i.e. corresponding to the debris) surrounded by bright pink tissue (Figure 8b, 8d). New dentin 
was observed also on the surface of the pulp canal, in the proximity of the sealing cap, where 
it was giving rise to a narrowing of the canal itself. This new type of dentin formed on the 
surface of the pulp canal walls showed irregular tubular structures, homogeneously distributed 
and in continuity with pre-existing tubules in the secondary dentin, hence classified as 
reactionary-like dentin (Figure 8 and S7).  
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Figure 8. Histological overview of different experimental groups after direct pulp capping performed in vivo in 
goat incisors. Respectively in (a) an example of empty defect incisor, in (b) a defect filled with CPC, in (c) a 
defect filled with CPC/csDCA and in (d) a defect filled with CPC/csDCA/BMP-2. In each panel, on the left an 
overview of the incisor (X1 magnification), on the top-right the cylindrical defect (X10 magnification), on the 
bottom-right the pulp canal with the newly formed dentin (X10 magnification). All sections were made along the 
sagittal direction and perpendicularly to the created incisor defect. In all specimens tertiary dentin formed a 
dentin bridge consisting of a combination of reactionary dentin and reparative dentin. Reparative dentin was 
identified in the central part of the pulp canal (yellow arrows). Reactionary dentin was observed on the surface of 
the pulp canal (green arrows). In all specimens the applied glass ionomer was still clearly visible (blue arrows). 
All cement composites showed a diffuse porosity, while the samples treated with BMP-2 showed more cement 
degradation.  
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4.  Discussion 
A variety of biomaterials, e.g. calcium hydroxide, mineral trioxide aggregate, calcium cement 
phosphate, have been used for pulp treatment [1-10]. Since calcium hydro ide, the “gold 
standard” material for pulp capping applications, has several shortcomings, this study 
considered CPC [11-13]. Besides the optimal biological and handling properties, calcium 
phosphate-based composites can induce dentin remineralization and inhibit caries [14,15]. 
Within this study, an alternative theranostic agent for pulp treatment was presented. The 
theranostic pulp capping agent combined a calcium phosphate-based composite with csDCA 
for the enhancement of the MRI and CT imaging properties. In addition, in a part of the 
samples, BMP-2 was incorporated to improve the biological properties. In general, it was 
found that contrast agents could be combined with the CPC without changing the final 
handling and mechanical properties. Enhancement of the MRI contrast allowed in vivo 
detection of the CPC up to 7 weeks after implantation, while BMP-2 promoted increased 
dentin deposition and faster cement degradation.  
Several remarks can be made regarding the study set-up. First, pilot studies were performed 
to define the right DCA type to be added to the CPC with respect to a dental application. A 
previous study [27] had already confirmed that the combination of DCA particles with CPC at 
a final concentration of 5% wt/wt did not affect the handling and mechanical properties of the 
final composite. Therefore, in the current study, we decided to use the same ratio DCA to 
CPC. After testing different kind of DCA particles (Supplementary information, Table S1), 
csDCA was selected because of the best performance in terms of enhancement of the MRI 
and CT contrast (Figure S8 and S9). 
A second technical remark should be made regarding the coating procedure. The 
morphological characterization of the csDCA revealed the external surface structure of the 
particles as well as their inner part. Although we did not specifically investigate, the external 
apatite-like coating layer appeared to be advantageous for the affinity of the csDCA to the 
CPC phase, due to the formation of connective apatite-based junctions between particles and 
CPC matrix.  
Handling and mechanical properties of the hereby presented CPC/csDCA composite were 
investigated and compared to the CPC without csDCA. A slight increase in setting times was 
found, probably due to the physical incorporation of the csDCA into the CPC phase.  
Nevertheless, settings were occurring within the ranges that are acceptable for clinical use; i.e. 
initial time <10 min and final time <25 min [38]. Furthermore, the mechanical properties of 
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our cements were similar and in line with most of the ceramic compositions reported in the 
literature [11]. 
Incorporation of csDCA into the CPC, showed ex vivo a significant enhancement in MRI 
and µCT contrast. Consistently with previous studies, MRI acquisitions of the csDCA-doped 
CPC composite showed an overestimation of the shape and size of the CPC composite as a 
consequence of the strong magnetic susceptibility gradients caused by the iron oxide-based 
particles, which resulted in imaging artifacts (i.e. blooming effect) [26,27]. Such artifacts 
allow for an easy localization despite the relatively small size of the applied material (i.e. < 1 
mm
3
). Unequivocally, size overestimation results in a lack of anatomical information. New 
developed MR imaging techniques, such as slice encoding for metal artifact correction 
(SEMAC) and multi-acquisition variable-resonance imaging combination (MAVRIC) could 
be used to correct metal artifacts and improve image quality [39,40]. Furthermore, 
heteronuclear-based contrast agents, such as 
19
F-based compounds, could be used as a valid 
alternative to SPIO for the labeling of CPC composites [41].  
After ex vivo characterization of the imaging and mechanical properties, an in vivo study 
was imminent to investigate the imaging properties and biological response to the theranostic 
agent. Our in vivo study was based on a direct pulp capping procedure, which is a relatively 
simple model, which is well established and commonly performed in clinics (Figure S1). The 
goat was used as animal model due to its big body size, which allows to perform multiple 
implants in the same entity and reduce the total number of animals needed. Furthermore, the 
number of experiments performed on goats, and sheep, is constantly growing as these animals 
are considered food producing animal, therefore more ethically accepted by either the 
scientific and the not scientific community when compared to other models (i.e. dogs) [37]. 
It is known that the natural condition of the exposed pulp influences the success rate of a 
pulp capping treatment. In the case of teeth with mechanically exposed pulp or with the pulp 
exposed after trauma, dentin has more chance to recover when compared to teeth with the 
pulp exposed as consequence of caries [5,6]. Moreover, partial pulpotomy (i.e. removal of a 
small portion of pulp tissue) can also increase the healing process [4]. For this reason, in the 
present study, during the drilling of the cylindrical defect, a small portion of pulp was 
mechanically removed. Afterward, by MRI, it was possible to assess the degree of pulpotomy 
achieved, i.e. how much tissue was removed, and correlate the pulp condition to the new 
dentin formation (Figure S4).  
Within seven weeks from the implantation in vivo, a certain ratio of material degradation 
was expected [33]. Nevertheless, the CPC/csDCA/BMP-2 composite was still clearly 
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identifiable by MRI. Evidently, the blooming signals from cements implanted in vivo were 
visually reduced when compared to the ex vivo experiments. Such a decrease can be explained 
by the physical release of the entrapped csDCA particles from the CPC matrix [27]. 
Furthermore, the weaker signal from samples treated with CPC/csDCA/BMP-2 confirmed a 
faster occurring cement degradation. In other words, the different amount of cement present in 
the defect could be identified by different degree of blooming effect intensity. Still, 
differences in CT attenuation between CPC composites with and without csDCA almost 
vanished after 7 weeks of implantation in vivo. All these results supported the hypothesis that 
by using CPC/csDCA/BMP-2 as pulp capping agent, MRI evaluation of the signal can be 
used as non-invasive in vivo clinical screening tool for the monitoring of the material 
degradation.  
Surely, radiation-free MRI has many potential advantages when compared to the 
conventional X-ray techniques [42]. Bracher et al. [23] showed that the performance of 3D 
MRI to identify caries lesions is similar to conventional X-ray, and even superior, in cases 
where X-ray is limited by a structural superimposition. MRI can be used for early detection of 
caries by assessing the increase in T2 and T2* values which occur as consequence of the local 
acidic environment due to the bacterial infection [23]. Furthermore, magnetic resonance 
spectroscopy (MRS) can be used in combination with MRI to quantitatively characterize 
dental structures and obtain more precise information about the microscopic mineral 
structures [43,44]. However, high costs and long acquisition times are limiting the use of MRI 
as screening tool in dental daily practice. To date, dental MRI is restricted to ex vivo and in 
vivo studies and few clinical validations. [21,23-24, 42-44] Therefore, before a real translation 
of MRI into dental clinics, dedicated low-cost systems, dental coils, short acquisition 
sequences and MRI compatible materials are strongly demanded. As the cost to purchase an 
MRI is estimated to be around 1 million $ per Tesla, a cost-effective solution could be the use 
very low magnetic fields (i.e. 20 – 50 mT), which can show high imaging performances 
relying on the pre-polarized MRI concept, as well as the use of short-bore systems [45]. Few 
dental-specific coils have been already developed, either cable-bound or wireless, and one is 
already commercially available (4-channel dental-array, Noras MRI Products GmbH, 
Höchberg, Germany) [46]. The hereby described MRI-dedicated material is pioneering in this 
context, despite the fact that its clinical applicability is not proven yet.  
When considering the histology in none of the samples signs of unwanted dentin resorption 
were found. In our experimental model a severe damage was applied by drilling and partial 
pulpotomy, and therefore the formation of reparative dentin was expected. However, our 
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samples showed deposition of tertiary dentin consisting of a combination of reactionary and 
reparative dentin. New dentin deposition occurring on the surface of the pulp canal showed 
the typical structures of a reactionary dentin (i.e. tubular structures in continuity with the pre-
existing secondary dentin). Differently, new dentin forming the sealing cap in the central part 
of the pulp canal was mainly atubular and amorphous. Evidently, the deposition of tertiary 
dentin represented a reparative process, most likely mediated by fibroblasts, which were 
responsible of the deposition of a permanent calcified scar tissue [6]. Since all samples 
showed deposition for similar tertiary dentin in the pulp canal, such biological response was 
interpreted as a normal dental reaction to the harmful stimulus. These outcomes are in line 
with results obtained in similar studies where calcium hydroxide was used instead of CPC 
[4,6,47].  
Consistently to previous studies an early inflammatory response was expected in all groups 
as a resolutive mechanism in the dentin healing process [48]. Furthermore, it is known that 
BMP-2 can induce in vivo the activation of an inflammatory response as well as angiogenesis 
and increase of blood supply [47,49]. An inflammatory environment is characterized by a 
drop in local pH, which is considered one of the main causes of the faster cement erosion. 
Low levels of inflammation have been shown to be beneficial in stimulating bone metabolic 
activity and regeneration [48]. Therefore we speculated that the hereby developed theranostic 
CPC/csDCA/BMP-2 composite facilitated higher dentin deposition and cement degradation as 
a consequence of all the biological mechanisms triggered by the applied BMP-2. 
There is an increasing concern about the validity of animal studies, which are supposed to 
be the last step before a human clinical trial. However, especially in dentin and pulp 
regeneration field, there is a lack of quantitative assessments of the new dentin deposition, as 
most of the studies are based on qualitative histological analysis [50]. Therefore, the 
translation of outcomes achieved in preclinical studies into clinical trials has been always 
difficult. In the current study qualitative assessment of dentin deposition performed via 
histology was supported by µCT quantification. However, neuronal and pulp regeneration 
were not investigated as well as the vitality of the teeth after the surgical procedure. Another 
limitation of this study is also related to the used small sample size, which could be used only 
for the detection of large size effect, possibly associated with an increasing risk of bias. 
Indeed, while a statistical difference between the group receiving CPC/csDCA/BMP-2 and 
the negative control (i.e. empty defect) was detectable, no differences could be found when 
the treated group was compared to the positive control (i.e. CPC group). Still, the promising 
results of this study could be useful to foster further studies with large sample size. For this 
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reason the report of our methodology was performed following as much as possible the 
ARRIVE guidelines for reporting in vivo experiments [51].   
5. Conclusion  
By engineering biomaterials, it is possible to improve their specific properties according to 
the specific need and application. In this study, the visibility and biological features of a 
calcium phosphate based composite were enhanced by using csDCA and BMP-2, 
respectively. The resulted “theranostic” pulp capping agent presented herein was found to be 
suitable for dental applications bringing several advantages. Firstly, the contrast of the CPC 
composition is enhanced by allowing for a better visualization, identification and follow-up 
after implantation in an in vivo clinical situation. Second, dentinogenic properties of the CPC 
were improved by using BMP-2, which resulted in an improved dentin deposition and a faster 
material degradation. In view of an upcoming wider use of dental MRI in the clinic, the 
presented theranostic pulp capping agent may help to improve MRI visibility of dental 
materials. 
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7. Supplementary information 
 
Figure S1. Schematic representation of pulp capping procedure performed in vivo in goat incisors. The 
vestibular surface of goat incisors was drilled by means of a drill equipped with a dental bur (1 mm in diameter). 
A cylindrical defect was performed into the crown and into the underlying dentin until the pulp was reached (i.e. 
pulp punctuation). After partial pulpotomy, the pulp was covered with one of the experimental CPC composites 
by using an adequate dental tool. After pulp capping the defect was filled with standard glass ionomer and the 
external surface was shaped according to the anatomical morphology. 
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Figure S2. SEM pictures of α-TCP (a), 
CMC (b), PLGA (c) particles. 
Respectively, magnifications are 
X1000, X250 and X250. 
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Figure S3. Pictures from cohesion tests (n=3). Respectively are shown the images of the CPC and the 
CPC/csDCA pastes after 24h incubation in PBS at 37°C. A score based on the number of broken pieces obtained 
after extrusion from a syringe orifice (1.7 mm in diameter) was attributed to each sample. Specifically the 
following score were given: +++ = 1 single piece, ++ = > 2 pieces and <3 pieces, + = > 3 pieces. The table on 
the right summarizes the score for each group. 
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Figure S4. Representation of the same tooth acquired respectively by CT (a), MRI (b) and histology (c). In all 
figures, yellow arrows indicate the tertiary dentin. In figure (b) green arrow indicates empty pulp canal after the 
performed pulpotomy, while blue arrow indicates intact pulp tissue. 
 
 
 
Figure S5. Comparison between gray 
values distribution of cement compositions 
implanted ex vivo (full line) and in vivo 
(dashed line). Respectively, is reported 
CPC in red and CPC/csDCA in blue. 
 
 
Figure S6. Dentin volume (a) and cement volume (b) percentage, from each different experimental group, 
plotted as function of the animal. Note in (a) that the incisors receiving CPC/csDCA/BMP-2 (purple rectangles) 
showed more dentin formation when compared to the other incisors in each animal. In (b) the incisors receiving 
CPC/csDCA/BMP-2 showed less cement when compared to the other incisors in each animal. 
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Figure S7. Histology picture of tertiary dentin formed in the pulp canal (i.e. sagittal direction of one 
representative goat incisor). Tertiary dentin was forming a sealing cap in the pulp canal between the pulp and the 
applied defect. Tertiary dentin consisted of a combination of reactionary and reparative dentin. New dentin 
formed on the wall of the pulp canal was in continuity with the pre-existing secondary dentin and classified as 
reactionary dentin. Dentin formed in the deepest part of the pulp canal was classified as reparative dentin. 
Yellow arrows are pointing out newly formed tubular structures that are in continuity with the original dental 
tubules. In few cases tubular structures were found also in the dentin cap close to the healthy pulp tissue. 
Magnification X20.  
 
 
Figure S8. Gray value distribution of the CPC composites combined with different DCA (according to Table 1 
from supplementary information).  A cylindrical defect (2 x 3 mm) was performed on the buccal surface of 
human molars and filled with CPC combined to different DCA. csDCA means core-shell structured DCA. Mixed 
DCA means SPIO and gold independently included in the DCA particle. By brackets is reported the SPIO/gold 
ratio in volume/volume. All particles were combined with the CPC at a final concentration of 5% wt/wt. Notice 
that the cdDCA (3:1) gave the best CT enhancement compared to the CPC control (i.e. without contrast agents).  
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Figure S9. MRI acquisitions of human teeth along the sagittal direction. A cylindrical defect (2 x 3 mm) was 
performed on the buccal surface and filled with CPC combined to different DCA according to Table 1 from 
supplementary information. All particles were combined with the CPC at a final concentration of 5% wt/wt. 
Respectively, in (a) CPC control without DCA, in (b) CPC plus csDCA (SPIO/gold = 6/1), in (c) CPC plus 
csDCA (SPIO/gold = 3/1), in (d) CPC plus mixed_DCA (SPIO/Gold = 1/1), in (e) CPC plus mixed_DCA 
(SPIO/Gold = 2/1). SPIO/gold ratios are meant volume/volume. Notice that the CPC plus csDCA (SPIO/gold = 
3/1) combination gave the strongest blooming artifact. 
 
Table S1. List of the different DCA particles tested. In each column is reported the structure of the particles and 
the SPIO/Gold ratio, respectively. Core-shell_DCA indicates particles with a core of SPIO and a shell of gold. 
Mixed_DCA indicate that SPIO and gold are separate nanoparticles. All particles are embedded in a silica matrix 
and coated with an apatite-like layer. All particles were combined with the CPC at a final concentration of 5% 
wt/wt. 
Type of particle SPIO/Gold ratio (v/v %) 
Core-Shell_DCA 
6:1 
3:1 
Mixed_DCA 
1:1 
1:2 
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1. Introduction 
Bone grafting is the most common transplantation procedure, after blood, with more than two 
million patients worldwide receiving a bone transplant every year [1,2]. To date, autografting 
of autologous bone is still the gold standard procedure. However, drawbacks such as the need 
for a second surgery, high donor-site morbidity, and shortage of donor bone, are increasing 
the demand for artificial bone substitutes. Since 1920, calcium phosphate-based cement 
(CPC) has been extensively studied and used for orthopedic and dental applications, due to its 
high biocompatibility, biodegradability and osteoconductivity [3-5]. Moreover, the ability to 
be injected and to set at body temperature in vivo, makes CPC suitable for minimally invasive 
surgeries [6]. Two criteria are important in the application of CPC in bone repair: mechanical 
properties that are tailored to the specific application and an adequate imaging contrast that 
allows for monitoring cement after injection, particularly to monitor its degradation [6,7]. 
However, only a few strategies have been successful in the synthesis of CPC that meet both 
criteria, as labeling the cement typically affects its mechanical properties. X-ray and CT are 
the most common methods to monitor bone defects and the formation of new bone [8,9]. Non-
labeled CPCs have a slightly higher radio-density than the natural bone, resulting in a brighter 
signal on conventional X-ray radiographs. However, the geometrical conformation of the 
cement is barely recognizable after surgery. Longitudinal monitoring becomes even more 
challenging when degradation of the material and the in-growth of the new bone begins [10-
12]. Addition of radiopaque salts, such as barium sulfate or tantalum oxide, can enhance the 
radio-contrast of CPC without affecting its biological behavior [13-16]. However, the 
incorporation of such salts affects the setting and mechanical properties of the cement, 
making it less suitable for clinical application. To avoid changes in cement properties after 
labeling, different strategies, such as the encapsulation of probes into a silica carrier, have 
been described [17-18].
 
Also gold nanoparticles (AuNPs) are promising for CT because gold 
has a high atomic number (Z = 79) and high X-ray attenuation per mass (5.16 cm
2 
g
-1 
at 100 
keV). Moreover, biocompatibility, low toxicity, and high affinity of gold nanoparticles to 
different functional groups, for example thiol or phosphine, make AuNPs suitable for labeling 
biomaterials [19-21]. However, no successful strategy for long term labeling of CPC with 
gold has been described thus far. 
MR imaging of hard tissues (i.e. bone and teeth) requires acquisition sequences sensitive to 
their very short transversal relaxation such as ultra short echo time (UTE) and zero echo time 
(ZTE) sequences [22, 23]. However, in MR images with these sequences, bone transplants do 
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not provide enough contrast, making labeling essential [24]. Multimodal imaging with MRI 
and CT is advantageous, as it allows the acquisition of independent information using two 
different imaging techniques. The use of two independent labels with different 
physicochemical properties and different affinity to CPC, could reduce problems such as a 
decrease or complete loss of the signal due to, for example, diffusion of non-covalently 
attached label from the CPC matrix. The first CPC mixture that was labeled with multiple 
imaging agents contained superparamagnetic iron oxide particles (SPIO, 200 nm in diameter) 
and colloidal gold (4 nm in diameter), respectively as MRI and CT contrast agents [17, 18]. 
However, the strong susceptibility artifacts caused by SPIO particles resulted in a gross 
overestimation of the implant shape [25, 26]. Together with the fast decrease of the CT 
contrast over time, the use of this strategy became very limited. The labeling of CPC with 
heteronuclei, such as 
19
F, 
31
P or 
23
Na, natural isotopes with spin of ½ that can be directly 
detected with MRI, could be an excellent alternative to SPIO. Fluorine is especially attractive 
as it is almost completely absent from biological tissues, which results in a high MR contrast-
to-noise ratio and specificity, and it has a similar intrinsic high sensitivity as that of protons 
[27-32]. Typical 
19
F MRI labels contain organofluorine compounds, in particular liquid 
perfluorocarbons (PFCs). Perfluorocarbons are biologically inert and exhibit low toxicity. 
Therefore, they have been used in the clinic as blood substitutes, and more recently as MR 
imaging agents [33-36]. 
In this study, we combined 
19
F MRI and CT for imaging the CPC in bone for the first time, 
using perfluoro-15-crown-5-ether (PFCE)-loaded poly(d,l-lactide-co-glycolide) (PLGA) 
nanoparticles and commercially-available gold nanoparticles (AuNPs). PFCE nanoparticles 
have previously only been applied to image labeled cells, i.e. soft tissues [35].
 
Here we use 
these nanoparticles for imaging of bone substitutes. We decided to use AuNPs because they 
are also effective for both promoting osteoblast differentiation and bone formation [37, 38]. 
This newly developed CPC/PFCE/gold composite was first characterized in vitro and then 
implanted in vivo in a rat femoral condyle model. We followed material degradation by in 
vivo 
1
H/
19
F MRI and CT up to 8 weeks post-surgery, and correlated the images to the 
biological tissue response.  
2. Materials and methods 
2.1. CPC composite  
Calcium phosphate cement (CPC) was prepared as a w/w mixture of 78.5% alpha-tricalcium 
phosphate (α-TCP; CAM Bioceramics BV, Leiden, The Netherlands), 1.5% 
Chapter 5 
 
121 
 
carboxymethylcellulose (CMC; CAM Bioceramics) and 20% of cryo-grinded poly(d,l-lactide-
co-glycolide) microparticles (<200 µm) with a 50:50 ratio of lactic to glycolic acid 
(PURASOB 5002A, Purac, Gorinchem, the Netherlands).  
2.2. Contrast agents  
PFCE-loaded PLGA nanoparticles were prepared as described elsewhere [35]. Briefly, PLGA 
(100 mg) was dissolved in dichloromethane (3 mL) and mixed with PFCE (0.9 mL) and 
Prohance® (1.78 mL). The resulting emulsion was added quickly under sonication to 25 mL 
of 1.96% (w/w) solution of poly(vinyl alcohol) (9-10 kDa, 80% hydrolyzed) and sonicated for 
3 min at 40% amplitude (Branson Digital Sonifier 250; Branson Sonic power, Danbury, CT). 
After evaporation of the solvent over night the particles were washed four times with water at 
16000 g, resuspended in water and freeze-dried, yielding of approximately 100-150 mg of 
particles as white powder. PFCE was purchased from Exfluor, Rond Rock, TX; PLGA 
Resomer RG 502H, lactide:glycolide molar ratio 48:52-52:48, from Evonic, Germany; 
dichloromethane from Merck, Darmstadt, Germany; and PVA from Sigma-Aldrich, St Loius, 
MO. 
Gold nanoparticles (diameter 40 nm) stabilized by citrate in 0.1 mM phosphate buffered 
saline solution (PBS) were purchased from Sigma and used without any additional 
modification.  
2.3. Material preparation  
The CPC control (i.e. without contrast agents) was prepared by adding the mixed powders 
(i.e. α-TCP, CMC and PLGA) into an exit-closed 2 mL syringe (Terumo Europe N.V., 
Leuven, Belgium). Afterwards 50 µL of sterile-filtered (0.2 µm filter) sodium dihydrogen 
phosphate solution (4% NaH2PO4•2H2O) were added into the syringe and shaken for 30 s by 
means of a dental shaker machine (SilamatMixing apparatus, Vivadent, Schaan, 
Liechtenstein).  
In order to add the contrast agents to the starting CPC composition additional steps were 
requested. Briefly, 100 mg initial powders of CPC were first mixed with 1 mL AuNPs 
solution (corresponding to ~7.2 x 10
9
 particles), homogenized by vortex and freeze-dried over 
night. Thereafter, 20 mg PLGA/PFCE nanoparticles were first resuspended in 1 mL of 
MilliQ
®
 water and then added to the CPC/gold powder. The solution was then vortexed and 
freeze-dried again providing the final composition, which is indicated in this study as 
CPC/PFCE/gold.  
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An additional CPC composite was prepared by performing the same freeze-dry steps as 
described before, but using MilliQ
®
 water alone, without any contrast agents. This 
CPC/freeze-dry composite was used as an internal control for the characterization of the 
handling and mechanical properties. Samples were sterilized by using 25 kGy of gamma 
radiation (Synergy Health Ede B.V., Ede, the Netherlands). 
2.4. Material characterization  
Morphological assessment of the PFCE-loaded PLGA nanoparticles and of pre-set cylinders 
of CPC/PFCE/gold was performed by electron scanning microscopy (SEM, JEOL 6310, Jeol 
corporation, Tokyo, Japan). Images were acquired at 5 kV with X5000 magnification. 
The size and the zeta potential of the PLGA/PFCE nanoparticles was measured by dynamic 
light scattering (DLS) using a Malvern Zetaziser Nano ZS (Malvern Instrument, 
Worcestershire, UK) at sample concentration of 0.1 mg/mL, using ultrapure water as a solvent 
for DLS and 5 mM sodium chloride solution for zeta potential measurements. The content of 
PFCE was determined by 
19
F NMR (Bruker Avance 400) using trifluoroacetic acid as an 
internal reference and deuterium oxide as solvent (both from Sigma-Aldrich). 
2.5. Cement handling and mechanical properties  
Setting times, elasticity, compression strength, injectability and cohesion properties of the 
CPC with and without contrast agents were investigated. As internal control the CPC/freeze-
dried composite was also used.  
For the setting times, a Gillmore apparatus according to ASTM C266 was used. The cement 
pastes were injected in a cylindrical bronze mould of 6 mm in diameter and 12 mm in height, 
and immersed in a water bath at 37 °C after which initial and final setting times were 
recorded. The elasticity and the compressive strength were calculated by using a testing bench 
machine (858 MiniBionixII, MTS, Eden Prairie, MN). Cylinders of 4.5 mm in diameter and 9 
mm in height were prepared from the CPC mixtures, and compressed with a loading force of 
2.5 kN at a constant speed of 0.5 mm min
-1
. The injectability was assessed by using the same 
testing bench machine (858 MiniBionixII) set in a compression mode and adapted with a 
custom-made fixture metallic cage. A total weight of 500 mg for each cement composition 
was mixed into an exit-closed 2 mL syringe (Terumo Europe N.V.) with 250 µL of setting 
solution (4% NaH2PO4•2H2O). After mixing the components for 30 s, the syringe was placed 
in the metallic cage, the exit was opened, and a compression force of 100 N (i.e. estimated 
maximum force applicable by human operator) was applied with a constant speed of 20 mm 
min
-1
 until all the material was extruded from the syringe (33 ± 2 s). From the raw data, the 
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extrusion curve was obtained as reported in the literature as applied force (N) by the time (s) 
[39]. Finally all the cements extruded from the syringes were accumulated in 10 mL of PBS at 
37°C and the cohesive properties were qualitatively assessed (i.e. by counting the number of 
fragments). 
2.6. In vitro assay  
A cylindrical hole (3 x 3 mm) was drilled into bone blocks (~1 cm
3
) obtained from pig 
cadaver jaw. The hole was filled either with CPC or CPC with contrast agents and cured 
overnight. All the samples were prepared in triplicate (n=3).  
For MRI scan, the samples were first embedded in 5% gelatin type A (Sigma-Aldrich) in 
order to simulate a water environment. The gelatin was poured into a 15 mL plastic tube and 
solidified at + 4°C. For the micro-computed tomography (µCT) measurements the samples 
were wrapped in Parafilm® (SERVA Electrophoresis GmbH, Heidelberg, Germany) to avoid 
drying artifacts during the scan. 
2.7. In vitro µCT  
The bone blocks were scanned horizontally along the X-ray beam by using a µCT imaging 
system (Skyscan 1072, Kontich, Belgium). Samples were recorded using X15 Magnification 
(i.e. pixel resolution = 18.88 µm), X-ray source of 100 kV/ 98 µA, exposure time 3.9 s and 1 
mm aluminium filter. The obtained projected files were reconstructed with NRecon software 
(Skyscan) and analyzed with CtAnalyser software (version 1.10.1.0; Skyscan). The volume of 
interest (VOI) was defined manually by selecting a total of 135 slices (in height; i.e. 2.55 mm) 
and a circle of 3 mm (in diameter). Two-dimensional (2D) reconstructions were finally 
obtained by DataViewer software (Version 1.5.2.4; Skyscan). 
2.8. In vitro MRI  
All the samples embedded in gelatin were scanned on a 11.7 Tesla (T) MRI system (Biospec, 
Bruker, Germany) equipped with a 
1
H/
19
F volume coil. 
1
H/
19
F MR images of the bone 
phantom were acquired by a zero echo time (ZTE) sequence with the following parameters: 
repetition time (TR) = 2ms/4ms, image resolution = 1.56 x 1.56 x 1.56 mm, 1 average/16 
averages, flip angle (FA) = 2°/4° and acquisition time (TA) = 27sec/13.54 min. The obtained 
1
H and 
19
F MR images were processed with Matlab R2014b (MathWorks Inc, Natick, MA) 
and overlaid by using MRIcro software (Smith Micro software, Aliso Viejo, CA) [40]. 
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2.9. In vivo assay  
The animal study was performed in agreement with the standards and the protocols of the 
Radboud University Medical Center, Nijmegen, the Netherlands. All the surgeries were 
performed after the approval of the Animal Ethics Committee (RU-DEC number 2015-0035) 
for the care and the use of laboratory animals. Sixteen healthy male Wistar rats (body weight: 
250-300 g) were used as experimental animals. A rat femoral condyle defect model was used 
as described elsewhere [42]. In order to reduce the number of animals for this experiment 
both posterior legs of the animals were used. First the animal was anesthetized by inhalation 
of a mix of Isoflurane (Rhodia Organique Fine, Avonmouth, Bristol, UK) and oxygen, and 
then the legs were shaved and disinfected using povidone-iodine solution. The animal was 
located in the supine position on a heating mat in order to prevent hypothermia. A 
longitudinal incision was performed through the skin and the muscle on the medial surface of 
the knee (Supplementary Information, SI, Figure S1). After the exposition of the medial side 
of the distal femoral condyle, the patella was laterally dislocated in order to have a clear view 
of the knee joint. Three different dental burs with increasing diameter up to 2.5 mm were used 
in order to perform a cylindrical defect (2.5 mm in diameter and 3 mm in depth) along the 
same direction of the femur. A sterile 0.9% saline solution (Fresenius Kabi B.V., Emmer-
Compascuum, the Netherlands) was used to cool down the dental bur and to clean the drilled 
cavity. In the meantime, the CPC powders were mixed with the setting solution as described 
before. The defect was filled with CPC with or without contrast agents, while it was left 
empty in the case of the positive control group. As negative control group, the leg was kept 
untreated (Table S1). After cement implantation, the patella was moved back to the original 
position and the muscle and the skin were closed with absorbable sutures (Vicryl ® 4.0 
Ethicon, Somerville, NY). A subcutaneous injection of painkiller (5 mg/mL Rimadyl®, Pfizer 
animal health, NY) was performed post surgery in order to decrease postoperative discomfort. 
After the MRI and CT scans the skin was further fastened by using metallic wound-clips 
(Becton and Dickinson, Franklin Lakes, NJ). In vivo MRI and CT were performed right 
directly post-operative, and at 4 and 8 weeks post-surgery. After 8 weeks the animals were 
sacrificed by CO2/O2 inhalation and the femora were harvested for histological assessments.  
2.10. In vivo CT 
For the in vivo CT a small animal CT scanner was used (Inveon Micro-CT/PET, Siemens 
Medical Solution, Knoxville, TN). The animals were located in the supine position on a 
heating mat and always assessed under general anesthesia (Isoflurane/O2). Images were 
Chapter 5 
 
125 
 
recorded with an acquisition time of 6 min, spatial resolution of 30 µm, 80 kV tungsten anode 
source and exposure time of 1000 ms. Inveon Research Workplace (IRW, Siemens) software 
was used for 3D reconstruction of the projected files, and in order to define the VOI 
corresponding to the implanted material. As the shape of the implant was heterogeneous from 
leg to leg, the outline of the implant was carefully drawn. For each VOI the total volume in 
mm
3
 and the mean attenuation intensity in Hounsfield units (HU) was calculated. For each 
implant, the level of attenuation intensity was adjusted by the corresponding volume. Finally 
the mean value of the signal intensity at each time point was computed. Signal decrease over 
time was also investigated. Based on a constant VOI (of 15 mm
3
) the relative signal intensity 
at each time point was expressed as percentage and calculated as total signal intensity from 
the implants to the mean of the signal intensity from normal bone  (i.e. no defect group) 
(Figure S2).  
2.11.In vivo MRI 
 Animal MR experiments were performed with the same 11.7 T MRI system and 
1
H/
19
F 
volume coil as for in vitro experiments. Animals were anesthetized by Isoflurane/O2 and 
placed in the supine position. One by one each leg was immobilized inside the coil while body 
temperature and breathing were constantly monitored. For fluorine content quantification a 
200 mL Eppendorf tube filled with 20 mg of PLGA/PFCE nanoparticles dispersed in MilliQ
®
 
water was used as reference. The Eppendorf tube was placed adjacent to the medial side of the 
leg. 
1
H/
19
F images for each rat leg were acquired by ZTE sequence with TR=2ms, image 
resolution = 0.31mm
3
/1.25mm
3
, 1 averages/32 averages and FA = 2°/4°. The scan times were 
less than 7min and 14min for 
1
H and 
19
F respectively. The 
19
F signals in the rat legs as well as 
in the control sample were quantified in MRIcro software.
40
 Regions of interest (ROIs) were 
manually outlined based on the detected 
19
F signal on 
19
F ZTE images. 
19
F signal per ROI was 
calculated by multiplying the mean of the pixel intensity of the ROI by its volume (i.e. area 
per slice thickness). The total 
19
F amount was then summed over slices and expressed in 
arbitrary units (a.u.) [41]. Based on the quantified 
19
F signals of the control sample scanned 
together with each leg at day 0, 4 and 8 weeks, the normalization procedure for 
19
F signals has 
also been performed within each leg at three time points and between legs. 
2.12. MRI, CT and implant volume linear correlation 
Correlation analysis was performed by comparing 
19
F MRI signal (expressed in a.u.), CT 
signal (expressed in HU/mm
3
) and volume of the implant (expressed in mm
3
) at each time 
points. The volume of the implant at each time point was calculated by IRW (Siemens) based 
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on the in vivo CT acquisitions. For each time point, two-tailed Pearson correlation coefficient 
(ρ) between MRI signal and volume of the implant, CT signal and volume of the implant and 
between CT signal and MRI signal, were calculated respectively. Afterwards, Pearson 
coefficients were converted to Fisher`s coefficient (z) and the interval of confidence at 95% 
was computed by back-converting z to ρ. Pearson coefficients were ranked according to the 
rule of Thumb [43]. 
2.13. Histology 
Samples were decalcified in 10% ethylenediaminetetraacetic acid (EDTA) for two weeks. The 
decalcified bones were then dehydrated in a gradual ethanol series (from 70% to 100%) and 
embedded in paraffin. Sections of 4 µm in thickness were cut along the axial direction of the 
femur by using a microtome (RM2165, Leica Microsystems, Rijswijk, the Netherlands). The 
sections were stained with Hematoxylin/Eosin (H/E) and with trichrome Elastic van Gieson 
(EVG). For each specimen, at least two images from three sections (at 100 µm of 
interdistance) were analyzed. Images were acquired by using a light microscope (Axio Imager 
Z1, Carl Zeiss AG Light Microscopy, Gӧttingen, Germany) equipped with a digital camera 
(AxioCam MRc5, Carl Zeiss AG Light Microscopy). Histomorphometrical analysis was 
performed based on the EVG-stained slices by using a computer image analysis technique 
based on ImageJ software (Wayne Rasband, Research Services Branch, National Institute of 
Mental Health, Bethesda, MD). The amount of bone was calculated as area percentage inside 
a defined ROI (circle of 2.5 mm diameter, Figure S3). 
2.14. Statistical Analysis 
GraphPad Instat® (GraphPad Software, San Diego, CA) was used for all statistical 
measurements; data were reported as mean ± standard deviation. For comparison of data one-
way analysis of variance (ANOVA) with a Tukey`s post hoc test was used. All differences 
were considered significant at p-values <0.05. 
3. Results and Discussion  
3.1. Simultaneous labeling of CPC with PFCE-loaded PLGA and gold nanoparticles 
To label the cement for 
19
F MRI we used PFCE-loaded PLGA nanoparticles. These 
nanoparticles were developed at the Radboud University Medical Center (Nijmegen, the 
Netherlands) and are now being prepared for use in clinical trial for labeling dendritic cell-
based vaccines (clinicaltrial.gov identifier NCT02574377) [35]. These particles typically have 
a hydrodynamic radius of 100 nm, as determined by DLS, and zeta-potential values in a range 
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of -1 mV to -5 mV, due to steric stabilization by poly(vinyl alcohol). Scanning electron 
microscope (SEM) image of the nanoparticles is shown in Figure 1A. The amount of PFCE in 
the particles was determined by nuclear magnetic resonance (NMR) using an internal 
reference and was around 20 wt%. As CT contrast agent, we used commercially available 
AuNPs that are stabilized with citric acid in PBS.   
The largest initial challenge was the incorporation of both nanoparticle labels into the CPC 
matrix. Earlier combinations of CPCs and several contrast agents, were produced by mixing 
the dried powders, and therefore had only one easy production step [13-18]. However, our 
PFCE-loaded PLGA nanoparticles formed clusters in the freeze-dried state, making 
homogenous incorporation into the CPC difficult. Moreover, AuNPs were provided dispersed 
in PBS solution. Therefore, we developed an easy two-step method that allowed for the 
simultaneous incorporation of both nanoparticles into the CPC phase. All components were 
independently dispersed in water and mixed at high shear stress followed by fast freezing and 
freeze-drying the mixture to avoid the setting of CPC. In the second step, the obtained dual 
labeled-CPC powder could be mixed with the setting solution and handled further as the non-
labeled CPC. This method was more efficient for incorporation of both labels than adding the 
imaging agents, mixing them in the setting solution, or mixing the cement directly with 
freeze-dried powder of nanoparticles. The color of the cement composite changed from white 
to pink after AuNPs were added (Figure 1C). The uniform distribution of color in CPC 
indicated a homogeneous distribution of AuNPs. Morphological analysis based on SEM 
(Figure 1B and Figure S4) proved that PFCE-loaded PLGA nanoparticles were incorporated 
into the CPC matrix. After incorporation and setting of the CPC, the initial PFCE-loaded 
PLGA nanoparticles formed clusters of approximately 1-5 µm in diameter. This cluster 
formation could be due to reduced colloidal stability of nanoparticles in the cement mixture 
and to the relatively high concentration of nanoparticles at 17% w/w [44]. However, MR 
imaging of labeled CPC revealed that these agglomerates were homogeneously distributed in 
the cement matrix (Figure 2C). Thus, the agglomeration did not influence the imaging 
properties of the final material. Likely, this agglomeration could even be an advantage for our 
purpose, due to possibly slower degradation of aggregated nanoparticles that allowed the 
PFCE signal to last longer in the CPC matrix. Unfortunately, the AuNPs were too small to be 
identified by SEM in the morphologically complex CPC matrix. However, the change of the 
color and the enhanced CT visibility indicated that the incorporation was successful (Figure 
2E, Figure 2F and Figure 2G). 
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Figure 1. Scanning electron micrographs of the PFCE-loaded PLGA nanoparticles (A) and of the surface of a 
pre-set cylinder of CPC/PFCE/gold (B). Yellow arrows indicate the agglomerates of PLGA/PFCE nanoparticles 
that appeared after the material preparation. Scale bar 1 µm. In (C) a 2 mL syringe containing CPC/PFCE/gold 
paste is shown. 
 
3.2. Imaging of cement injected in vitro in pig jaw blocks 
To find out the optimal ratio between the CPC powders and the contrast agents, we performed 
µCT and 
19
F MR imaging of the final material. Based on these results we determined that a 
concentration of 20 mg of freeze-dried PFCE-loaded PLGA nanoparticles per 100 mg of CPC 
powder provided sufficient labeling with PFCE. For CT contrast 1 ml of AuNPs suspension 
was necessary for significant enhancement (data not shown).  
Next, we imaged CPC composites injected in pig bone blocks (Figure 2A) using 
1
H and 
19
F 
MRI. On the 
1
H MR image (Figure 2B), CPC could not be distinguished from pig bone. 
However, a strong fluorine signal was detected from the CPC/PFCE/gold composite in the 
19
F 
ZTE MR image (Figure 2C). Thus overlaying the 
19
F on the 
1
H image allowed identification 
of the labeled CPC (Figure 2D).  
Two-dimensional gray scale images of the CPC injected in pig blocks were obtained by 
µCT acquisition. As shown in Figure 2, CPC with contrast agents (Figure 2F) appeared 
visually darker than non-labeled CPC (Figure 2E). A quantitative estimation of the gray value 
distribution confirmed this observation. CPC/PFCE/gold reported significantly higher pixel 
frequency compared to the CPC control as well as a rightward shift of the gray values curve 
(Figure 2G). Furthermore, the narrowing of the peak indicated an even distribution of the 
particles in the CPC phase.  
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3.3. Characterization of the handling and mechanical properties 
The mechanical and handling properties of the final cement mixture are very important for the 
application as a bone filler. These mechanical properties should match those of the treated 
bone. Furthermore, the in situ setting should be fast, but also provide enough time for the 
surgeon to implant and model the paste. Further, hydraulic features should allow easy 
injection of the material, enabling minimally invasive operations [4-6]. To investigate whether 
the incorporation of the two types of nanoparticles affected the material properties of the 
CPC, we performed handling and mechanical testing. As a control we used CPC that was 
treated in the usual way (CPC- control), and another CPC that we prepared in the same way as 
the labeled CPC but without nanoparticles (CPC/Freeze-dried). The last control is important 
as possible changes in material properties can be caused either by incorporation of 
nanoparticles or by the extra steps involving resuspension in water and freeze-drying. Setting 
times of the CPC/PFCE/gold composite that we obtained from the Gillmore tests (Figure 3A 
and Figure 3B) showed an increase in the initial and final times by 1.7 ± 0.3 min and 3.2 ± 0.3 
min respectively, compared to CPC-control. However, this small increase did not affect 
injection during surgery. Setting times of both non-labeled CPC controls -the freeze-dried and 
the non-freeze dried- were similar to each other. This behavior indicates that the incorporation 
of the particles did cause an increase in setting time. Ideally, the initial setting time should be 
 
Figure 2. In vitro MRI and CT imaging of a bone 
block obtained from pig jaw. In (A) the morphological 
representation of the bone block; In (B) and (C) 
1
H 
and 
19
F ZTE MR images of CPC/PFCE/gold 
composite obtained at 11.7 T. Note that the 
19
F signal 
corresponds to the cylindrical defect in the 
1
H ZTE 
image as highlighted by the yellow lines. (D) The ZTE 
MR images of 
19
F overlaid on those of 
1
H ZTE. In (E) 
and (F) the gray scale 2D images from the µCT of the 
pig block filled with the CPC composite are shown 
without (E) and with (F) contrast agents. The yellow 
arrows indicate the implanted material. In (G) the 
graph from the gray values distribution calculated for 
a defined volume of interest (n=3). Note that the 
signal intensity is elevated and much more defined. 
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between 6-10 minutes, and the final hardening should be reached within 20 minutes [5,6]. 
Thus, the setting time of our labeled composite is within this range confirming that it can be 
used as a bone implant.  
Comparing the compressive strength and the E-modulus of the CPC/PFCE/gold composite 
to the non-labeled CPC showed that labeling does not affect the mechanical properties of CPC 
(Figure 3C and Figure 3D). Particularly, both values are similar compared to the CPC that 
was only freeze-dried (i.e. CPC/freeze-dried), indicating that the freeze-drying rather than the 
incorporation of the nanoparticles affected the properties of the final material. Importantly, 
these differences were not significantly different when compared to standard CPC. Thus, 
compressive strength and E-modulus are comparable with the values of the most common α-
TCP composites reported in the literature that are typically between 1 and 70 MPa and 0.5 and 
9 GPa, respectively, depending on the exact composition of the material [5]. In particular, 
commercially available injectable bone cement, chronOSTM Inject, has a compressive 
strength of 3.0±0.6 MPa [44]. This value is very close to the results of this study (i.e. 
CPC/PFCE/gold = 4.6±2.1 MPa) meaning that our composite could be used for similar 
applications. Surely, CPC/PFCE/gold is indicated for non-load-bearing bone defects, 
specifically in cancellous bone, which shows similar compressive strength and elasticity (i.e. 
4-12 MPa and 0.1-0.5 GPa, respectively) [46]. 
Finally, CPC/PFCE/gold composite showed excellent hydraulic and cohesive features. All 
samples could be completely extruded from the syringe through a 1.7 mm orifice, and 
thereafter set in an aqueous solution (Figure 3E, Figure 3F, Figure 3G and Figure S5). Even 
if, we used no needles in this study, our results indicate that CPC/PFCE/gold composite is 
suitable for use with needles up to 15 Gauge. Such needles are used, for example, in several 
back and face surgeries [6, 39]. 
3.4. Imaging of cement injected in vivo in rat bone model  
Having promising in vitro results on both imaging and materials properties, we then 
investigated the performance of our labeled composite in vivo for longitudinal monitoring up 
to 8 weeks from the injection in a rat femoral condyle defect. This defect involves relatively 
simple surgery and is a well-established non-load bearing model to study bone biomaterials 
[42]. The time of 8 weeks was chosen, as we expected from our in vitro study (data not 
shown) and from previous works on CPC degradation in the same model that the CPC would 
stay in the bone for at least 4 weeks [17, 18]. 
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Figure 3. Mechanical and handling properties of the CPC composite with and without contrast agents: 
respectively the initial (A) and the final (B) setting time from Gilmore tests (n=3); the E-Modulus (C) and the 
compressive strength (D) from the compression tests (n=5); the extrusion curves from the injectability tests (E) 
(n=3); CPC/PFCE/gold composite (F) and CPC (G) representative samples from cohesion tests (n=3). # and * 
mean p<0.05. 
 
For in vivo testing, we used non freeze-dried CPC as a control as well as another group of 
animals with an empty defect. None of the animals showed any sign of discomfort, swelling 
or restriction in movement after surgery. To monitor the cement after injection, we performed 
MRI and CT image acquisitions immediately after surgery (i.e. day 0), and at 4 and 8 weeks 
post-surgery. High-resolution anatomical MR images of the rat leg were acquired at day 0, 4 
weeks and 8 weeks after injection (Figure S6). As expected from in vitro imaging results, it 
was not possible to distinguish the non-labeled CPC composite in rat legs from the 
surrounding bone on 1H ZTE images. In contrast, after injection, the labeled composite could 
be imaged with both MRI and CT for the whole duration of 8 weeks. 
The shape of the labeled composite was clearly recognizable on 
19
F ZTE MR images, shown 
in false color, providing precise geometrical information (Figure 4). Moreover, comparing the 
images at different time-points after injection showed that the 
19
F signal area was shrinking. 
Indeed, further quantitative analysis of 
19
F signal confirmed this observation, and showed a 
gradual decrease of the 
19
F-containing region over 8 weeks (Figure 5). Moreover, this 
reduction in signal area correlates to the decrease in the volume of the implant as a 
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consequence of cement degradation. This suggests that dissolution of the cement causes 
clearance of the PFCE-loaded PLGA nanoparticles, resulting in a signal decrease. 
 
Figure 4. Representative in vivo ZTE MR images of 
19
F overlaid on those of 
1
H of a rat leg at day 0, 4 weeks 
and 8 weeks in axial and coronal directions. The presence of 
19
F is shown in false color. Yellow arrows indicate 
the implanted material, while the bright yellowish spot next to each leg corresponds to the reference (i.e. 
Eppendorf tube containing PFCE-loaded nanoparticles dispersed in water). 
 
 
 
Figure 5. 
19
F MRI and CT signal 
quantification of the CPC/PFCE/gold 
composite at day 0, 4 weeks and 8 
weeks. 
19
F signal (red) in 
19
F ZTE 
MR images and relative signal (blue) 
in CT images were quantified and 
expressed as arbitrary unit and in 
percentage of relative attenuation 
intensity, respectively (n=8). Lines 
indicate the trend of the data points. 
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Because of the high calcium salts content, CPCs generally show higher radiographic 
attenuation when compared to the natural bone phase [10].
 
However, there are many available 
calcium phosphate-based composites, which may consist of different mineral components (i.e. 
α-TCP, hydroxyapatite) often combined with different additives, polymers or fibers [4-6]. 
Depending on the specific mixture of components, CPCs may show different X-ray 
attenuation, with better or worst contrast when compared to the natural bone. Thus, a 
“natural” contrast between CPC and bone is not always a given, yet is dependent on 
parameters, such as the CPC composition, the type/density of the bone, and the biological 
phase of bone remodeling. We aimed to achieve a labeling methodology in which, 
irrespective of these circumstances, a reliable contrast can always be achieved. Composites 
with improved contrast are demanded especially when need to be injected in the vertebral 
spine. In such clinical circumstances, leakage of CPC from the vertebral body can occur 
leading to several symptomatic complications (i.e. neurological complication, collapse of the 
adjacent vertebrae) [11,12]. A clear view of the implanted CPC can be also hindered by the 
presence of extensive soft tissue around the implant that can obscure its precise shape 
identification [11]. Furthermore, CPC monitoring over time is changeling and less precise. It 
has been proven that only after disappearance of the 50% of the implanted material and 
subsequent replacement with new bone, it is possible to recognize a visible change in bone 
remodeling [10,11]. CPC/PFCE/gold composite showed not only visual enhancement of CT 
attenuation right after the surgery (i.e. Day 0), but the shape of the implant was clearly visible 
during the all duration of the experiment (Figure 6). By contrast, the non-labeled CPC used as 
control, shows similar attenuation as the natural bone phase. Although it is possible to identify 
the implanted non-labeled CPC after surgery, the border between the bone and the implanted 
cement was not always recognizable. The identification of the implanted control cement 
became more challenging at 4 weeks post surgery after the CPC degradation took place 
(Figure 6). Evaluation of the mean attenuation coefficients expressed in Hounsfield unit (HU) 
per mm
3
 confirmed these results. At all the time points, the CPC/PFCE/gold composite 
showed higher values than both empty defect group and non-labeled CPC composite (Figure 
6). However, this difference was statistically relevant only at 4 and 8 weeks. The higher signal 
intensity from the CPC/PFCE/gold composite allowed for a better definition of implant shape 
and volume, in comparison to the non-labeled CPC. A narrowing of the shape of the labeled 
implant was clearly visible for all the experimental times. For this reason, CT acquisitions 
enabled a more precise quantification of the volume of the labeled implant at each time point. 
Moreover, by comparing the relative signal intensities over time, it was possible to see a 
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gradual decrease of the signal intensity, indicating clearance of the label with cement 
degradation (Figure 5).  
 
 
Figure 6. Qualitative and quantitative in vivo CT 
results. The CT images of the coronal direction of 
the rat femoral condyle are shown for defects left 
empty or/and filled with CPC alone or/and with 
CPC/PFCE/gold. From the top to the bottom, the 
pictures of the same specimen are shown directly 
after the surgery (Day 0) and at 4 and 8 weeks 
post-surgery. The bar graph presents the signal 
quantification estimated by IRW, based on a 
defined region of interest. Values are reported as 
mean of attenuation coefficients in HU per the 
total volume in mm
3
 (n=8). 
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Only few studies on the long-term imaging of radiopaque bone substitutes are available. 
However, most of these studies concern in vitro tests or focus on in vivo biological response 
without imaging its degradation [13-16]. In a previous study, Ventura et al., used smaller 
AuNPs with 4 nm diameter that were embedded in silica matrix to enhance CT contrast [17]. 
However, these nanoparticles diffused from the silica particles 4 weeks after the implantation 
in vivo resulting in loss of CT contrast. In this study, larger nanoparticles with diameter of 40 
nm provided long-term enhancement CT contrast, at least up to 8 weeks. We assume the 
bigger size of AuNPs hindered the diffusion of nanoparticles out of CPC resulting in 
prolonged enhancement of CT.  
Finally, the combination of both imaging modalities enabled to monitor degradation of the 
cement. To compare quantitative MRI and CT signals, we investigated if there is a correlation 
between 
19
F MRI signal, CT attenuation coefficient and volume of the implant at each time 
point. The Pearson correlation coefficients and confidence intervals are summarized in Table 
1. Pearson coefficients were ranked according to the rule of Thumb [43]. Very strong (i.e. 
0.9<r<1) and strong (i.e. 0.7<r<0.9) statistically significant linear relationship (i.e. p<0.05) 
between the two variables, were found at day 0 and at 4 weeks respectively, for correlation of 
MRI signal to implant volume, CT signal to implant volume and MRI signal to CT signal. In 
contrast, at 8 weeks, a strong linear correlation was found between CT signal and volume of 
the implant, while the relationships between MRI signal and implant volume or MRI signal 
and CT signal were low and moderate respectively (i.e. moderate = 0.5<r<0.7, low = 
0.3<r<0.5). This lower correlation of MRI signal could be due to limited MRI resolution for 
such a small implant volume (i.e. < 4.41±1.96 mm
3
), resulting in relatively few voxels over 
the implant and thus larger error due to the partial volume effect [29]. However, both MRI 
and CT demonstrated that the degradation of the cement mainly occurred as a gradual process 
of dissolution that starts from the edges of the implant. Thus, in total, it was possible to follow 
CPC degradation qualitatively and quantitatively up to 8 weeks post-surgery. 
The versatility of a dual-labeling approach allows to produce patient-tuned composites that 
could include either both or only one of the two contrast agents depending on the specific 
bone applications. In imaging-guided vertebroplasty a CPC composite with initial enhanced 
contrast is preferred by the surgeons as it can help for the identification of any cement leakage 
[11]. By contrast, when the monitoring of the material degradation over time and the 
subsequent bone regeneration become the crucial aspect, e.g. in orthopedic and maxillofacial 
applications, a non-invasive imaging modality (i.e. MRI) is alternatively suggested [6].
 
 
PERFLUOROCARBON/GOLD-LOADING FOR BONE FILLERS 
136 
 
Table 1. Correlation analysis comparing mean intensities from 
19
F MRI signal, CT 
attenuation coefficient and implant volume. 
 
 
 
 
 
 
 
 
 
 
 
Multimodal imaging approaches (i.e. PET/CT, PET/MRI) have gained clinical interest over 
the last years as two imaging modalities can provide synergistic benefits [23]. In this study a 
multimodal visible bone substitute (i.e. visible either by CT and MRI) was developed. Such 
dual-labeled composite could give to the radiologists the possibility to provide a patient-
tailored imaging workflow according to each specific clinical circumstance (i.e. CT 
acquisition could be performed right after the surgery, while MRI applied for longitudinal 
monitoring). To date, a CT/MRI multimodal approach is aimed only in pre-clinical or clinical 
studies related to bone remodeling and biomaterials development. However, as MRI is 
superior to CT for many aspects (i.e. it is radiation-free, provides soft and hard tissues 
contrast, it gives 3D anatomical and functional information) an ultimate long-term focus for 
research should still be to make MRI as a preferential bone imaging screening tool [8, 22].
 
3.5. Bone-Growth Assessment by Histology and Histomorphometry 
To investigate the tissue reaction on the CPC composites with and without imaging 
nanoparticles, we made histological sections at week 8. Due to the decalcification process 
during histological preparation, it was not possible to detect CPC remnants in the sections. 
However, the circular area of the original defect was still clearly recognizable and thus we 
used this area for qualitative and quantitative analysis (Figure 7). The empty defect group 
shows incomplete healing proving that the performed defect was a critical-size-defect for the 
8-week period. Furthermore, both labeled and non-labeled CPC materials did not induce any 
immune response or fibrotic encapsulation. However, in several samples, a layer of fibrous 
tissue was present at the interface between bone and implant. This layer was not always 
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continuous, and appeared to contain fibrous tissue and immature extracellular matrix fibers, 
yet often also showed red-stained calcified nodules, indicating the onset of mineralization. 
This effect was present in 1/8 samples of the CPC group and 4/8 samples of the 
CPC/PFCE/gold group. Chi-square testing demonstrated that such frequencies are not 
significantly different (p>0.05) between both groups. In all cases, there was direct contact 
between bone and CPC, and uniform bone growth in all the groups was observed. Such bone 
growth began at the edges and then proceeded throughout the entire contact area towards the 
inside of the implant.  
 
Figure 7. Histological sections of the femora stained with EVG after 8 weeks of implantation. The original bone 
structure in (A), the empty defect in (B), the defect filled with CPC in (C) and the defect filled with 
CPC/PFCE/gold composite in (D) are shown. For each specimen, a picture of the general overview taken at 1X 
magnification (inset) and the respective zoomed view (magnification 10X) are shown. The markers correspond 
to 1 mm.  
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Histomorphometrical analysis of a defined ROI (i.e. circle of 2.5 mm in diameter) 
demonstrated the relative formation of the new bone, with approximate filling of defect of 
50%, which is typical for this length of time [17]. No statistical differences in bone content 
were found between the empty defect group, the CPC group and the CPC/PFCE/gold group 
(Figure 8). This new bone formation is in the range of the decrease of both MRI and CT 
signals. Aiming at clinical application, further studies with longer experimental times and 
with materials of different degradation kinetics, could help to develop a reliable method for 
quantitative monitoring the degradation with MRI and CT contrasts in vivo.  
 
 
 
Figure 8. The relative bone formation 
quantification based on histology performed 
after 8 weeks from the surgery (n=8). No 
statistical differences were found. 
 
 
One limitation of presented experimental model was that we did not focus on the clearance 
of the applied labels from the body. However, many previous investigations studied body 
uptake of either perfluorocarbons (PFCs) and gold nanoparticles (AuNPs) as well as their 
biological compatibility [34, 36, 47-50].
  
Specifically, it has been proven that PFCs are firstly 
removed from the blood circulation by reticuloendothelial system filtration, and also can 
ultimately be exhaled through the respiration system [34, 36]. Differently, AuNPs uptake 
seems to be size-dependent. Small AuNPs (i.e. 5-15 nm) are excreted through kidney 
filtration, while large particles (>200 nm) are captured by the immune system and delivered 
into the liver or the spleen [47,48]. After 24 h from intravenous administration of  50 nm 
AuNPs in a rat model, particles showed accumulation only in the blood, liver and spleen [49]. 
Therefore, it could be speculated that the 40 nm AuNPs used in this study would undergo a 
similar fate and finally be eliminated from the body through the feces [50]. Another 
consideration is the concentration of contrast agents used for the preparation of the 
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CPC/PFCE/gold composite. Specifically, the estimated PFCE concentration is less than 5 mg 
per 100 mg of cement. Such concentration is considerably low when compared to the large 
concentration that is requested when PFCs are used in the blood circulation (i.e. about 10 
g/Kg) [36]. Similarly, the used gold concentration (i.e. about 0.5 mg per 100 mg of cement) 
resulted to fall in the “therapeutic window” within which AuNPs can be used without any side 
effects, suggesting that an even higher concentration may be investigated for further 
improvement of the CT contrast [48]. 
4. Conclusions 
Nowadays, one of the main challenges in tissue engineering is to develop detectable materials 
that can be followed longitudinally once implanted in the body. Here, we propose an 
innovative ceramic material with enhanced 
19
F MRI and CT contrast, for bone application. By 
labeling a CPC with PLGA/PFCE and AuNPs, we obtained a composite that can be 
qualitatively and quantitatively detected until 8 weeks post-surgery in an in vivo rat model of 
bone regeneration. Thus, our CPC/PFCE/gold provided more correct anatomical and 
functional information, with both MRI and CT, helping to overcome the imaging limitation of 
ceramics materials. Successful development of this CPC composite has substantial potential 
for clinical use.  
The combination of the current contrast agents-based strategy is suggested for all kinds of 
ceramic materials as well as for polymeric scaffold or hydrogels. Certainly, for every different 
material or application, a certain degree of customization (e.g. fine-tuning the amount of 
nanoparticles) is required. For ceramics, PFCE could be incorporated in specific cement-
dedicated carriers (e.g. microrods, fibers, bigger particles). Simultaneously, gold could be 
directly combined with the carrier containing PFCE by following many strategies, such as 
coating or incorporation in bigger beads. In this way, specific-cement-dedicated carriers can 
easily be developed and scaled-up for clinical applications. Furthermore, further improvement 
of the biological properties of the dual-labeled CPC composite could be pursuit by adding 
specific growth factors (i.e. BMP-2) which can be used to trigger new bone formation.  
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6. Supplementary Information 
 
Figure S1. Femoral condyle defect, in vivo surgical procedure. A longitudinal incision was performed on the 
medial surface of the knee (a). After patella dislocation, the condyle is exposed (b). With a dental drill a 
cylindrical defect (2.5 mm in diameter) it is performed along the direction of the femur, (c) and (d). The CPC 
with or without contrast agents was used to fill the defect. In (e) the CPC/PFCE/gold composition is injected in 
the condyle defect. By using a spatula the shape of the cement was adapted to the anatomical shape (f), and 
thereafter the wound was closed in layers, using resorbable stitches. 
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Figure S2. CT representation of a rat condyle filled with CPC. The coronal direction in (a) and the sagittal 
direction in (b) are shown. By using IRW, a constant volume of interest (VOI) including the implanted material 
was drawn. Based on this VOI, the relative signal intensity in percentage was calculated. 
 
 
 
 
Figure S3. Bone formation quantification based on the images from histology. In (a) the starting EVG stained 
picture of one section and the selected ROI (i.e. circle of 2.5 mm in diameter), in (b) the region outside of the 
circle is excluded, in (c) the selected area after threshold adjustment. By using ImageJ software, the total area (in 
µm
2
)
 
of the circle is calculated. The total bone formation is expressed as ratio between the bone area and the total 
selected area (in percentage). 
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Figure S4. Scanning electron micrographs of (A) an overview of the surface of CPC/PFCE/gold composite 
(magnification X2500). Yellow rectangles indicate (B, C) agglomerates of PLGA/PFCE, (D) agglomerates of 
PLGA/PFCE and cryo-grinded PLGA particle, (E) cryo-grinded PLGA particle. For figure B, C, D 
magnification is X15000; for Figure E magnification is X5000. White arrows indicate singular PLGA/PFCE 
nanoparticles attached to the overall agglomerate. Note that in (E) individual PLGA/PFCE nanoparticles resulted 
attached also to the cryo-grinded PLGA particles. 
 
 
 CPC CPC/PFC-Gold 
S1 ++ + 
S2 ++ +++ 
S3 + ++ 
Total ++ ++ 
Figure S5. Cohesion test. Pictures from the CPC and the CPC/PFCE/gold pastes are shown after 24 hours 
incubation in PBS at 37 °C. On the top three samples from the CPC composite, while on the bottom the same 
amount of samples from the CPC/PFCE/gold composite. In the table are reported the score from the cohesion 
test. Score was attributed as follows: +++ = the paste broke in 1 single piece, ++ = the paste broke in > 2 pieces 
and <3 pieces, + = the paste broke in > 3 pieces. 
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Figure S6. 1H ZTE images (coronal view) of an example rat condyle directly after surgery (A), at 4 weeks (B) 
and at 8 weeks (C). 
 
Table S1. Randomization scheme of the experimental groups 
No defect Empty defect CPC CPC/PFCE/gold 
Rat 5 - Right leg Rat 7 - Right leg Rat 10 - Left leg Rat 8 - Left leg 
Rat 9 - Right leg Rat 6 - Left leg Rat 11 - Left leg Rat 4 - Right leg 
Rat 12 - Right leg Rat 6 - Right leg Rat 4 - Left leg Rat 14 - Left leg 
Rat 13 - Left leg Rat 1 - Left leg Rat 15 - Left leg Rat 5 - Right leg 
Rat 15 - Right leg Rat 16 - Right leg Rat 8 - Right leg Rat 7 - Left leg 
Rat 2 -Left leg Rat 9 - Left leg Rat 11 - Right leg Rat 10 - Right leg 
Rat 3 - Right leg Rat 3 - Left leg Rat 14 - Right leg Rat 16 - left leg 
Rat 12 - Left leg Rat 13 - Right leg Rat 1 - Right leg Rat 2 - Right leg 
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1. Introduction 
In the field of tissue engineering (TE) and regenerative medicine (RM), biological constructs 
have reached such a high similarity with native tissues, that conventional imaging techniques 
tend to be inadequate for detection [1,2]. Therefore, there is a pressing need for the 
development of innovative non-invasive imaging approaches, for example, based on 
multimodal imaging strategies combining magnetic resonance imaging (MRI) and computed 
tomography (CT) [3-5]. For e ample, calcium phosphate derived cements (CPCs) – a class of 
advanced injectable and biodegradable bone substitutes    show such high structural similarity 
with the mineral phase of mammalian osseous tissue that their detection is hampered [3]. On 
conventional radiographs, CPC has similar radiopacity to cortical bone, and a slightly more 
radiodense appearance than the surrounding trabecular bone, making the monitoring of the 
material performance over clinically relevant periods both problematic and inaccurate [9-11].  
The demand for non-invasive imaging modalities makes MRI an excellent option as it 
allows non-invasive anatomical imaging and functional 3D reconstruction of soft tissues with 
high spatial resolution. Imaging of CPCs using the MR modality can be achieved by 
application of short or zero echo time acquisition sequences (i.e. UTE and ZTE respectively), 
which acquire data quasi-simultaneously with the excitation pulse. Nevertheless, due to 
similar transverse relaxation values between cortical bone and CPC (i.e. T2< 1 ms), the 
contrast is not sufficient for the material characterization in vivo, thus incorporation of 
additional agent component is required [12-14]. 
Gadolinium(III) is a lanthanide element with seven unpaired electrons, a symmetric S-state, 
and it shortens T1 relaxation times of the tissues leading to a positive signal enhancement in 
MRI due to these paramagnetic properties [15-17]. Commercially available gadolinium(III) 
based contrast agents (GBCAs) have already been utilised to enhance the T1 signal of CPC 
constructs in vivo. However, the employed strategy utilised molecular agents that were not 
strongly linked to the material, showing an insufficient performance level that did not meet 
the required contrast and longitudinal imaging properties. The CPC degradation profile in 
vivo and the highly porous nature of the material led to leaching of the contrast agent, limiting 
long term monitoring properties [18]. Therefore, the aim of this work was two-fold: to 
improve the contrast properties (both in CT and MRI) by the use of nanoparticles versus 
molecular agents, and to more firmly anchor the contrast agent into the material. 
Functionalization of the nanoparticles with biphosphonates (BPs) allows them to strongly 
interact with CPCs offering multiple bonding interactions with calcium ions (Ca
2+
) from each 
BP component [19-21]. These interactions specifically bind the GBACs into the CPC matrix 
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and prolong the residence of the imaging probe in situ, despite of the ongoing material 
degradation occurs.  
Thus, in the presented study, we have developed a surface functionalized GBCAs that can 
be used for long-term non-invasive monitoring of a specific CPC composite. To this end, 
gadolinium oxide (Gd2O3) nanoparticles (<5 nm in diameter) for multimodal MR/CT imaging 
were synthesized via the polyol method. Surface functionalization of the nanoparticles to 
encapsulate them in a mesoporous silica shell by addition of trimethoxysilane (GTPES) was 
used to stabilize the system in aqueous media and to facilitate further functionalization with 
BP derivatives. The presence of the BP groups in the final constructs enhanced the affinity 
towards the hydroxyapatite, the main component of the CPC composite, and created the CPC-
specific contrast agent (Scheme 1). Elemental analysis and infrared (IR) spectroscopy were 
used to characterize the BP functionalization of the GBCAs, while in vitro binding 
experiments confirmed the high affinity of the BP functionalized GBCAs (GBCAs-BP) 
towards the solid state CPC. After in vitro toxicity tests, and characterization of the handling 
and mechanochemical properties, the obtained CPC-GBCAs nanocomposite was implanted in 
vivo in a rat model and the behavior of the material was followed by CT and MR imaging.  
The dual-modality nanoparticle probe allowed the visualization of the implanted cement for 
the entire experimental time course of 8 weeks. Finally, histological assessments were 
performed to investigate the biological effect of the applied material on the surrounding bone 
tissues and showed no adverse reactions or inhibition of bone formation. 
2. Materials and methods 
2.1. Materials  
Alpha-tricalcium phosphate (α-TCP) and carboxymethylcellulose (CMC) were provided by 
CAM Bioceramics BV, Leiden, the Netherlands. Cryo-grinded poly(D,L-lactide-co-glycolide) 
microparticles (<200 µm) with 50:50 ratio of lactic to glycolic acid (PLGA, PURASOB 
5002A) was purchased from Purac, Gorinchem, the Netherlands. Sodium dihydrogen 
phosphate dehydrate (NaH2PO4•2H2O) was purchased from Merck Chemicals BV, 
Amsterdam-Zuidoost, the Netherlands. Gelatin Type A, gadolinium chloride hexahydrate 
(GdCl3), gadolinium acetate, diethylene glycol (DEG), and toluene were purchased from Alfa 
Aesar and Fisher, Karlsruhe, Germany. Sodium hydroxide (NaOH), polyacrylic acid (PAA, 
Mw = 2.1 kDa), 3-Glycidyloxypropyl trimethoxysilane (GPTES), pyridine (anhydrous) and 
O-(5-Norbornene-2,3-dicarboximido)-tetramethyluronium tetrafluoroborate (TNTU), were 
purchased from Sigma-Aldrich, St Louis, MO. All chemicals were used without further 
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purification. Bisphosphonate derivate (6-amino-1-hydroxyhexane-1, 1-diyl-bisphosphonic 
acid) was provided by Dr. Rafael Torres de Rosales (King’s College, London, UK).  
 
Scheme 1. Schematic illustration of the GBCA-BP synthesis and combination within the CPC. The multidentate 
bonding interaction between the phosphonate groups from the BP derivative and the calcium ions from the CPC 
increases the affinity of GBCA-BP to the mineral phase of CPC. 
 
2.2. Synthesis of gadolinium based contrast agents (GBCAs) 
GBCAs were synthesized according to a well-established synthetic method: the polyol 
method [22]. Briefly, GdCl3 (1.86 g, 7 mmol) was dissolved in DEG (25 mL) at 70 °C and 
directly mixed with NaOH (0.6 g, 15 mmol) and dissolved in DEG (10 mL). The obtained 
white precipitate was heated up to 180 °C and the solution stirred for 24 h. The same steps of 
collection, purification, dialysis and freeze-dry were performed as done for the particles 
synthesized according to the traditional polyol-like method. These GBCAs were stabilized 
afterward by GPTES conjugation. Briefly, GBCAs (0.25 g) was suspended in toluene (50 
mL), sonicated for 10-15 min and then stirred at 90 °C. While the solution was stirring, 
GPTES (2 mL) was added dropwise and then left stirring for 48 h at 90 °C. The obtained 
FUNCTIONALIZED GADOLINIUM OXIDE NANOPARTICLES 
154 
 
silica capped GBCAs were collected by centrifugation (10 min, 13000 rpm at 4 °C), washed 
several times with toluene and ethanol and freeze-dried.  
2.3. GBCAs functionalization with bisphosphonate (GBCAs-BP) 
BP functionalization was based on a coupling rout method as reported elsewhere [22]. Silica 
capped GBCAs (0.15 g) and BP derivate (0.15 g) was suspended in pyridine anhydrous (10 
mL) and sonicated for 5 min. The mixture was stirred at 65 °C for 48 h. The same steps of 
washing, dialysis and freeze-dry were performed as in the case of the PAA capped GBCAs.   
2.4. GBCAs characterization 
All synthesized GBCAs were chemically and morphologically characterized.  
CHN elemental analysis was used to measure the hydrogen, carbon and nitrogen content. 
An elemental analyzer 1108 CHN (CE Instruments ltd, Wigan, UK) was used for the 
measurements. The results were expressed in wt %.  
Inductively coupled optical emission spectroscopy (ICP-OES) was performed on an Optima 
5300 DV spectrometer system (Perkin Elmer, Waltham, MA). Phosphorous (P) and 
Gadolinium (Gd) content were determined for freeze dried powders and expressed as wt %. 
Infrared (IR) spectroscopy was performed on a Fourier transform IR (FT-IR) spectrometer 
(Spectrum RX I, Perkin Elmer, Waltham, MA).  
Dynamic Light Scattering (DLS) was performed in Zeta Nanosizer (Malvern Instruments, 
ZEN3600, Malvern UK) at 25 °C using disposable polystyrene cuvettes. 
Transmission electron microscopy (TEM) analysis was performed on a JEOL 2010 TEM 
(Joel Ltd., Tokio, Japan) equipped with a Gatan US 4000 digital camera (Gatan, Oxford, UK) 
and 200 kV. EDS was performed on the central part of the acquired picture were the highest 
particle population was observed.  
Relaxivity measurements on the synthesized GBCAs were performed either using a 3 Tesla 
(T) horizontal clinical MR scanner (Discovery MR750 general Electric scanner, GE 
Healthcare, Chicago, IL) or an 11.7 T vertical-bore preclinical MRI system (Bruker, 
Ettlingen, Germany). Longitudinal (T1) and transverse (T2) relaxation times were determined 
at range of gadolinium concentrations in water. A linear plot of concentrations versus 
1/relaxation time gives r1 and r2 as the plot gradient.  
Images were acquired at 3T using RARE (rapid acquisition with relaxation enhancement) 
inversion recovery sequence, field of view (FOV) = 4.0 cm, flip angle (FA) = 180°, repetition 
time (TR) = 3500 ms, echo time (TE) = 7.5 ms, inversion time (TI) = 1500 ms, bandwidth 
(BW) = 79365.1 Hz, acquisition time (TA) = 2.48 min.  
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2.5. MRI-visible bone filler (CPC-GBCAs-BP) preparation 
The synthesized GBCAs-BP nanoparticles were combined with a defined CPC-PLGA-CMC 
composite. The CPC-PLGA-CMC composite labeled with GBCAs-BP is indicated in this 
study as CPC-GBCAs-BP nanocomposite. CPC was prepared as a weight/weight (wt/wt) mix 
of 78.5% α-TCP, 1.5% of CMC, and 20% of PLGA. To this starting CPC composition the 
selected GBCAs were added at different increasing wt/wt concentrations (i.e. 1%, 2.5%, 5% 
and 10%). Dried powders (final weight 100 mg) were added into an exit-closed 2 mL syringe 
(Termo Europe N.V., Leuven, Belgium) and mixed for 30s with a liquid phase (i.e. 4 wt% 
NaH2PO4•2H2O, final volume 50 µL) through a dental shaker machine (Silmat
®
Mixing 
apparatus, Vivadent, Schaan, Liechtenstein). Two additional CPC-PLGA-CMC composites 
were prepared in the same way as internal controls. One control consisted of calcium 
phosphate-based, PLGA, and CMC without contrast agents (i.e. 78.5% α-TCP, 20% PLGA, 
and 1.5% CMC) and indicated in this study as CPC. The second control consisted of CPC-
PLGA-CMC combined with GBCAs without bisphosphonate functionalization (i.e. 77.5% α-
TCP, 1.5% CMC, 20% PLGA and 1% GBCAs) and is indicated in this study as CPC-GBCAs. 
For the in vivo study, materials were sterilized by using gamma radiation (25 kGy; Synergy 
Health, Ede, the Netherlands), while the liquid solution was filtered by 0.2 µm filters 
(Whatman, GE Healthcare Life Sciences, Eindhoven, the Netherlands).  
2.6. GBCA-BP towards CPC in vitro binding affinity study: 
Briefly, cylindrical cylinders (4.5 in diameter, 9 mm in height and ~ 40 mg in weight) of CPC 
were prepared and incubated in Eppendorf tubes with different concentration of GBCAs-BP 
nanoparticles dispersed in water, i.e. 10, 100 and 1000 µM of Gadolinium (III) in 2 mL of 
water (n=3). The samples were gently mixed for 2, 6 and 24 h. Afterward, the supernatant was 
collected and analyzed by ICP-MS to detect any release of gadolinium (see above for ICP-
MS). The binding efficacy was calculated according to the following equation: 
Binding affinity = (Ci-Cm)/Ci 
Where Ci is the initial concentration of used particles, while Cm is the concentration of 
gadolinium measured in the supernatant. Binding affinity was expressed as µg of gadolinium 
(III) per surface of CPC (m
2
). The surface of the CPC composition was measured by 
Brunauer-Emmett-Teller (BET) analysis through a BET-Micromeritics system (Micromeritcs 
Ltd., Dunstable, UK). Surface area was measured using nitrogen adsorption and desorption 
isotherms at -196.15 °C.  
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2.7. In vitro GBCAs-BP toxicity assay 
Biocompatibility of the GBCAs-BP particles was investigated using primary human 
osteoblasts (HOb). Hob (CAI no: 406-05f) from the European Collection of Authenticated 
Cell Cultures (ECACC, PHE, London, UK) were seeded in 96 well-plates at a final 
concentration of 1000 cells/well and cultured with 200 µl of osteoblast growth medium 
(PromoCells GmbH, Heidelberg, Germany). After one day incubation at 37 °C and 5% CO2 
the medium was removed and the cells were treated with 100 µL of GBCA-BP water solution. 
GBCAs-BP were used at different concentration, i.e. 0.1, 1, 10, and 100 µM, and incubated 
for 48 h, 96 h, and 120 h (n=3). At each time point cell vitality was estimated by MTT 
calorimetric assay (Promega, Fitchburg, WI). Briefly, at each time point cells were incubated 
with 20 µL of MTT reagent (dimethylthiazol-2-yl-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl) tetrazolium) for 4 h at 37 °C and 5% CO2. Afterwards, adsorption rate was 
measured at 490 nm using a Synergy 
TM
HT microplate reader (Biotek, Winooski, VT). The 
obtained values were normalized by the control group (i.e. medium without particle) and 
expressed as percentage of cell viability.  
2.8. In vitro MRI assessment of CPC-GBCAs-BP injected in pig bone blocks 
CPC composite with and without GBCAs-BP was injected in cylindrical defect (3 mm in 
height and 3 mm in diameter) performed in bone blocks obtained from pig jaw (Figure 2g). 
Specimens were wrapped in Parafilm
® 
(SERVA electrophoresis GmbH, Heidelberg, 
Germany) and embedded in 5 wt% gelatin type A. Then samples were scanned on a 11.7 T 
MRI system (Biospec, Brucker) equipped with a 
1
H volume coil with inner diameter of 40 
mm. Images were acquired by using a zero echo time (ZTE) sequence with the following scan 
parameters: TR = 2 ms, matrix size = 256 x 256 x 256, image resolution = 0.313 x 0.313 x 
0.313 mm
3
, 1 average, FA = 3.7°, TA = 6.53 min. The obtained images were displayed by 
using MRIcro software (Smith Micro software, Aliso Viejo, CA). 
2.9. In vitro micro-computed tomography (µCT) assessment of CPC-GBCAs-BP injected 
in pig bone blocks 
Cylindrical blocks (3 mm in height and 6 mm in diameter) made of CPC and CPC-GBCAs-
BP were prepared as described before. Cylinders were scanned horizontally along the X-ray 
direction by using a µCT system (Skyscan 1275, Kontich, Belgium). The following settings 
were used for images acquisition: magnification X15 (i.e. pixel resolution 18.88 µm), source 
voltage 100 kV, source current 98 µA, rotation angle 180°, rotation step 0.9°, 1 mm 
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aluminum filter. Acquired files were reconstructed with NRecon software (Skyscan). 
Attenuation intensity for each sample was calculated by CtAnalyser software (version 
1.10.1.0; Skyscan) based on a constant volume of interest (VOI) and expressed as frequency 
intensity of the gray values. Two-dimensional (2D) images reconstructions were obtained by 
Data Viewer software (Version 1.5.2.4; Skyscan). 
2.10. Handling and mechanical properties characterization of CPC-GBCAs-BP 
nanocomposite 
Only the CPC composition with 1% wt/wt of GBCAs was considered for further studies. 
Handling and mechanical properties of the chosen CPC-GBCAs-BP nanocomposite were 
investigated and compared either to the CPC control (i.e. non labeled CPC) and to the CPC-
GBCAs composites (i.e. CPC combined with non functionalized GBCAs). 
Setting time was investigated with a Gillmore apparatus (according to ASTM C266). Initial 
and final setting times were recorded after injection of cement pastes in a bronze mold of 6 
mm in diameter and 12 mm in height immersed in a water bath at 37 °C.  
Compressive strength and E-modulus were calculated from compression test performed 
through a testing bench machine (858 MiniBionixII, MTS, Eden Prairie, MN). Cement pastes 
were used to prepare cylinders of 4.5 mm in diameter and 9 mm in height. Cylinders were 
compressed along the vertical direction with a loading force of 2.5 kN and a constant speed of 
0.5 mm min
-1
. Injectability features were investigated using the same testing bench machine 
(858 MiniBionixII) set in a compression mode and adapted with a custom-made metallic 
cage. Briefly, 500 mg of CPC mixtures were mixed with 250 µL of setting solution into an 
exit-closed 2 ml syringe (Terumo Europe N.V.). After mixing the components for 30 s the 
syringe was placed in the metallic cage, the exit was opened and a compression force of 100 
N was applied with a constant speed of 20 mm min
-1
. When all the cement pastes were 
extruded from the syringe (after 33±2 s) compression force was stopped and the extrusion 
curve was calculated as applied force (N) by the time (s).
 
2.11. In vivo assay of CPC-GBCAs-BP injected in rat condyle model 
To investigate the feasibility of long-term MRI imaging and to evaluate bone response to the 
CPC-GBCAs-BP nanocomposite an in vivo study was carried out. CPC composite with and 
without GBCAs-BP was injected in a rat condyle defect model. The animal study was 
performed after the approval of the Animal Ethics Committee for the care and use of 
laboratory animals (RU-DEC number 2015-0035) and in agreement with the standards of the 
Radboud University Medical Center, Nijmegen, The Netherlands. Six healthy male Wistar 
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rats (body weight: 250-300 g) were used as experimental animals. In order to reduce the 
number of animals for this experiment, both posterior legs of the animal were used. 
Furthermore, historical controls (i.e. leg left untreated and leg with defect left empty) were 
also included in this study.   
For the surgery, the animals were anesthetized by inhalation of a mix of isoflurane 
(Pharmachemie, Haarlem, the Netherlands) and oxygen. Then, the animals were located in 
supine position on a heating mat in order to prevent hypothermia. Both legs were shaved and 
disinfected with povidone-iodine solution (Betadine, Kuinre, the Netherlands). A longitudinal 
incision was performed on the medial side of the knee through the skin and the underlying 
muscle (Supplementary Information, Figure S1). The patella was dislocated laterally in order 
to have a clear view of the articulating surface and patellar groove of the femoral condyle. A 
dental drill (Astra Tech Elcomed 100, Dentsply Implants, Zoetermeer, the Netherlands) 
equipped with three different dental burs with increasing diameter up to 2.5 mm was used to 
create a cylindrical defect (2.5 mm in diameter and 3 mm in dept) perpendicular on the 
patellar groove. During the drilling, a sterile saline solution (Fresenius Kabi, Emmer-
Compascuum, the Netherlands) was used to cool down the dental bur and to clean the cavity. 
After defect preparation, pre-shaken cement paste was injected to fill the defect. Then the 
patella was moved back to the original position and the muscle and the skin were closed with 
absorbable sutures (Vicryl® 4.0 Ethicon, Somerville, NY). To decrease post-operative 
discomfort a subcutaneous injection of painkiller (5 mg/Kg Rimadyl®, Cattle, Capelle a/d 
Ijssel, the Netherlands) was performed post-surgery. Eight weeks after surgery, the animals 
were sacrificed by CO2/O2 inhalation. Femora were harvested, placed in formalin 10 wt% for 
48 h and then kept in ethanol 70% until histological assessment.  
2.12. In vivo MRI and CT imaging of the implanted CPC-GBCAs-BP nanocomposite 
In vivo MRI and CT acquisitions were performed post-surgery (i.e Day 0), and at 4 and 8 
weeks after the surgery. 
MRI acquisitions were performed on the same 11.7T MRI system (Biospec) as in the in 
vitro study. Animals were anesthetized by inhalation of isoflurane/O2 and located on the 
supine position. Body temperature and breathing were constantly monitored. One by one each 
leg was immobilized inside the coil and scanned by using same parameterized ZTE sequence 
applied for the in vitro experiments. The obtained images were shown by using MRIcro 
software (Smith Micro software). 
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CT acquisitions were performed on a small animal CT scanner (Inveon Micro-CT/PET, 
Siemens Medical solution, Knoxville, TN). Animals were kept under general anesthesia 
(isoflurane/O2) and located in the supine position on a heating mat. Images were recorded 
with an acquisition time of 6 mins, spatial resolution of 30 µm, tungsten anode source (source 
voltage 80 kV) and exposure time of 1000 ms. Reconstructions of the acquired file were 
obtained by Inveon Research Workplace software (IRW, Siemens).  
2.13. Histology and Histomorphometry 
For histological analysis samples were first decalcified in 10 wt% ethylenediaminetetraacetic 
acid (pH 7.2) for two weeks, dehydrated in a gradual ethanol series (from 70% to 100%) and 
embedded in paraffin. At least three sections (4 µm in thickness at 100 µm of interdistance) 
were cut along the axial direction of the femur by using a microtome (RM2165, Leica 
Microsystems, Rijswijk, the Netherlands). Afterwards, sections were stained with 
Hematoxylin/Eosin (H/E) and with trichrome Elastic van Gieson (EVG). Images were 
acquired by using a light microscope (Axio Imager Z1, Carl Zeiss AG Light Microscopy, 
Göttingen, Germany) equipped with a digital camera (Axiocam MRc5, Carl Zeiss AG Light 
Microscopy). EVG-stained pictures were used for histomorphometrical analysis based on a 
computer image analysis technique through ImageJ software (Wayne Rasband, Research 
Services Branch, National Institute of Mental Health, Bethesda, MD). Bone amount was 
calculated as area percentage inside a defined ROI corresponding to the original defect (i.e. 
circle of 2.5 mm in diameter) 
2.14. Statistical analysis 
Statistical analysis was performed by using GraphPad Instat® (GraphPad Software, San 
Diego, CA). Data were reported as mean ± standard deviation. Statistical significant 
differences were calculated by one-way analysis of variance (ANOVA) with Tukey post hoc 
test. Differences in new bone formation were calculated with Student`s T-test with Welch`s 
corrections. All differences were considered significant at p-values <0.05. 
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3. Results and Discussion  
To form contrast agent, gadolinium oxide nanoparticles were coated with a biocompatible 
stable silica layer that gives high colloidal stability and contains epoxy rings (from GPTES), 
which were used to react with the bisphosphonate precursor and functionalize the surface of 
the GBCAs (Scheme 1) [22].
 
Elemental analyses (CHN combustion analysis and inductively 
coupled optical emission spectroscopy, ICP-OES) were performed on the nanoparticles before 
and after functionalization, showing the chemical modification of the surface of the 
nanoparticles at each synthetic step (Figure 1). The results from before and after addition of 
GPTES offered an assessment of the amount of silica polymerized on the nanoparticles 
surface. Thus, allowing an estimation of the molar amount of epoxide groups available for 
covalent conjugation with BP derivative. As expected, analysis of the resulted nanoparticles 
showed a decrease in the percentage of gadolinium(III) and an increase of the organic 
component (Figure 1a). The presence of carbon in the “uncoated” gadolinium o ide sample is 
due to the diethylene glycol (DEG), which is used as a solvent in the reaction, as it adsorbs 
onto nanoparticles surface via interactions with the hydroxyl groups [23].
 
The detection of 
nitrogen and phosphorous in the final product (i.e. GBCAs-BP) indicated the presence of the 
BP derivative on the surface of the nanoparticles. Thermogravimetric analysis (TGA, Figure 
1b) was used to assess the overall mass of the organic layer, which was found to be around 
30% of the total weight. Transmission electron microscopy (TEM) showed a slight size 
increase (~ 1-2 nm) of the Gd2O3 nanoparticles core size after GPTES coating, while no 
differences were observed after BP functionalization (Figure S2). GBCA-BP nanoparticles 
were shown to have homogeneous size and morphology with a final core diameter less than 5 
nm (Figure 1c), while the measured hydrodynamic diameter was 70 nm. Successful BP 
functionalization was also confirmed by energy dispersive X-ray spectroscopy (EDX, Figure 
S2) as well as by infrared spectroscopy (IR) (Figure 1d, e, f). The IR spectrum of the 
precursor Gd2O3 nanoparticles contains a distinctive peak at 2871 cm
-1 
corresponding to the 
stretching and bending of the methylene chain (CH2), a sharp band at 1084 cm
-1
 is assigned to 
the C-O stretch, and the broad peak at 3100 to 3500 cm
-1
 corresponds to the O-H stretch 
(Figure 1d). After GPTES coating, the symmetric epoxy ring deformation gives a peak in the 
IR at 788 cm
-1
, while the sharp band at 1248 cm
-1 
is associated with ring stretching vibrations 
(Figure 1e), matching previous studies of epoxide derivatives [23].
 
In the BP functionalized 
derivative, the appearance of peaks at 1057 cm
-1 
and 1521 cm
-1
 corresponds to the 
phosphonate groups and to the N-H amide bonds respectively, confirming that the BP 
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functionalization had been achieved (Figure 1f). The characterization data for the GBCAs-BP 
are summarized in Table S1. 
 
Figure 1. Chemical and morphological characterization of the synthesized nanoparticles. (a) Table summarizing 
the elemental analysis results for the particles after the polyol synthesis, after GPTES stabilization and after BP 
functionalization,  respectively. CHN analysis was performed by combustion using a CHN analyzer, while Gd 
and P were quantified by ICP-OS. (b) TGA analysis of the GBCAs after GPTES coating. (c) TEM of GBCAs-
BP. Yellow circles define a single particle. In (d), (e) and (f) FTIR spectrum of the particles after the polyol 
synthesis, after GPTES coating and after BP functionalization, respectively. 
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An ideal GBCA, needs to have high relaxivity showing significantly shortened T1 relaxation 
values, which will allow the required signal enhancement to be achieved at a low enough 
concentration, and to be incorporated into the CPC without significantly disrupting the 
properties of the material. In vitro relaxivity studies were performed on the gadolinium 
nanoparticles with measurements at different magnetic field strengths that are typically found 
in clinical and preclinical settings (using 3 T clinical scanner and 11.7 T small bore system 
across a range of concentrations) (Figure 2 and Table S2). Increasing the magnetic field 
strength is known to reduce T1 relaxivity for gadolinium(III) agents and, in many cases, 
increase the T2 relaxivity [24,25]. 
To be an effective T1 contrast agent, the nanoparticles should possess an ultra-small core 
size and a hydrophilic coating surface, this ensures that a large surface area of Gd2O3 is 
available to directly interacts with the surrounding water molecules and that they can rapidly 
exchange. Aqueous suspensions of the GBCAs-BP with a concentration of gadolinium(III) 
varying between 0.2 and 2 mM were scanned using inversion recovery for T1 [26-28]. The 
linear fit of the data acquired versus the concentration of gadolinium(III), gives an overall 
relaxation rate indicating the efficiency of the contrast agent under the experimental 
conditions. Specifically, GBCAs-BP showed r1 equal to 15.41 mM
-1
s
-1 
at 3 T,
 
which is almost 
4 times higher than the commercially available contrast agents (e.g. Magnevist
®
 or 
Omniscan
®
) [24,25]. Furthermore, the nanoparticles showed only a slight decrease of T1 
relaxivity at 11.7 T with r1 equal to 13.44 mM
-1
s
-1
, while the final r2/ r1 ratio remained similar 
at the two magnetic field strengths (r2/ r1 = 4.77 at 3 T and r2/ r1 = 4.30 at 11.7 T) (Figure 2a, 
b, c, d, Table S2). The images of the GBACs-BP phantoms at different concentrations (Figure 
2e) show the dominant T2 effect at higher contrast agent concentrations, indicating that the 
lower concentrations of GBCAs-BP (i.e. 1.5 mM) are effective for a T1-weighted signal 
enhancement, which correlates with appropriate amounts to incorporate into CPC materials. 
In vitro binding tests demonstrated the high affinity of the GBCAs-BP (> 95 %) towards the 
CPC material at up to 24 hours incubation time (Figure 2f) with no dissociation observed.  
In vitro cytotoxicity studies were performed on primary human osteoblast (HOb) showing a 
negative effect on cell viability at high concentrations of the GBCAs-BP (i.e. > 100 µM, 
Figure 2g). However, at low concentrations (0.1, 1, and 10 µM) of the GBCAs-BP showed a 
beneficial effect on the HOb viability when compared to the non-treated cells (i.e. the internal 
control) as the nanoparticles induced cell proliferation (Figure 2g). Such findings not only 
suggested a non-toxic and concentration-dependent effect of the GBCAs-BP nanoparticles, 
but also highlighted the beneficial potential of the BP functionalization on the cell behavior. 
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This is as expected and in line with the known properties of bisphosphonate compounds, and 
the role of BP derivatives on the proliferation and differentiation of HOb cells has been 
investigated [29]. With this study, we confirm the beneficial effect of BP coated nanoparticles 
derivatives on HOb and support further investigation of this strategy for bone regenerative 
applications.      
 
Figure 2. Characterization of the relaxation properties of the particles, their affinity towards the CPC mineral 
phase, and the in vitro cytotoxicity. (a) and (b) plot of 1/T1 and 1/T2 measured at 3 T, (c) and (d) plot of 1/T1 and 
1/T2 measured at 11.7 T as a function of GBCAs-BP concentration respectively. r1 and r2 were calculated from 
the slope. (e) the T1-weighted phantom of GBCAs-BP is  shown at different concentrations (image recorded 
simultaneously). (f) the binding profile of GBCAs-BP after 2, 6 and 24 h incubation with CPC cylindrical 
blocks. (g) MTT assay performed on HOb. 
 
Once the GBCAs-BP particles were synthesized, characterized, and found to have 
appropriate properties to enhance contrast in the application, it was important to determine the 
concentration of the nanoparticles contrast agent that could be added to the CPC composite 
without affecting its final handling and mechanical properties, and so preliminary studies 
were carried out (data not shown). Our findings corroborated with the reports in the available 
literature on CPC doping and suggested that adding  GBCAs-BP into the CPC composite with 
a final concentration of 1 wt/wt% would be appropriate. Furthermore, this contrast agent 
concentration would allow direct comparison of the longitudinal in vivo imaging 
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performances of the CPC-GBCAs-BP construct with the CPC composite doped with a 
commercial molecular gadolinium(III) contrast that has been described in previous studies 
[18]. 
 
The handling and mechanical properties, as well as the imaging features of the prepared 
CPC-GBCAs-BP nanocomposite were investigated in vitro (Figure 3). The setting time 
assessment showed an increase in the initial and final setting profiles for the CPC-GBCAs-BP 
nanocomposite when compared to the non-labeled composite (Figure 3a). It is known that by 
increasing the alendronate concentration in the CPC matrix the setting time increases as a 
consequence of the coordination interaction between the phosphonate ions and the calcium 
salts present in the solution, preventing their rapid incorporation into the crystal lattice and 
hindering the crystals growth and agglomeration [30-33]. The internal CPC control consisting 
of unfunctionalized nanoparticles (i.e. CPC-GBCAs), confirmed the role of the BP groups in 
increasing the setting time of the CPC nanocomposite. However, the setting features observed 
for the CPC-GBCAs-BP nanocomposite, i.e. initial time of 11 min and final time of 23 min, 
are still acceptable for clinical use [34]. The addition of the GBCAs-BP was shown to 
statistically increase the compressive strength and the E-modulus of the final composite when 
compared to the non labeled cement (Figure 3b, c). The non-functionalized control (i.e. CPC-
GBCAs) showed no differences in properties when compared to the CPC-GBCAs-BP 
nanocomposite, suggesting that the mechanical properties were improved by the nanoparticles 
themselves rather than the BP functionalization on the surface. As measured by BET analysis 
the CPC composite consisted of a nanoporous structure (pore width = 18.8 nm, surface area 
9.7 m
2
/g), thereby suggesting that the applied GBCAs-BP were filling these pores to give 
rises to a more dense microstructure. The final mechanical properties of the CPC-GBCAs-BP 
were comparable with most of the studied calcium phosphate-based compositions, hence it is 
suitable as cancellous bone filler [35].
 
Finally, the GBCAs-BP labeled CPC composition 
showed excellent hydraulic properties as all the pastes could be extruded from the syringe 
through a 1.7 mm orifice in less than 30 sec by applying a minimal injection force (see Figure 
3d). 
Gadolinium has a high atomic number (Z = 64) and high X-ray attenuation per mass (3.11 
cm
2 
g
-1 
at100 keV) and it has been used as CT contrast agent especially for angiography and 
aortography applications [36-38]. Therefore, the capability of the GBCAs-BP to enhance the 
CT contrast of the non-labeled CPC composite was also investigated. Gray value 
quantification, based on in vitro micro-CT acquisition, reported an evident leftward shift of 
the values which resulted in a darkening of the CPC-GBCAs-Bp nanocomposite versus the 
control (Figure 3e, f). The enhancement of the CT contrast of a calcium phosphate-based 
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composite by using gadolinium-based nanoparticles could offer additional information, 
especially in cases of a multimodal imaging assessment of the CPC degradation (i.e. using 
both MRI and CT).  
 
Figure 3. Characterization of the handling and imaging properties of the CPC-GBCAs-Bp. (a) setting time, (b) 
compressive strength, and (c) E-Modulus of the CPC composite without contrast agent, combined with GBCAs 
and with GBCAs-BP, respectively. (d) Injectability trend of the CPC with and without GBCAs-BP. (e) gray 
value distribution of the CPC with and without GBCAs-BP obtained from µCT assessment (note the pronounced 
shift to the left from the CPC composition with GBCAs-BP). (f) 2D reconstruction of pre-set cylinders of CPC 
with (on the top) and without GBCAs-BP (on the bottom) obtained from µCT acquisitions (note the clear visual 
difference in color of the CPC with and without contrast agent). (g) overview of a pig jaw bone block with a 
cylindrical defect (3x3 mm, panel (g)I). CPC with and without GBCAs-BP was used to fill the defect as show 
(panel (g)II and (g)III). (h) MR images of CPC with and without GBCAs-BP after injection in pig bone blocks. 
For each sample the axial and sagittal view is shown respectively (note the shape overestimation caused by the 
added contrast agent).  
 
Finally, the MRI properties of the CPC-GBCAs-BP material were investigated after 
injection in pig bone blocks (Figure 3g) and compared to the non-labeled CPC. ZTE-MRI 
acquisitions of the samples containing GBCAs-BP performed at 11.7 T showed a typical T2
* 
shortening effect which resulted in an imaging artifact that led to a sample size overestimation 
(Figure 3h). It is known that gadolinium(III) not only has a T1-shorthening effect, but also a 
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T2 (T2
*
) shortening effect, depending on its concentration [39-42]. Comparing our results with 
previous studies where the CPC was combined with commercially available molecular 
gadolinium(III) agents (i.e. Gd-DTPA from MagneVist
®
), the GBCA-BP nanoparticles 
showed excellent contrast with a higher signal intensity, confirming the superior imaging 
performance of our nanoparticles [18]. 
To assess the longitudinal MRI and CT imaging behavior of the CPC-GBCAs-BP 
nanocomposite, an in vivo study was performed (Figure S1). Respectively, labeled and non-
labeled CPCs were injected in a cylindrical defect prepared in a rat condyle, which is a well 
established non-load bearing model commonly used for testing biomaterials [43].
 
MRI and 
CT acquisitions were performed post-surgery (i.e. Day 0), and at 4 and 8 weeks with the data 
shown in Figure 4. After the surgeries, high resolution ZTE images of the CPC-GBCAs-BP 
showed a T2 weighted signal, which resulted in an implant size overestimation (Figure 4a). In 
contrast, the CPC composite without contrast agent appeared as a dark hypodense region on 
ZTE MR images. Such findings were in line with our in vitro assessments (Figure 3h). 
Longitudinal monitoring showed the superior imaging performances of the CPC-GBCAs-BP 
compared to the non-labeled CPC as in the former case it was possible to clearly identify the 
implanted material at every time point. Moreover, at 4 weeks post-surgery, the implant size of 
the CPC-GBCAs-BP nanocomposite was observed to have slightly decreased, while in the 
center of the implant a brighter area appeared. Interestingly, the relative intensity of this 
bright region increased at 8 weeks (Figure 4a). It is known that GBCAs can lead to a 
competitive behavior between T1 and T2 shortening effects resulting in a bright or dark signal 
respectively [44,45]. Such a competitive effect may explain the appearance of the brighter 
region in the central part of the implant, although variations in agent concentration could also 
be an important factor determining the change in signal intensity.  
CT images showed an enhanced signal intensity in the case of the CPC-GBCAs-BP 
nanocomposite when compared either to the non-labeled CPC or to the natural bone phase. 
The CT signal enhancement persisted for all of the time points and allowed a facile 
morphological assessment of the implant shape and volume (Figure 4b). Interestingly, 4 
weeks post-surgery, the CT acquisitions of the implanted CPC-GBCAs-BP showed a 
heterogeneity in material density. Specifically, the central part of the implant appeared to be 
less dense compared to the outer area. Such findings were in line with the MRI acquisitions 
and confirmed that there is a lower GBCAs-BP concentration in the central part of the CPC 
composite. Moreover, the comparison of these findings with longitudinal studies performed in 
a similar animal model, but with non-functionalized contrast agents (i.e. molecular 
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gadolinium(III) agents or superparamagnetic iron oxide particles), proved the feasibility of 
our strategy in prolonging the residence of the contrast agent in the CPC matrix up to at least 
8 weeks post-surgery [19-21,44,45]. One potential issue is the observed implant size 
overestimation on MR images, however, this property could be considered an advantage for 
detection especially when small amounts of the cement need to be identified in the body. 
Histological assessment was performed 8 weeks after surgeries and showed a direct contact 
between bone and the cement, without sign of inflammation or fibrous encapsulation (see 
Figure 4c and Figure S3). BP-loaded CPCs have been used to increase bone augmentation 
after in vivo implantation in femora and vertebra of osteoporotic rats. Specifically, release of 
BP derivatives from the CPC phase resulted in an increased bone density in the immediate 
proximity of the implant (i.e. in an area from 0.4 to 0.7 mm far the cement) [46,47].
 
Our 
histological findings were in line with these previous studies and showed higher bone density 
around the implant when compared to the CPC composition without BP components (Figure 
4c). However, statistical t-testing did not show significant differences in new bone formation 
between the experimental groups of this size and so further studies are necessary (Figure 4c).  
One area of further study that is ongoing is to look at the release profile in vivo and the 
biodistribution of the GBCAs-BP when released from the CPC composite. Methods for 
radiolabeling are under investigation to determine a valid quantitative tracking. Previous 
studies have shown that GBCAs do not undergo to intracellular accumulation and are 
generally excreted by the hepatobiliary or renal systems [48,49]. The decrease in MRI and CT 
signal over time and the absence of background signals in the surrounding tissues indicate that 
any GBCAs-BP released from the materials did not accumulate and were eliminated from the 
body. The overall profile of the ultrasmall Gd2O3 nanoparticles that have been designed and 
produced in this work offers a significant advance over the current state-of-the-art for 
longitudinal imaging of calcium phosphate cements. The key image acquisition features are 
effective multiple modality imaging (combining contrast in both MR and CT from a single 
agent) and high relaxivity across appropriate MR field strengths. A feature of equally high 
importance for longitudinal studies is the high affinity for the cement material which is due to 
the bisphosphonate coating added to the silica layer.    
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Figure 4. CPC composite with and without GBCAs-BP after injection in a rat condyle defect. (a) the ZTE MR 
images and  (b) the CT acquisitions are shown respectively. From the top to the bottom the axial view of the 
same leg after surgery, at 4 and 8 weeks post-surgery are shown respectively. Note yellow dashed circles that 
indicate the difference in size between CPC with and without GBCAs-BP. Green arrows indicate the bright 
region that appears in the middle of the implant on the MRI acquisitions after 4 weeks from the surgery. The 
bright region corresponds on the CT images to a less dense material. Red arrow indicates the CPC that become 
indistinguishable from the surrounding bone after 8 weeks from implantation in vivo. In (c) histological sections 
after EVG staining (scale bar 500 µm). The inserts show the new bone formation quantification based on the 
histological sections. The red dashed lines indicate the bone volume observed in the non-treated samples. No 
significant differences between the groups were found (p<0.05). 
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5. Supplementary Information 
Figure S1. In vivo surgical procedure for a femoral condyle defect model. In (a) an incision was performed on 
the medial side of the knee. In (b) and (c) dental drill used to perform a cylindrical defect (2.5 mm in diameter) 
along the direction of the femur. In (d) pre-shaken paste of CPC with and without GBACs-BP was used to fill 
the defect. In (e) cement after injection in the condyle defect. 
Figure S2. Core diameter and morphology of the nanoparticles was assessed by TEM. Energy dispersive 
spectroscopy (EDS) coupled to the TEM was used for elemental analysis. In (a) Gd2O3 nanoparticles synthesized 
via polyol-like method. The average size of such particles is below 5 nm (on the top), the main element detected 
was Gd (on the bottom). In (b) Gd2O3 after GPTES stabilization. The average size underwent a slight increase of 
~1-2 nm compared to the Gd2O3 nanoparticles (on the top), while a typical silicon peak at 1.74 keV was shown 
by EDS analysis (on the bottom). In (c) the GBCAs-BP nanoparticles. The average size remained unchanged 
compared to the Gd2O3 nanoparticles after GPTES stabilization (on the top). A clear peak at 2 keV, 
corresponding to the P atoms belonging to BP molecules was observed by EDS analysis (on the bottom). 
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Figure S3. 
Histological sections of 
the femora after 8 weeks 
in vivo implantation. On 
the top a general 
overview of the femora 
(1X magnification) on 
the bottom the 
respective zoomed view 
(10 X magnification). 
 
Table S1. Summary of the chemical properties of the GBCAsBP 
GBCAs-BP 
 
 
Synthesis Method Polyol method 
Hydrodynamic size  from DLS 70 nm 
Elemental Composition (wt %) C = 12.28 
H = 3.29 
N = 1.52 
ICP-MS (wt %) Gd = 27.54 
P = 6.08 
FT-IR (cm-1) 3324, 2922, 1521, 1395, 1057, 967 
 
Table S2. Relaxivity values of different synthesized GBCAs measured at 3T and 11.7T 
 
  
3 Tesla 11.7 Tesla 
r1 (mM
-1
s
-1
)    r2 (mM
-1
s
-1
)     r2/r1 r1 (mM
-1
s
-1
)    r2 (mM
-1
s
-1
)     r2/r1 
 
15.41             73.51            4.77 
 
13.44               57.75            4.30 
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1. Introduction 
Gelatin methacrylate (GelMA) hydrogels are widely used for cartilage regeneration due to 
their optimal biological properties and their ability to induce extensive cartilage matrix 
formation [1,2]. Furthermore, GelMA is also used for the regeneration of 3D vascular 
structures [3,4]. Recent insights indicate that GelMA can also induce osteogenic 
differentiation and calcium deposition in vitro as well as endochondral bone formation in 
vivo, hence supporting its potential use also in bone tissue engineering (BTE) [5–7].  
Additionally, the methacrylate moieties on GelMA’s backbone give rise to a stable 
crosslinked hydrogel upon exposition to UV light and in presence of a suitable photoinitiator. 
Thus, GelMA hydrogels are suitable materials for different manufacturing techniques such as 
photopatterning, micromolding and layer-by-layer 3D printing [8]. 
Layer-by-layer 3D printing is one of the most convenient techniques to create TE-dedicated 
scaffolds with well distributed and interconnected pores which ensure cell penetration, 
vascular in-growth and nutrient diffusion, as well as removal of waste products [9–12]. 
Furthermore, printing hydrogels with this technique allow creating patient-specific designed 
scaffolds with structural complexity, low-cost, and high-efficiency [13].  
Once the appropriate material is selected and manufactured according to the tissue-specific 
anatomical requirements, non-invasive monitoring of the scaffold integration into an in vivo 
environment, occurrence of the material degradation, and subsequent tissue regeneration are 
the important aspects for its final translation in BTE [14]. Up to date, computed tomography 
(CT) is considered the gold standard technique for pre-clinical imaging of bone tissues [15]. 
In CT imaging, the X-ray attenuation of a material is proportionally related to its atomic 
number (Z) and density (ρ), thereby the CT signal is high in mineralized tissues (e.g. bone and 
teeth), while it becomes weak in mainly-water containing tissues (i.e. soft tissues) [16]. For 
the same reasons, hydrogels show little or no signal on CT images as they consist mainly of 
water [17]. Enhancement of the CT signal can be achieved by combination with specific 
contrast agents (CA) [18,19]. To date, gold nanoparticles (AuNPs) has been suggested as 
promising CA, as they show high X-ray attenuation (5.16 cm
2
 g
-1
 at 100 keV), 
biocompatibility and low toxicity. Moreover, AuNPs showed ability to enhance CT contrast 
of ceramic-based bone substitutes as well as to induce osteoblast differentiation and new bone 
formation [20–22]. Alternatively to CT imaging, magnetic resonance imaging (MRI) is a 
valid screening option in BTE. The development of ultrashort echo time (UTE) MRI 
sequences allows the visualization of bone structures that are otherwise not visible by using 
conventional MRI sequences [23,24]. On the other hand, due to the high proton content, 
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hydrogels can be easily visualized and monitored in vivo through conventional T1-weighted 
MRI [25].  
Despite the huge potential in using GelMA in BTE, in vivo studies that prove its 
biocompatibility with respect to bone tissues remain unexplored. In this study for the first 
time, a 3D printed GelMA hydrogel for bone regeneration was designed and tested in a 
defined in vivo rat animal model (e.g. critical-size condyle defect). Furthermore, considering 
the advantages of non-invasive follow-up of BTE-dedicated scaffolds, two different imaging 
strategies were investigated as possible screening tools. The first strategy was based on the 
enhancement of the CT contrast of GelMA by means of labeling with AuNPs. The second 
strategy was based on the combination of T1-weighted and UTE based MRI acquisitions for a 
dual imaging of GelMA and bone, respectively. 
2. Materials and Methods 
2.1. Preparation of gelatin methacrylate (GelMA) and GelMA pre-polymer solution 
GelMA was synthesized as described elsewhere [26]. Briefly, type A porcine skin gelatin 
(Sigma-Aldrich, St. Luis, MO) was suspended at final concentration of 10 % (w/v) in 
phosphate buffer solution (PBS) at 60 °C and stirred until the gelatin was fully dissolved. 
Afterwards, 0.8 mL methacrylate (Sigma-Aldrich) per gram of gelatin was added under 
constant stirring. Once the reaction was completed, the mixture was dialyzed against distilled 
water using 12-14 kDa cut-off dialysis tubing (Spectra/Por 1 Dialysis Membranes, Spectrum 
Labs, Rancho Dominguez, CA) to remove exciding salts and methacrylic acid. Finally, the 
solution was lyophilized to generate a white porous foam and stored at -80 °C until further 
use. 
The pre-polymer solution of GelMA was prepared as follows. The photoinitiator 2-
Hydroxy-4′-(2-hydroxyethoxy)-2-methylpropiophenone (Irgacure 2959, Sigma-Aldrich) was 
dissolved in 10 mM PBS at 37 °C at concentration of 0.05 % (w/v). After complete dispersion 
of Irgacure 2959, 5 % (w/v) GelMA was added to the solution to obtain GelMA pre-polymer 
solution.  
2.2. Evaluation of mechanical properties, in vitro cytocompatibility and µCT visibility of 
GelMA and GelMA-AuNPs bulk hydrogels  
To enhance CT contrast of GelMA-based scaffolds, AuNPs (Sigma-Aldrich) stabilized by 
citrate in 0.1 mM PBS, with different size and concentration were added to GelMA pre-
polymer solution. Specifically, different concentrations of AuNPs were calculated as 0.08 
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mM, 0.16 mM and 0.40 mM. These same concentrations were used for two AuNPs size, i.e. 
40 nm and 60 nm. 
To assess the influence of AuNPs on the mechanical properties, in vitro cytocompatibility, 
and µCT visibility of GelMA, cylindrical discs of GelMA and GelMA-AuNPs (diameter = 10 
mm, thickness = 1 mm) were prepared from pre-polymer solutions. To assess mechanical 
properties GelMA and GelMA-AuNPs hydrogels were detached from the molds and tested at 
a rate of 20% strain/min on a DMA Q800 apparatus (TA Instruments). The compressive 
modulus was determined as the slope of the linear region corresponding to 0-5% strain (n=5). 
To evaluate the acute cytotoxic effect of AuNPs size and concentration, GelMA-AuNPs 
hydrogels (prepared in sterile conditions), were cultured with L929 fibroblasts (mouse 
C3H/An, ECACC, UK) in Dulbecco's Modified Eagle Medium (DMEM, Gibco, Grand 
Island, MA), 10% FBS (EuroClone S.p.A., Pero, Italy), and 100 µg/mL Penicillin-
Streptomycin (10,000 U/mL, Gibco) at 37 °C and 5% CO2 for 72 hours. Subsequently, 
CellTiter Cell Proliferation Assay (MTS, Promega, Fitchburg, WI) was performed to measure 
the metabolic activity colorimetrically (FLUOstar Omega UV/Vis spectrometer, BMG 
LabTech, Ortenberg, Germany) of the fibroblasts incubated with the GelMA control (i.e. non 
labeled) and the GelMA-AuNPs.  
Radiopacity assessments of the GelMA-AuNPs hydrogels containing different size of 
AuNPs in different concentrations, were carried out using a Skyscan 1172 (Bruker, Kontich, 
Belgium) micro CT (µCT) system with the following settings: 40 kV, 250 µA, pixel size of 
12.7 µm, exposure time 100 ms, and 1 mm aluminum filter. Acquired files were reconstructed 
through NRecon (Skyscan) reconstruction software, while assessment of the gray value of the 
hydrogels was performed using CTAnalyser software (version 1.10.1.0, Skyscan). 
2.3. Rheological characterization of GelMA and GelMA-AuNPs pre-polymer solutions 
Storage (G’) and loss modulus (G”) of the GelMA pre-polymer were studied with a stress-
controlled rheometer (Discovery HR-1, TA Instruments, New Castle, DE). The rheometer was 
equipped with aluminum parallel plate geometry (40 mm diameter), while the gap between 
the plates was set to 250 μm. In order to verify the sol-gel transition point of the GelMA and 
GelMA-AuNPs pre-polymer solutions, rheological measurements were performed at 
controlled temperature gradient (i.e. from 3 to 40°C), with a heating rate of 2°C/min, a 
constant strain of 1% and a frequency of 1Hz. 
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2.4. Layer-by-layer 3D printing of GelMA and GelMA-AuNPs hydrogels 
GelMA pre-polymer solution was prepared as previously described, decontaminated by 
filtering (PES membrane, 0.22 µm), and transferred into the plotting cartridge (Nordson EFD, 
Westlake, OH), which was kept under sterile conditions. The plotting cartridge was installed 
on the printing head of a bioplotter (Envisiontec, Gladbeck, Germany) and the GelMA 
solution was cooled down to 22 °C. GelMA solution was dispensed through a 22G needle, 
layer by layer with speed of 17 mm/s, forming 0° / 90° strand structures. A CAD file 
specifying the geometry of the scaffold was used as input to produce the physical model for 
the apparatus. Cuboids of 20 mm wide and 5 mm thick were fabricated during this process 
with 220 µm layer thickness and 800 µm strand distance. Later, they were exposed to 12.5 
mW/cm
2
 UV light (BlueWave® 75 UV Light Curing Spot Lamp, 365 nm, Torrington, CT) 
for 60 seconds. Subsequently, each scaffold was punched into discs of 3 mm in diameter 
(Figure 1). The same 3D printing parameters and steps were followed in the case of GelMA-
AuNPs. 
 
 
Figure 1. Schematic representation of 
the manufacturing steps followed for 
the preparation of 3D hydrogels for the 
in vivo assay. Firstly, cooled GelMA 
solution was 3D printed through layer-
by-layer method. Secondly, the 3D-
printed GelMA-based hydrogels were 
crosslinked by using UV light. Finally, 
the achieved 3D block was punched in 
the desired size. The same steps were 
followed for the production of 3D 
GelMA-AuNPs hydrogels. The insert 
is showing an overview of the 
morphology of 3D scaffolds used for 
the in vivo study. Notice that the 
GelMA scaffold appears slightly pink 
colored due to the presence of the 
AuNPs.      
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2.5. Pore and fiber size measurements by scanning electron microscopy (SEM) imaging 
SEM imaging was used to determine the fiber size and pore size of 3D printed GelMA 
hydrogels. To this end, 3D printed GelMA hydrogels were rinsed with PBS and soaked for 5 
minutes in Karnovsky fixative (2.5 % glutaraldehyde in 0.1 M sodium cacodylate) at 4 °C. 
The fixed samples were dehydrated through a series of ethanol solutions (i.e. 70 %, 80 %, 90 
%, 100 %), and sputtered with a 7 nm layer of gold. Specimens were examined by using a 
SEM system (Phenom proX, PIK Instruments, Warsaw, Poland).  
2.6. In vivo implantation in a rat defect model  
The GelMA-AuNPs formulation which showed best performances in terms of mechanical 
properties, cytocompatibility and enhancement of the µCT, i.e. GelMA plus 0.16 mM AuNPs 
60 nm, was printed as done for the non-labeled GelMA solution and used for further in vivo 
studies. The animal study was performed after the approval of the Animal Ethics Committee 
for the care and use of laboratory animals (RU-DEC number 2015-0035) and in agreement 
with the standards of the Radboud Univerisity Medical Center, Nijmegen, The Netherlands. 
The in vivo study is described according to the ARRIVE guidelines for reporting in vivo 
experiments [27]. The in vivo study was designed to answer three specific experimental 
hypothesis: 1) is 3D-printed GelMA scaffold suitable for BTE, hence allowing bone growth 
instead of adverse reaction (i.e. fibrotic encapsulation of the scaffold and hampering the bone 
formation); 2) are AuNPs able to enhance the CT contrast of GelMA and allow in vivo 
monitoring; 3) is MRI a suitable screening tool for the simultaneous monitoring of bone 
growth and GelMA-based hydrogel degradation.  
For the in vivo assay sample size was calculated by using a significance level of 0.05 and 
power of 80%, while a standard deviation of 7% and effect size of 15% were defined based on 
values reported in the literature [22]. G*Power software was used for the power calculation 
[28]. Five samples (n=5) were assigned to two experimental groups (i.e. GelMA and GelMA-
AuNPs 0.16 mM, 60 nm) and to two time points (i.e. 4 and 8 weeks), respectively. In order to 
reduce the number of animals for this experiment both posterior legs of the same animal were 
used. Therefore, the final study population consisted of 10 healthy male 6-7 weeks old Wistar 
rats (Rattus Norvegicus, bodyweight: 200-250 g, Charles River Laboratories, Leiden, The 
Netherlands). The animals were randomly allocated to each time point and to each 
experimental group. Surgical operations were performed by a single expert operator trained in 
the standardization of the surgical procedure. For the surgery the animal was anesthetized by 
inhalation of a mix of isoflurane (Rhodia Organique Fine, Avonmouth, Bristol, UK) and 
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oxygen and then located in supine position on a heating mat. Both legs were shaved and 
disinfected with povidone-iodine solution (Betadine, Kuinre, The Netherlands). A 
longitudinal incision was performed on the medial side of the knee through the skin and the 
underlying muscle until the femur was reached. Then, the patella was manually dislocated on 
the lateral side in order to have a clear view of the distal femoral condyle. A dental drill (Astra 
Tech Elcomed 100, Dentsply Implants, Zoetermeer, The Netherlands) equipped with three 
different dental burs with increasing diameter up to 3 mm was used to perform a cylindrical 
defect of 5 mm in depth (Figure SI a-b). During the drilling a sterile saline solution (Fresenius 
Kabi B.V., Emmer-Compuscum, the Netherlands) was used to cool down the dental bur and 
to clean the cavity. Sterile gauze was used to control the bleeding. After the defect 
preparation, pre-printed GelMA and GelMA-AuNPs hydrogels, prepared and kept in sterile 
condition, were taken through sterile tweezers and inserted into the defect. Due to the 
difference in color between the hydrogels from the two experimental groups (i.e. GelMA in 
white and GelMA-AuNPs in pink) the operator could not blindly operate. Once the 3D device 
was inserted, the patella was moved back to the original position; the muscle and the skin 
were closed with absorbable sutures (Vicryl® 4.0 Ethicon, Somerville, NY). To decrease 
post-operative discomfort a subcutaneous injection of painkiller (5 mg/Kg Rimadyl®, Cattle, 
Capelle a/d Ijssel, The Netherlands) was performed post-surgery. At 4 and 8 weeks from the 
surgery five animals were sacrificed by CO2/O2 inhalation and scanned again with both MRI 
and CT. Finally, femora were harvested, placed in formalin 10 wt% for 48 h and kept in 
ethanol 70% until histological assessments.  
2.7. Ex vivo µCT 
Ex vivo µCT examinations were used for the assessment of the hydrogel degradation and the 
bone healing. The scans were carried out using the SkyScan1172 (Skyscan) with the 
following settings: 100 kV, 100 µA, pixel size of 12.7 µm, exposure time 460 ms, and 1 mm 
aluminum filter. The new bone formation was quantified through CTAnalyser software. To 
this end, a defined volume of interest (VOI) of 3 mm in diameter and 2.5 mm in dept, and a 
standardized threshold selection were used. The new bone formation was normalized 
according to the initial bone volume in the same selected VOI.  
2.8. In vivo CT 
CT acquisitions were performed on a small animal CT scanner (Inveon Micro-CT/PET, 
Siemens Medical solution, Knoxville, TN). After the surgery (i.e. Day 0) the animals were 
kept under general anesthesia (isoflurane/O2) and located on the supine position on a heating 
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mat. At 4 and 8 weeks the animals were scanned right after the sacrifice. Images were 
recorded with an acquisition time of 6 min, spatial resolution of 30 µm, tungsten anode source 
(source voltage 80 kV) and exposure time of 1000 ms. Two-dimentional reconstructions of 
the acquired file were obtained by Inveon Research Workplace software (IRW, Siemens).  
2.9. In vivo MRI  
MRI acquisitions were performed on a 11.7 T MRI system (Biospec, Bruker, Germany) 
equipped with a 
1
H volume coil with inner diameter of 40 mm. Images were acquired by 
using T1weighted rapid acquisition with relaxation enhancement (RARE) followed by and 
2D-UTE sequence with the following scan parameters. For the T1-RARE: echo time (TE) = 9 
ms, repetition time (TR) = 900 ms, RARE factor = 4, matrix size = 512 x 512 x 512, image 
resolution = 0.098 x 0.098 x 0.098 mm
3
, averages = 4, acquisition time (TA) = 5.45 min. For 
the UTE: TE = 0.5 ms, TR = 5 ms, FA = 15°, matrix size = 256 x 256 x 256, slice thickness = 
0.8 mm, image resolution = 0.234 x 0.234 mm
2
, number of slice = 15, bandwidth = 200 kHz, 
averages = 1, acquisition time (TA) = 1.03 min. After the surgery (i.e. Day 0) the animals 
were kept under anesthesia by inhalation of isoflurane/O2 and located on the supine position. 
Body temperature and breathing were constantly monitored. At 4 and 8 weeks the animals 
were scanned right after the sacrifice. One by one each leg was immobilized inside the coil 
and scanned. The obtained images were reconstructed by using MRIcro software (Smith 
Micro software, Aliso Viejo, CA). MRIcro was also used to define the size of the scaffold.  
2.10. Histology and Histomorphometry 
Specimens were decalcified in a solution of 10 wt% ethylenediaminetetraacetic acid (EDTA, 
pH 7.2) for two weeks under stirring, dehydrated in a gradual ethanol series (from 70% to 
100%) and then embedded in paraffin. Three sections (4 µm in thickness at 100 µm of 
interdistance) were cut along the axial direction of the femur by using a microtome (RM2165, 
Leica Microsystems, Rijswijk, the Netherlands). Afterwards, sections were stained with 
Hematoxylin/Eosin (H/E) and with trichrome Elastic van Gieson (EVG). Images were 
acquired by using an automated light microscope (VisionTek, Sakura Finetek Europe B.V., 
Leiden, The Netherlands) with X10 magnification.  
2.11. Statistical analysis  
Samples were tested in quintet if otherwise indicated, and data are reported in mean value +/- 
standard deviation. Statistical analysis was performed using unpaired t-test for bone 
quantification based on µCT acquisitions, and two-way ANOVA followed by Sidak’s 
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multiple comparison test, for the metabolic activity and compressive modulus. Statistical 
differences were computed through Prism software (v5.00, GraphPad, San Diego, CA). 
Difference was considered statistically significant if p< 0.05 (*), p< 0.01 (**), p< 0.0003 
(***), and p< 0.0001(****). 
3. Results  
3.1. Characterization of GelMA-AuNPs bulk hydrogel  
To enhance CT contrast of GelMA-based scaffolds AuNPs, with different size and 
concentration, were added to GelMA pre-polymer solution. No significant reduction in 
cellular metabolic activity for AuNPs concentrations below 0.16 mM, for both 40 nm and 60 
nm sized nanoparticles, was observed (Figure 2a). Mechanical testing on GelMA-AuNPs in 
the concentration range they were biocompatible was performed subsequently (Figure 2b). 
Results indicated that the addition of the both 40 nm and 60 nm AuNPs did not significantly 
affect the compressive modulus of the hydrogels. Afterwards, both GelMA and GelMA-
AuNPs hydrogels were scanned and compared regarding the changes in x-ray attenuation 
(Figure 2c). The histogram of the gray values distribution showed a shift in the gray values for 
the hydrogels compositions labelled with the AuNPs. Particularly, a distinctive shift in gray 
value and sharper curve with increased frequency was attained when 60 nm AuNPs were used 
with concentration of 0.16 mM. Therefore, the GelMA-AuNPs formulation containing 0.16 
mM 60 nm AuNPs was selected as showing the best performance in terms of mechanical 
properties, cytocompatibility and enhanced radiopacity. Such GelMA-AuNPs hydrogel was 
used to prepare 3D printed scaffold for the in vivo assay. 
3.2. 3D printing of GelMA and GelMA-AuNPs hydrogels 
To understand the thermoresponsive properties of the GelMA hydrogels and the effect of 
AuNPs addition on thermoresponsivitivy, the rheological properties of the GelMA and 
GelMA-AuNPs pre-polymer solutions were investigated. A rapid decrease in G’ around 18°C 
was observed, which also corresponded to the intersection point between G” and G’ for both 
GelMA and GelMA-Au pre-polymer solutions (Figure 3a). These findings indicate that pre-
polymer solutions, at 5% GelMA (w/v) concentration, exhibited gel-like properties at 
temperatures below 18°C and liquid-like properties above 18°C. Therefore, printing 
temperature of both hydrogels was set to 22°C, which was considered the temperature that 
forms a weak gel and gives stable rheological properties just before the gelation occurs 
(Figure 3b, 3c, 3e, and 3f). In Figure 3d and Figure 3g, SEM images of high-resolution 3D 
printed dried GelMA and GelMA-AuNPs hydrogels were shown. Based on SEM observation 
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it was possible to observe that the scaffolds had regular pores, i.e. 285 ± 35 µm, and strands, 
i.e. 100 ± 15 µm.  
 
Figure 2. Evaluation of in vitro cytocompatibility, mechanical properties, and µCT visibility of GelMA-AuNPs 
hydrogels. In (a) evaluation of the effect of AuNPs size and concentration on cell metabolic activity (*: p*<0.01, 
***: p<0.003). Note that at 0.08 mM and 0.16 mM, for both 40 nm and 60 nm size, no differences were observed 
when compared to the control. In (b) the assessment of the effect of AuNPs size and concentration on 
mechanical properties of the GelMA hydrogel in cytocompatible AuNPs concentration range; no differences 
between the experimental groups were observed. In (c) the effect of AuNPs size and concentration on 
radiopacity of GelMA-AuNPs hydrogels. In blue the composition that showed the best x-ray attenuation value. 
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Figure 3.  Sol-gel transition of GelMA and morphology of 3D printed GelMA hydrogels. In (a) the storage 
modulus (G’) and the loss modulus (G”) were plotted as function of temperature. The representative image of 
GelMA solution (b) and GelMA-AuNPs solution (e) at 37°C, i.e. the solution state of GelMAand GelMA-
AuNPs, while in (c) and (f) the representative image of GelMA solution and GelMA-AuNPs at 22°C, 
respectively, i.e. the gel state of both hydrogels. In (d) and (g) SEM image of 3D printed GelMA hydrogels and 
GelMA-AuNPs hydrogels (magnification 250X).Both chemically dried hydrogels had regular pores of around 
285 µm and strands with a thickness of 100 µm. 
 
3.3. Longitudinal evaluation of 3D printed GelMA and GelMA-AuNPs implanted in rat 
model 
To assess the longitudinal in vivo biological performance of the 3D GelMA and GelMA-
AuNPs, pre-printed hydrogels were inserted into defects performed in rat leg. After the 
surgery, the animals were recovering quickly, were moving in an unrestricted manner, and no 
post-surgical complications were observed. Assessment of the primary outcomes showed 
good handling properties for both type of 3D hydrogels. Specifically, scaffolds could be easily 
handled and inserted in the defect by using a surgical tweezers. Furthermore, once the 
hydrogels were placed in to the defect, by visual inspection it was possible to notice that the 
scaffolds were quickly perfused by bloodstream. 
Estimation of bone regeneration over time was performed qualitatively and quantitatively 
via µCT (Figure 4). MicroCT images reconstructions showed that the size of the initial defect 
was gradually decreased at 4 weeks and 8 weeks followed by a subsequent new bone 
ingrowth (Figure 4a). Consistently, bone quantification showed a gradual increase in bone of 
15% at 4 weeks and 28% at 8 weeks (Figure 4b). 
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Figure 4. Longitudinal evaluation of 3D printed GelMA.  µCT tomograms of the rat condyle (a) and the 
implanted GelMA hydrogels at day 0, 4 weeks, and 8 weeks, GelMA-AuNPs at day 0, 4 weeks, and 8 weeks 
along the transverse plane. Yellow arrows indicate the defect area in the condyle. In (b) newly bone formation 
quantification in the defect area assessed from µCT scans. No differences between GelMA and GelMA-AuNPs 
were observed over time. 
Histological assessment proved the optimal integration between the hydrogels and 
surrounding bone tissue (Figure 5). No fibrotic encapsulation of the hydrogel or extensive 
inflammation reactions was observed. The original 3D morphology of the scaffold persisted 
for the full experimental time and micro (< 10 µm) and macro (> 10 µm) porous structures 
could be still identified (Figure 5a). The new bone formation was mainly observed on the 
external side of the implanted scaffolds. However, bone deposition was also observed in the 
pores of the scaffold in correspondence of the big porous structures (Figure 5b). Such findings 
suggested the occurrence of enough nutrients efflux through all the scaffolds that promoted 
bone tissue ingrowth in the deepest area of the implant. In 6 out of 10 samples the bone 
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regeneration occurred in the central part of the implant, appeared to follow the square 
geometrical morphology of the 3D GelMA (Figure 5b).   
 
Figure 5. Histological section of femoral condyle at 8 weeks post-surgery. In (a) overview of a histological 
section of the condyle filled with GelMA and GelMA-AuNPs, respectively. The sections were stained with EVG 
and acquired with x5 magnification. In (b) the enlarged view of the rectangles. The same section is reported after 
staining with EVG (on the top) and HE (on the bottom). Blue arrows indicate bone growing in contact with the 
scaffold, green arrows indicate expected onset of new bone following scaffold morphology. Magnification 20x. 
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3.4. In vivo monitoring by CT and MRI 
The CT tomograms over 8 weeks monitoring for both GelMA and GelMA-AuNPs hydrogels, 
show that both scaffolds were only barely visible on CT acquisition performed after the 
surgery; still at this stage the porous structures of the scaffold could be recognized (Figure 6). 
However, the used AuNPs did not provide sufficient radiopacity enhancement of the CT 
contrast in vivo when compared to the GelMA control scaffolds, as no differences between the 
labeled and non-labeled hydrogels were observed. The morphology of the 3D printed scaffold 
became less distinguishable at 4 weeks post surgery. 
 
Figure 6. In vivo CT images of the GelMA/GelMA-AuNPs hydrogels implanted in rat condyle. Notice that 
hydrogels were visible only after surgery, red arrows indicate the porous structures of the 3D printed scaffolds.  
 
In Figure 7, the T1-weighted and UTE MRI acquisitions of the implanted 3D GelMA 
hydrogels are shown at day zero, 4 weeks, and 8 weeks, respectively. On the T1-weighted 
acquisition 3D GelMA scaffolds were clearly visible for the full experimental time. 
Furthermore, through T1-weighted MR images it was possible to visualize the fine 3D 
morphology of the scaffold including the square-shaped porous structure. Over time, the size 
of the porous structure resulted to be smaller. MRI based on T1-weighted acquisition could be 
also used for the quantitative assessment of the size of the scaffolds that resulted to be 
decreased over time (Figure 7b). As expected T1-weighted acquisition could not provide 
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signal from the bone phase which resulted in a dark area (Figure 7a). Differently, MRI 
acquisitions based on UTE were able to give more information about the bone structures 
rather than the implanted GelMA hydrogel. Specifically, on UTE-MR images bone mineral 
phase was clearly recognizable over all the experimental time, hence allowing the 
visualization of the pre-existing and of the newly formed bone in the proximity of the 
implanted scaffold. Also, it could be observed that the fine morphology of the hydrogels was 
lost. 
 
 
Figure 7. In (a) in vivo monitoring of 3D 
printed GelMA hydrogels via MRI based on 
T1-weighted (on the top) and UTE 
acquisition (on the bottom). Yellow arrows 
indicate the 3D printed GelMA hydrogels, 
red arrows indicate the pores in the 3D 
printed structure, blue arrows indicate the 
bone around the GelMA hydrogels. Note 
that only T1-weighted picture can give a 
clear view of the scaffold, while UTE can be 
used to visualize bone tissue. In (b) 
quantification of the scaffold size performed 
based on T1-weighted MRI. Note that over 
time the diameter was decreasing. 
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4. Discussion  
The integration between BTE constructs and host tissue can be improved using hydrogels 
with distributed and interconnected pores [12,13]. However, a lack of proper porosity may 
cause insufficient vascularization into the defect site and lead to necrosis [29]. In this study, 
the possibility to use a 3D printing manufacturing process to obtain a porous hydrogel 
scaffold that could be used for bone regeneration was investigated in a rat condyle defect 
model, in addition to investigating its optimal imaging properties.  
GelMA-based hydrogels can serve as 3D model systems for different tissue engineering 
applications as its chemical, biological and mechanical properties can easily be adjusted for 
the application of interest [30]. Our recent study showed the osteogenic differentiation of 
mesenchymal stem cells and the homogeneous calcification through the GelMA hydrogels 
[6]. After testing hydrogels containing different concentrations of GelMA, the composition 
with 5% (w/v) ratio showed higher MSC attachment. Similarly, more homogeneous and 
significantly higher calcium deposition was also observed when 5% GelMA hydrogels were 
used. These results supported our choice for GelMA as suitable material for BTE and also 
indicated the ideal concentration that needed to be used in further studies (i.e. 5% w/v). 
Bone is a vascular tissue, thereby the integration of microchannels into GelMA hydrogels 
can further stimulate vascular network formation and increase the perfusion through the 
hydrogel [31]. Although microchannels can be created using 3D printing technology, 3D 
printing of GelMA is a challenging process. The current strategies for creating microchannels 
into GelMA hydrogels are blending with other biopolymers, pre-crosslinking, supporting with 
thermoplastic scaffolds, and thermoresponsive-based approach [9,32–34]. In previous studies, 
different polymers were added into GelMA hydrogels prior to the printing both to increase the 
viscosity of the pre-polymer solution or to cage the GelMA into a crosslinked polymer 
network [9,32]. For direct printing GelMA, without addition of different polymers or support 
constructs, different approaches were suggested by Bertassoni et al. [33] and Billiet et al. 
[34], respectively. Specifically, Bertassoni et al. suggested pre-polymerizing the GelMA 
hydrogel prior to the crosslinking. However, they indicated that this approach was not suitable 
for forming continuous well-structured fibers for the GelMA concentrations below 7% (w/v). 
On the other hand, Billiet et al. proposed to use the thermoresponsive characteristic of the 
GelMA hydrogel and adjusted the extrusion temperature to sol-gel temperature of the GelMA 
hydrogels to attain continuous fibers. However, they also implied that the printing potential 
was significantly limited, especially for hydrogels with 5% (w/v) concentration. The printing 
procedure suggested by Billiet et al., which utilizes the thermoresponsive characteristic of 
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GelMA, was an advantageous method for our study as this technique did not require further 
modification in printing system, and allowed us to print solely GelMA with high resolution. 
The GelMA 5% hydrogel solution used in this study, showed sol-gel temperature at 
significantly lower temperatures (i.e 18°C) with increased G’ and G” values which were 
sufficient to create continuous fibers and 3D constructs even when 5% GelMA concentrations 
were used. Besides, with further optimization on printing conditions suggested by Billiet et 
al., the 3D printing parameters for 5% GelMA hydrogels was achieved with 150 µm 
resolution, which certainly represents an improvement in resolution when compared to similar 
studies [35]. The achieved printing resolution obtained in this study warrants for further 
applications with definitive scaffold architecture for GelMA hydrogels.  
Implantation in vivo of the 3D GelMA and GelMA-AuNPs demonstrated the occurrence of 
new bone formation over all the hydrogel surface suggesting optimal biological compatibility 
for both used materials. Fine integration of the newly formed bone tissue onto the surface of 
the scaffolds with and without AuNPs suggested potential osteoconductive characteristics 
[36]. The presence of viable tissues, also in the central part of the scaffold, suggested an 
appropriate nutrient supply through the scaffolds matrix. It can be expected that full 
ossification throughout the scaffold would even occur, at longer implantation times (>16 
weeks), however, this was beyond the scope of the current study. In addition, the ossification 
process could further be enhanced by functionalizing the scaffold with added mineral, surface 
modification with attachment proteins, or simply by adding a BMP release system, to result in 
a “theranostic” medical device. Still, the current result was promising, showing the evident 
promotion of a defined bone ingrowth according to the microporous structure of the implanted 
scaffolds. The efflux of nutrients could have played an important role in this finding. Bulk 
hydrogels consist of an intrinsic micro-porosity nature [31]. However, such network may not 
be fully permeable to the nutrient efflux limiting the new bone formation mostly on bone-
hydrogel junctions [21]. Differently, the high and interconnected porosity of 3D GelMA and 
GelMA-AuNPs hydrogels, promoted a more extend bone formation, hence supporting the use 
of 3D printing in manufacturing bone dedicated scaffolds. No differences in new bone 
formation between GelMA with and without AuNPs were observed in the current study. 
AuNps have been described to play a crucial role in vitro in the osteogenic differentiation of 
mesenchymal stem cells through the P38 mitogen-activated protein kinase pathway (MAPK) 
patway [20]. Moreover, bulk GelMA combined with 14 µg of AuNPs, 27 nm in diameter, and 
implanted in critical-size defect performed in the skull of healthy rabbit has been shown to 
induce more bone formation (i.e. > 12%) when compared toGelMA without AuNPs [21]. 
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These previous findings are in contrast with the outcomes of this study, hence questioning the 
ability of AuNPs to induce bone formation. 
Besides manufacturing a suitable scaffold for BTE, non-invasive monitoring strategies that 
can allow the assessment of its integration and degradation in vivo was another important 
aspect of our study. Computed tomography is the most commonly used modality imaging for 
hard tissues as this technique provides high-resolution 3D anatomical information [37–39]. 
Therefore, CT was used in various studies to quantify and demonstrate bone regeneration in 
the performed defect area. Even though CT is the gold standard for hard tissue imaging, its 
translation to BTE applications is hampered by some challenges. Specifically, in case of 
hydrogel-based scaffolds, CT imaging results difficult due to their high water content. Thus, 
even though hydrogels have been used for BTE applications, CT was only used to image the 
newly formed bone [40-42] To overcome the challenge of imaging GelMA hydrogel via CT, 
it was hypothesized that the combination of GelMA with specific CA would improve the 
overall X-ray attenuation of the scaffold. Previously, different iodinated hydrogel 
formulations were already studied in embolization of blood vessels applications, nucleus 
pulposus replacements and as fiducial markers in gynecologic-cancer patients [43–45]. Hertig 
et al. [17], suggested iodixanol combined fibrin hydrogels for endodontic applications. Their 
ex vivo preliminary experiments in human teeth showed that the radiopacity of the fibrin 
hydrogels was only sufficient for a correct localization of the implant. Nonetheless, it was 
indicated that the swelling characteristics of hydrogels changed dramatically due to the 
addition of the iodixanol CA [17]. Among different CAs, AuNPs have been suggested as 
promising candidate as they show high X-ray attenuation depending on their size and 
concentration [46]. Our in vitro results showed that AuNPs could be used to enhance the CT 
signal of GelMA only to a certain extent, which resulted not enough for the in vivo 
monitoring. Most likely higher AuNPs concentrations (> 0.4 mM) could give better CT 
attenuation also in vivo, however this would have also dramatically affected the mechanical 
and biological properties of the GelMA. Therefore, CT imaging of GelMA hydrogel still 
remains a challenging issue.  
MRI is the leading non-invasive screening technique as it is able to provide 3D anatomical 
and functional information especially in soft tissues [47]. To date, MR- imaging, spectroscopy 
(MRS), and elastography (MRE) have been used to provide respectively high-resolution 
images, assessment in changes of the molecular structures, and measurement of the 
mechanical properties of cartilage-dedicated TE constructs [48,49]. Furthermore,T1- and T2- 
weighted MRI was used for the non-invasive monitoring of hydrogel-based scaffolds 
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integration after implantation in trapezius muscle in rabbit model, and for the assessment of 
the impact of injectable hydrogels on the ventricular remodeling after myocardial infarction 
[25]. Recent developments of UTE MRI sequences allow the visualization also of hard tissues 
(e.g. bone and teeth) that are otherwise showing little or no signal on conventional MRI 
sequences [50]. Therefore, ultrashort acquisition-based MRI is expected to have a strong 
impact also in the field of BTE. Specifically, we hypothesized its use for the non-invasive 
longitudinal follow up of bone regeneration when dedicated 3D printed hydrogels are used. 
The MRI workflow acquisition was based on a T1-weighted sequence, which was used to 
obtain morphological reconstruction of the 3D GelMA, followed by an UTE sequence, which 
was used to obtain morphological information of the pre-existing and the newly formed bone. 
When comparing the imaging acquisitions performed by CT with the one obtained through 
the MRI workflow proposed in this study, the latter method resulted to be superior in terms of 
achievable information related to both scaffold degradation and new bone formation. Recent 
advances on MRI based on chemical exchange saturation transfer (CEST) showed the 
feasibility to specifically assess in vivo differences in hydrogels chemical composition [51]. 
On the other hand, high resolution UTE-based MRI of bone tissues has been already applied 
in clinics, and is theoretically available also for BTE application [52]. Therefore, this study 
can be used as proof-of-concept for further pre-clinical imaging investigations in BTE. 
5. Conclusions 
The longitudinal monitoring of TE constructs in vivo is of vital importance for translational 
research. Thus, the design of new TE scaffolds should not only address the need of 
biomaterials with optimal biological properties but also to focus on the imaging strategies 
required to follow its fate once implanted in vivo.  In this study, a 3D printed GelMA scaffold 
with high porosity and interconnectivity was designed and tested in vivo. This GelMA showed 
optimal biological properties and evident osteoconductive features. Furthermore, with these 
scaffolds an MRI workflow consisting of T1-weighted MRI and UTE-MRI acquisition is 
superior to CT imaging to visualize both scaffold and bone tissue.        
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1. Summary 
Every year more than two million of patients worldwide undergo bone transplantation due to 
bone diseases and trauma. The gold standard treatment is the transplantation of autologous 
bone. Nevertheless, a lack of transplantable bone and high morbidity risks associated with this 
procedure, increase the demand for suitable synthetic materials. The developments in this 
research field have resulted in several biocompatible materials that can be implanted in the 
body through minimally invasive surgery while promoting a faster bone healing and repair. 
The translation of such biomaterials to clinical use relies on pre-clinical in vivo animal models 
that are used to test their tissue integration properties.  
One of the current challenges in the bone regeneration field is the development of less 
invasive pre-clinical imaging strategies that can be used to understand the biological behavior 
of biomaterials after installation into the body. An ideal imaging modality can give 
longitudinal quantitative and qualitative high-resolution information about the biomaterial 
integration and the subsequent new tissue replacement.  
A general introduction to bone regeneration, biomaterials, and imaging challenges was 
provided in Chapter 1. Among all the pre-clinical imaging modalities, magnetic resonance 
imaging (MRI) is a technique that does not involve the use of ionizing radiations. 
Furthermore, MRI allows high spatial resolution, high soft tissue contrast and specificity, and 
unlimited penetration depth. However, MRI of hard tissues, such as bone and teeth, has been 
always challenging because of the low proton content in these tissues as well as a very short 
transverse relaxation (T2). New MRI sequences, such as sweep imaging with Fourier 
transformation (SWIFT), ultra-short echo time (UTE), and zero echo time (ZTE), have been 
developed to image tissues with short T2. Within Chapter 2, all MRI sequences used for the 
detection of hard tissues, such as bone and dental tissues, are reviewed. The main goal was to 
give a broad overview of the potential clinical and preclinical applications of these MRI 
sequences and on the future direction of such techniques. Furthermore, an insight in MRI of 
biomaterials for hard tissue application was also given. Evidently, Chapter 2 indicates that 
proton-based MRI by ultrashort echo time sequences is an excellent method to image bone, 
teeth, and biomaterials for bone and dental applications.  
To date, different materials have been developed for bone and dental applications. Calcium 
phosphate cement (CPC) is a typical example as it shows optimal biological and handling 
properties. However, the high similarity between CPC and the natural osseous phase results in 
poor image contrast in most of the available in vivo imaging techniques such as computed 
tomography (CT) and magnetic resonance imaging (MRI). To date, it remains still unclear if 
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CPC can be detected by MRI after insertion in vivo as a dental agent. Therefore, the aim of 
Chapter 3 was to optimize high field ZTE imaging to enable the visualization of a new CPC 
formulation implanted in teeth and to apply this in the assessment of its decomposition in 
vivo. To this end, CPC was implanted in three human and three goat teeth ex vivo and in three 
goat teeth in vivo. An ultra-short echo time sequence with multiple flip angles and echo times 
was applied at 11.7 T to measure T1 and T2
*
 values of CPC, enamel, and dentin. Teeth with 
CPC were imaged by an optimized ZTE sequence. Goat teeth implanted with CPC in vivo 
were imaged after seven weeks ex vivo. T2
*
 relaxation of implanted CPC, dentin and enamel 
was better fitted by a model assuming a Gaussian rather than a Lorentzian distribution. For 
CPC and human enamel and dentin, the average T2
*
 was 273 ± 19 μs, 562 ± 221 μs and 476 ± 
147 μs respectively; the average T2 was 1234 ± 27 μs, 963 ± 151 μs and 577 ± 41 μs 
respectively and the average T1 was 1065 ± 45 ms, 972 ± 40 ms and 903 ± 7 ms respectively. 
In ZTE images, CPC had a higher signal-to-noise-ratio than dentin and enamel due to a higher 
water content. Seven weeks after in vivo implantation the CPC filled lesions showed less 
homogeneous structures, a lower T1 value and T2
*
 separated into two components. MRI by 
ZTE provided excellent contrast for CPC in teeth and allows to follow its degradation over 
time.  
Still, the combination of CPC with specific contrast agents (CAs) results to be the better 
option for in vivo follow-up. Specifically, by using CAs it is possible to enhance the contrast 
of the CPC composition not only for MRI acquisition but also for other imaging modalities, 
such as CT. Furthermore, by combining diagnostic with therapeutic agents (i.e. theragnostic) 
it is possible to deliver materials with improved imaging and biological features. In Chapter 
4, a theranostic agent for vital dental pulp treatment was designed. Specifically, a pulp 
capping agent that could show appropriate biological performance, excellent handling 
properties, and good imaging contrast was developed. Calcium phosphate-based composites 
are a potentially ideal candidate for pulp treatment, regardless their poor imaging contrast and 
poor dentino-inductive properties. Therefore, firstly the imaging properties of the CPC were 
improved by using a core-shell structured dual contrast agent (csDCA) consisting of 
superparamagnetic iron oxide (SPIO) and colloidal gold, as MRI and CT contrast agent 
respectively. Second, biological properties were implemented by using a dentinogenic factor 
(i.e. bone morphogenetic protein 2, BMP-2). The obtained CPC/csDCA/BMP-2 composite 
was tested in vivo, as direct pulp capping agent, in a male Habsi goat incisor model. Our 
outcomes showed no relevant alteration of the handling and mechanical properties (e.g. 
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setting time, injectability, and compressive strength) by the incorporation of csDCA particles. 
In vivo results proved MRI contrast enhancement up to 7 weeks post-surgery. Incisors treated 
with BMP-2 showed improved tertiary dentin deposition as well as faster cement degradation 
as measured by µCT assessment. In conclusion, the presented theranostic agent matches the 
imaging and regenerative requirements for pulp capping applications.  
CPCs have commonly used also for bone repair. For accurate identification and localization 
during and after implantation in vivo, a composition with enhanced image contrast is needed 
for any potential bone applications. In Chapter 5, CPC was labeled with perfluoro-15-crown-
5-ether-loaded (PFCE) poly(lactic-co-glycolic acid) nanoparticles (hydrodynamic radius 100 
nm) and gold nanoparticles (diameter 40 nm), as 
19
F MRI and CT contrast agents 
respectively. The resulting CPC/PFCE/gold composite was implanted in a rat model for in 
vivo longitudinal imaging. Our findings showed that the incorporation of the two types of 
different nanoparticles did result in adequate handling properties of the cement. Qualitative 
and quantitative long-term assessment of CPC/PFCE/gold degradation was achieved in vivo 
and correlated to the new bone formation. Finally, no adverse biological effects on the bone 
tissue were observed via histology. In conclusion, an easy and efficient strategy for following 
CPC implantation and degradation in vivo was developed. As all materials used are 
biocompatible, this CPC/PFCE/gold composite is clinically applicable.  
In Chapter 6, we designed a CPC construct with gadolinium-oxide nanoparticles 
incorporated to act as an MRI/CT multimodal contrast agent. The gadolinium(III) oxide 
nanoparticles were synthesized via the polyol method and surface functionalized with a 
bisphosphonate (BP) derivative to give a construct (GBCAs-BP) with a strong affinity 
towards calcium phosphate. The CPC-GBCAs-BP functional material was longitudinally 
monitored after in vivo implantation in a rat model (i.e. condyle defect). The synthetic method 
applied to produce nanoparticles that are stable in aqueous solution (hydrodynamic diameter 
70 nm) with significant T1 and T2 relaxivity was demonstrated in both clinical 3 T and 
preclinical 11.7 T MR imaging systems. The combination of GBACs-BP nanoparticles with 
CPC gives an injectable material with handling properties that are suitable for clinical 
applications. The BP functionalization prolonged the residence of the contrast agent within 
the CPC that allowed long-term follow-up imaging studies. The useful contrast agent 
properties combined with appropriate biological response indicates further investigation of the 
novel bone substitute hybrid material towards clinical application. 
Beside CPCs other materials have been proposed for BTE. Gelatin methacrylate (GelMA) is 
an inexpensive, photocrosslinkable, cell-responsive hydrogel. 3D printing GelMA was 
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previously demonstrated to promote cell penetration, vascular in-growth, and the diffusion of 
nutrients due to an evenly distributed and interconnected porosity. In Chapter 7, a printed 
GelMA hydrogel was designed and tested in vivo for BTE applications. Furthermore, two 
imaging strategies for the non-invasive monitoring of the scaffold degradation in vivo were 
investigated: i.e. 1) combination of GelMA with gold nanoparticles (AuNPs) for computed 
tomography (CT) imaging; 2) T1-weighted and ultrashort echo time (UTE) magnetic 
resonance imaging (MRI). To this end, 3D printed GelMA hydrogels were implanted in 
cylindrical defect created into the condyle of 6/7 weeks-old Wistar rats. GelMA showed to 
form a gel-like structure when it was cooled down to 22°C. The in vivo assay proved excellent 
biological properties for the 3D printed GelMA scaffolds and no signs of fibrotic 
encapsulation or inhibition of the bone formation as estimated via histology and micro-CT. 
Imaging assessment showed no feasible enhancement of the GelMA CT contrast by using 
AuNPs, while T1-weighted and UTE MRI can give more morphological information for both 
GelMA and bone tissue. In conclusion, the 3D printed GelMA designed in Chapter 7 was 
proven to be a good candidate scaffold material for BTE purposes, while MRI is suggested as 
optimal technique for its non-invasive longitudinal monitoring.  
2. Closing remarks and future perspectives 
This thesis aimed to investigate pre-clinical imaging strategies for the in vivo monitoring of 
specific biomaterials as used for the restoration of bone and teeth. Although CT remains the 
commonly used imaging modality for hard tissues, within this thesis MRI was considered as 
promising alternative candidate. For this purpose, the first main focus was the investigation of 
newly developed ultrashort echo time MRI sequences for the imaging of tissues and 
biomaterials characterized by very low water content. Nevertheless, with both CT and MRI 
modalities, the use of dedicated CAs was requested, especially for the in vivo monitoring of 
calcium phosphate-based composites. For this reason, CPC was combined with different types 
of CA (i.e. SPIO, Gadolinium, PFC) and tested in in vivo animal models for both dental and 
bone applications. Specifically, CAs were combined with bone-specific growth factors (i.e. 
BMP-2), incorporated in a CPC-dedicated carrier (i.e. silica carrier, PLGA nanoparticles) and 
functionalized with CPC-targeting compounds (i.e. bisphosphonate derivatives). Each 
contrast-enhanced CPC composition allowed long-term non-invasive in vivo follow-up. 
Therefore, with this thesis, a wide platform of visible materials for bone and dental 
applications was provided. Each composition presented specific strength and weaknesses, but 
still fulfilling all the biological requirements and thereby available for further investigations 
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as demanded prior their clinical use. Furthermore, this thesis showed that the choice of the 
imaging modality and the need of CAs depends on the specific type of biomaterial. For 
instance, in case of hydrogel-based constructs, CAs were not essential, while MRI was found 
to be superior to CT. 
Despite the successful achievements of this thesis, still many challenges exist. Although 
MRI of hard tissues and CPC through ultrashort echo time sequences, such as ZTE and UTE, 
is an established method, optimization of the acquisition protocols is still required. This 
optimization should focus on shortening the acquisition time, which is currently relatively 
long for the imaging of dental tissues. When CAs are used, easy and fast methods to quantify 
the achieved signal yet need to be developed. An in vivo highly-sensitive quantitative 
evaluation of the CA present in the implanted CPC will allow for a more precise 
understanding of CPC degradation over time. Furthermore, signal quantification is essential, 
especially when the combination of CPC with CAs results in typical MR imaging artifacts. 
For instance, such artifacts were observed when SPIO and Gadolinium were combined with 
CPC and acquired through ZTE sequences. Although it was always possible to visually 
recognize a decrease in CAs and the subsequent signal intensity, a quantitative evaluation was 
found to be very challenging. In view of this, quantitative susceptibility mapping based on 
MRI phase images can be a feasible strategy. It is known that CAs with different 
paramagnetic properties can affect the uniformity of the applied magnetic field (B0). Phase 
images give information about local frequency distributions, which depend on the bulk 
magnetic susceptibility of the different tissues. Therefore, MRI phase image acquisitions can 
be used to quantify the imaging artifact as caused by the use of CA. Alternatively, T1 
mapping based on UTE acquisition with variable flip angles (VFA) is also suggested for 
further investigation. The VFA-UTE method relies on MRI acquisition with multiple flip 
angles and can be used for the assessment of the relaxation properties of tissues with 
extremely fast signal decay. 
To date, MRI seems the only technique that allows the non-invasive imaging of the tissue 
regeneration process. Theoretically, MRI can be used to image cell migration into the 
scaffold, the morphology and degradation of the scaffold, and the final biological response of 
the host tissue. However, the use of MRI in bone tissue engineering is still at an early stage 
and more investigations are required. Moreover, the use of MRI in dentistry is still considered 
a long-term scenario especially due to the high costs associated with this technique. This 
thesis proved the huge potential of using MRI as a dental screening tool, as MRI permits the 
visualization of soft and hard dental tissues simultaneously and to assess their chemical 
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composition. Consequently, the development of MRI-visible materials is needed and their 
further investigation for dental applications is warranted.  
A screening approach based on different imaging modalities, i.e. CT/MRI, was also one of 
the topics in this thesis. A multimodal imaging approach is able to give complementary 
information as every limitation of one imaging modality can be potentially overcome by the 
other one. However, the lack of an integrated MRI/CT machine makes the imaging 
acquisition laborious and the interpretation of the data not always easy. Considering the 
technical challenge in building an MRI/CT scanner, a standardized and automated post-
processing imaging approach is instead suggested for future studies. 
Other considerations can still be made on the use of CAs. Different types of MRI-based 
CAs were successfully investigated in this thesis, yet still many other options remain 
unexplored. Metalloproteins (e.g. hemoglobin and ferritin), which have per se paramagnetic 
properties, are considered valid candidates for the development of a new generation of safe 
MRI probes for biomedical applications. In addition, it has to be noticed that the CA can have 
a significant effect on the properties of a biomaterial. For example, the incorporation of any 
new component in a calcium phosphate matrix, like CPC, will unavoidably interact with the 
crystallization process and change the handling properties of the final composition. On the 
other hand, although the optimal biological properties, most of the current forms of CPC are 
not showing osteoinductivity. Therefore, dedicated CAs have to be developed for a wide 
range of different biomaterials as used for dental restorations and bone regeneration, which 
have proven not to affect the final biomaterial properties. 
The final consideration is dealing with the safety requirements of the used CAs. All the CAs 
presented in this thesis are already described as biocompatible and were used in relatively low 
concentrations, hence considered compatible for bone and dental tissues applications. 
However, it is known that nanoparticles can accumulate in specific organs (e.g. spleen, liver) 
instead of being excreted from the body. The assessment of the biodistribution of the CAs and 
the occurrence of any tissue accumulation was out of the scope of this thesis but is 
recommended in further studies. Such information will help in a better understanding of the 
fate of the CAs once they are released from the implanted material and solve any safety 
concerns about their use. Strong prove about the biological compatibility of the used materials 
will facilitate and speed up their clinical application. 
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1. Samenvatting  
Jaarlijks ondergaan er meer dan 2 miljoen patiënten een bottransplantatie als gevolg van 
ziekte of trauma. De behandeling die daarbij als gouden standaard geldt, is een transplantatie 
van autoloog donorbot. Er bestaat echter een gebrek aan transplanteerbaar bot. Daarnaast 
brengt een dergelijke procedure risico op morbiditeit met zich mee. Hierdoorbestaat er een 
toenemende vraag naar geschikte synthetische materialen. Onderzoek heeft verschillende 
biocompatibele materialen opgeleverd, die geïmplanteerd kunnen worden door middel van 
minimaal invasieve operatie technieken en die resulteren in een snellere botgenezing. Het 
transleren van dergelijke biomaterialen vanonderzoek naar klinisch bruikbare producten, 
maakt het noodzakelijk om pre-klinische in vivo modellen te gebruiken, om zo de 
weefselintegratie te kunnen bestuderen. 
Een van de uitdagingen in het veld van botregeneratie, is de ontwikkeling van laag 
invasieve, pre-klinische beeldvorming, om daarmee het biologisch gedrag van de 
biomaterialen na plaatsing in het lichaam beter te kunnen begrijpen. Een optimale 
beeldvormende techniek kan longitudinaal en met hoge resolutie zowel kwantitatieve als 
kwalitatieve informatie opleveren over de integratie van het biomateriaal en vervolgens over 
het weefselherstel. 
Een algemene inleiding met betrekking tot botregeneratie, biomaterialen en uitdagingen in 
de bijbehorende beeldvorming wordt gegeven in Hoofdstuk 1. Van alle manieren van pre-
klinische beeldvorming, is magnetische resonantie (magnetic resonance imaging; MRI) een 
techniek die geen gebruik maakt van ioniserende straling. MRI kent een hoge resolutie, een 
goed zacht weefsel contrast, en een oneindige penetratie diepte. MRI van de harde weefsels, 
zoals botten en tanden, is echter nog steeds uitdagend vanwege het lage aantal protonen in 
deze weefsels en de zeer korte transverse relaxatie (T2). Nieuwe MRI sequenties, zoals de 
zogenoemde. sweep imaging with Fourier transformation (SWIFT), ultra-short echo time 
(UTE) en zero echo time (ZTE) sequentie, zijn specifiek ontwikkeld om weefsels met een 
dergelijke korte T2 af te kunnen beelden. In Hoofdstuk 2 wordt een overzicht gegeven van 
alle MRI-sequenties die gebruikt kunnen worden voor de harde weefsels. Het doel was om 
een zeer breed overzicht te geven van de potentiële klinische en pre-klinische toepassingen 
van deze MRI-sequenties, en daarnaast over de toekomstige ontwikkelingen van dergelijke 
technieken. Vervolgens wordt ook de toepassing van MRI bij het gebruik van biomaterialen 
beschreven. In hoofdstuk 2 wordt duidelijk dat bijvoorbeeld de UTE-sequentie een zeer 
geschikte methode is om botten, tanden, en biomaterialen weer te geven. 
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Op dit moment worden vele materialen ontwikkeld voor het gebruik in bot en tandweefsel. 
Een typisch voorbeeld is calcium fosfaat cement (calcium phosphate cement; CPC), een 
materiaal dat zeer geschikte biologische eigenschappen heeft en tegelijkertijd ook klinisch 
goed hanteerbaar is. De grote overeenkomst tussen CPC en natuurlijk botweefsel zorgt echter 
voor een slecht beeldcontrast bij het gebruik van conventionele in vivo beeldvorming, zoals 
computed tomography (CT) of MRI. Op dit moment is het ook onzeker of CPC herkend kan 
worden met MRI na plaatsing in een tand. Het doel van Hoofdstuk 3 was daarom de ZTE 
techniek te gebruiken om een CPC af te kunnen beelden, en de afbraak van het materiaal in 
vivo te kunnen volgen. Het CPC materiaal werd ex vivo geïmplanteerd in drie menselijke 
tanden en drie geitentanden, en eveneens in vivo in drie geitentanden. Een specifieke UTE-
sequentie (UTE with multiple flip angles and echo times) werd toegepast bij een veld van 
11.7T om de T1 en T2
*
 waarden van CPC, glazuur, en dentine te bepalen. Tanden met CPC 
werden afgebeeld met een geoptimaliseerde ZTE-sequentie. Geitentanden die in vivo met 
CPC geïmplanteerd waren, werden na zeven weken ex vivo geanalyseerd. De T2
*
 relaxatie van 
CPC, dentine en glazuur kon beter beschreven worden met een Gauss distributie dan met een 
Lorentz distributie. Voor CPC, humaan glazuur en dentine, was de gemiddelde T2
*
 waarde 
respectievelijk 273 ± 19 μs, 562 ± 221 μs en 476 ± 147 μs; de gemiddelde T2 was 1234 ± 27 
μs, 963 ± 151 μs en 577 ± 41 μs; en de gemiddelde T1 was 1065 ± 45 ms, 972 ± 40 ms en 903 
± 7 ms. In de ZTE beelden, had CPC een betere signaal-tot-ruis verhouding dan dentine of 
glazuur, vanwege de hoge hoeveelheid water. Zeven weken na implantatie werd het gebied 
dat gevuld was met CPC duidelijk minder homogeen van structuur, was er een lagere T1 
waarde, en bestond de T2
*
 uit twee losse componenten. De MRI ZTE vertoonde daarmee 
voldoende contrast en maakte het bovendien mogelijk de afbraak van het CPC materiaal in 
tanden over de tijd te volgen. 
Desalniettemin, zou het samenvoegen van CPC met specifieke contrastmiddelen (contrast 
agents; CAs) een nog betere oplossing kunnen zijn voor het vervolgen van het materiaal in 
vivo. Bij het gebruik van CAs is het bovendien mogelijk niet alleen MRI acquisitie te 
gebruiken, maar tegelijk een combinatie te maken met andere beeldvormende technieken, 
zoals CT. Het zou zelfs mogelijk zijn om een samenstelling te bewerkstelligen waarin 
toevoegingen zitten die zowel de diagnostiek als de therapie ten bate zijn (de zogenaamde 
‘theranostische’ materialen). Op deze manier is het mogelijk materialen te maken die 
tegelijkertijd verbeterde beeldvormende en biologische eigenschappen hebben. In Hoofdstuk 
4 werd een theranostisch materiaal voor vitale pulpa behandeling ontwikkeld. Een materiaal 
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voor de overkapping van pulpaweefsel zou goede biologische eigenschappen moeten bezitten, 
goed hanteerbaar moeten zijn, en een bruikbaar contrast op moeten leveren. CPC composieten 
zouden een potentiële kandidaat vormen voor deze behandeling, maar beschikken over een 
slecht contrast en bevorderen de uitgroei van dentine niet. Daarom werd als eerste de 
beeldvorming van CPC verbeterd met een dubbel contrastmiddel (core-shell structured dual 
contrast agent; csDCA) wat bestond uit superparamagnetisch ijzeroxide (superparamagnetic 
iron oxide; SPIO) en colloïdaal goud, wat respectievelijk diende als MRI- en CT-contrast. Als 
tweede werden de biologische eigenschappen verbeterd, door toevoeging van een dentinogene 
groeifactor (bone morphogenetic protein 2; BMP-2). Het zodanig verkregen 
CPC/csDCA/BMP-2 composiet werd in vivo getest, als een materiaal voor directe pulpa 
overkapping, in snijtanden van de Habsi geit. Het resultaat liet zien dat de toevoegingen geen 
relevante veranderingen opleverden in de hanteerbaarheid en mechanische eigenschappen, 
zoals uithardingstijd, injecteerbaarheid, en compressiesterkte. De in vivo resultaten lieten een 
verbetering zien in het MRI-contrast tot aan 7 weken na de operatie. Snijtanden die behandeld 
waren met BMP-2 lieten meer afzetting van tertiair dentine zien en ook een snellere afbraak 
van het CPC in de µCT metingen. Er kan geconcludeerd worden dat het theranostische 
materiaal voldoet aan de vereisten voor beeldvorming en regeneratie bij een toepassing als 
pulpa overkapping. 
CPC materiaal wordt voornamelijk gebruikt voor toepassing in botrestauratie. Voor een 
accurate identificatie en lokalisatie, zowel gedurende en na afloop van de implantatie, is een 
CPC compositie met een aanmerkelijk verbeterd contrast noodzakelijk. In Hoofdstuk 5, werd 
het CPC materiaal voorzien van perfluoro-15-crown-5-ether-loaded (PFCE) poly(lactic-co-
glycolic acid) nanopartikels (met een radius van 100 nm) en van goud nanopartikels (met een 
diameter van 40 nm), om respectievelijk te dienen als 
19
F MRI en CT contrastmiddel. Het 
resulterende CPC/PFCE/goud composiet werd geïmplanteerd in een rattenmodel voor in vivo 
longitudinale beeldvorming. De bevindingen lieten zien dat het incorporeren van de twee 
typen nanopartikels nog steeds resulteerde in goede hanteerbaarheid van het cement. 
Kwalitatieve en kwantitatieve metingen van de degradatie van CPC/PFCE/gold konden over 
langere tijd uitgevoerd worden en bleken gecorreleerd te zijn aan de vorming van nieuw 
botachtig weefsel. Tenslotte konden negatieve biologische effecten op het botweefsel 
uitgesloten worden door middel van histologie. Concluderend kan gezegd worden dater een 
eenvoudige en efficiënte strategie is ontwikkeld om het implanteren en degraderen van CPC 
in vivo te kunnen monitoren. Aangezien de materialen ook biocompatibel werden bevonden, 
zou dit CPC/PFCE/goud composiet op termijn klinisch toepasbaar zijn. 
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In Hoofdstuk 6, werd een CPC construct gemaakt met daarin gadolinium-oxide 
nanopartikels, wat diende als een multi-modaal MRI/CT contrastmiddel. De gadolinium(III) 
oxide nanopartikels werden gesynthetiseerd via de polyol methode en daarna aan het 
oppervlak gefunctionaliseerd met een bisfosfonaat (bisphosphonate; BP) derivaat om op die 
manier een sterke affiniteit te verkrijgen voor calciumfosfaat. Het verkregen CPC-GBCAs-BP 
materiaal werd vervolgens longitudinaal gevolgd na in vivo implantatie in een condylair 
defect in de rat. De synthetische methode die gebruikt werd om nanopartikels te maken – die 
stabiel zijn in water (diameter 70 nm) en een significante T1 en T2 relaxatie vertoonden – 
werd effectief bewezen in zowel klinische 3 T als pre-klinische 11.7 T MR systemen. De 
combinatie van GBACs-BP nanopartikels met CPC leidt tot een injecteerbaar materiaal met 
een voldoende klinische hanteerbaarheid. Het functionaliseren met BP zorgde ervoor dat het 
contrastmiddel langer bij de CPC aanwezig bleef, wat beeldvormende studies over lange 
termijn mogelijk maakt. De bijdrage van het contrastmiddel, gecombineerd met de juiste 
biologische respons, maakt vervolgonderzoek van dit nieuwe hybride bot vervangende 
materiaal tot aan de fase van klinische toepassing aannemelijk. 
Naast CPC zijn ook veel andere biomaterialen wellicht geschikt voor bot 
weefselregeneratie. Gelatine methacrylaat (GelMA) is een goedkope, en lichtuithardende 
hydrogel die geschikt is voor celkweek. Er is eerder al aangetoond dat het 3D printen van 
GelMA een geschikte methode is om dragermaterialen te produceren die ingroei van cellen en 
vasculatuur bevorderen en die diffusie van nutriënten mogelijk maken dankzij de evenredig 
verdeelde open porositeit. In Hoofdstuk 7 werd een geprinte GelMA hydrogel ontworpen en 
getest voor bot weefselregeneratie in vivo. Daarbij werden ook 2 niet-invasieve methoden 
onderzocht om de afbraak van het dragermateriaal te kunnen volgen, namelijk; 1) een 
combinatie van GelMA met goud nanopartikels (AuNPs) als contrastmiddel voor CT; 2) MRI 
scanning met de T1-weighted ultrashort echo time (UTE) methode. Voor deze doeleinden 
werd het 3D geprinte GelMA hydrogel materiaal geïmplanteerd in cilindrische defecten in de 
condyl van 6 a 7 weken oude Wistar ratten. Resultaten lieten zien dat de GelMA een gel-
achtige structuur vormde na afkoeling tot 22°C. Het in vivo experiment liet, zowel bij analyse 
met histologische technieken als met micro-CT, goede biologische eigenschappen zien. Er 
was geen sprake van de vorming van bindweefselkapsel of hindering van de botvorming. De 
beeldvorming liet geen duidelijke verandering van het beeld zien bij het GelMA CT signaal, 
bij het gebruik van de  AuNps. In tegenstelling verschaft de MRI bruikbare morfologische 
informatie over de GelMA en het botweefsel. In conclusie kan gezegd worden dat het 3D 
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geprinte GelMA materiaal ontworpen in hoofdstuk 7 een goede kandidaat zou zijn als 
dragermateriaal voor botweefselregeneratie, terwijl MRI aanbevolen kan worden als meest 
optimale techniek voor langdurige niet-invasieve, longitudinale opvolging. 
2. Afsluitende opmerkingen en toekomstperspectief 
Dit proefschrift had als doel om pre-klinische beeldvormende technieken te onderzoeken die 
bruikbaar zijn voor het opvolgen van specifieke biomaterialen, gebruikt voor het herstel van 
botten en tanden. Alhoewel CT de meest gebruikte techniek voor het afbeelden van harde 
weefsels blijft, werd er in dit proefschrift bijzondere aandacht geschonken aan MRI als 
veelbelovend alternatief. Voor dergelijke doeleinden, lag de eerste focus bij het onderzoeken 
van nieuwe UTE MRI-sequenties die ontwikkeld waren voor het afbeelden van weefsels en 
materialen die gekarakteriseerd worden door een laag water gehalte. Desalniettemin was, 
zowel voor CT als voor MRI, het toevoegen van een contrastmiddel vereist, zeker wanneer 
het ging om de in vivo opvolging van calcium fosfaat composieten. Daarom werd dergelijk 
CPC gecombineerd met verschillende typen CAs (zoals SPIO, Gadolinium, PFC) en 
vervolgens getest in pre-klinische modellen voor zowel dentale- als bottoepassingen. 
Specifiek werden de CAs verder gecombineerd met een bot stimulerende groeifactor (BMP-
2), geïncorporeerd in een dragermateriaal (silica, PLGA nanopartikels) en gefunctionaliseerd 
met CPC-bindende stofjes (bisfosfonaat derivaat). Elke geteste CPC samenstelling met 
contrastmiddel maakte het mogelijk om het materiaal over langere tijd  niet-invasief, in vivo te 
kunnen volgen. Ten gevolge kan zonder meer gesteld worden dat dit proefschrift voorziet in 
een breed platform van visualiseerbare materialen voor toepassing in bot en tanden. Elke 
samenstelling had daarbij specifieke sterke en zwakke eigenschappen, maar voldeed aan de 
biologische vereisten die verdere studie naar klinische toepassing mogelijk maken. Tenslotte 
liet dit proefschrift zien dat de keuze voor een bepaalde beeldvormende techniek en een 
bepaald CA afhankelijk is van het type biomateriaal. Bij de hydrogel materialen was 
bijvoorbeeld een CA niet essentieel, terwijl MRI beter geschikt was dan CT. 
Ondanks de bereikte resultaten weergegeven in dit proefschrift, zijn er nog vele uitdagingen. 
Alhoewel MRI van harde weefsels en CPC met sequenties zoals ZTE en UTE nu een goed 
beschreven methode lijkt, is verdere optimalisering van de acquisitieprotocollen nog steeds 
noodzakelijk. Een dergelijke optimalisering zou de nadruk moeten leggen op het verder 
verkorten van de acquisitietijd, die nog steeds relatief lang is, voornamelijk voor het afbeelden 
van tandweefsels. Wanneer CAs gebruikt worden, is er verdere ontwikkeling nodig van 
eenvoudige en snelle methoden om het verkregen signaal ook te kwantificeren. Een gevoelige 
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kwantitatieve evaluatiemethode voor de hoeveelheid CAs in een geïmplanteerd CPC zou het 
mogelijk kunnen maken om het proces van de degradatie van CPC gedurende de tijd zeer 
precies te kunnen gaan begrijpen. Een dergelijke signaalkwantificatie is zeker ook essentieel 
in gevallen waarbij de combinatie van CPC met CAs resulteert in typische MR artefacten. 
Zulke artefacten worden bijvoorbeeld gezien wanneer SPIO en Gadolinium gecombineerd 
worden met CPC en vervolgens bekeken worden met ZTE sequenties. Alhoewel het steeds 
mogelijk bleek om de afname van het gehalte Cas (en de daarbij behorende signaal intensiteit) 
visueel te herkennen, bleek een kwantitatieve evaluatie nog te uitdagend. Een mogelijke 
strategie zou kunnen zijn, om gebruik te maken van een techniek als quantitative 
susceptibility mapping based on MRI phase images. Het is bekend dat CAs met verschillende 
paramagnetische eigenschappen de uniformiteit van het toegepaste magnetische veld (B0) 
kunnen beïnvloeden. Fase beelden geven informatie over de lokale verdeling van frequenties, 
die weer afhankelijk zijn van de bulk magnetische susceptibiliteit van de verschillende 
weefsels. En dus zou MRI fase beeldvorming gebruikt kunnen worden om beeldvormings-
artefacten te kwantificeren die het gevolg zijn van het gebruik van CA. Als alternatief zou ook 
T1 mapping based on UTE acquisition with variable flip angles (VFA) voorgesteld kunnen 
worden voor vervolgonderzoek. De VFA-UTE method is gebaseerd op MRI acquisitie met 
verschillende flip angles en kan gebruikt worden om de relaxatie eigenschappen te 
beschrijven van weefsels met een extreem snelle afname van het signaal. 
Op dit moment lijkt MRI de enige techniek die geschikt is voor niet-invasieve beeldvorming 
van alle processen betrokken bij weefselregeneratie. In theorie kan MRI gebruikt worden om 
te kijken naar celmigratie in een dragermateriaal, naar de morfologie en degradatie van dat 
materiaal en naar de uiteindelijke biologische reactie van de gastheer. Het gebruik van MRI in 
het veld van botweefselregeneratie is echter nog in een zeer vroege fase en er is aanvullend 
onderzoek nodig. Bovendien zijn de kosten voor MRI in de tandheelkunde aanzienlijk, en 
wordt een dergelijk scenario dus alleen voorzien op de langere termijn. Dit proefschrift liet 
zien dat er desondanks een groot potentieel in het tandheelkundig gebruik van MRI 
verscholen ligt, aangezien MRI toestaat zowel zachte en harde weefsels af te beelden, en zelfs 
gelijktijdig chemische eigenschappen te bestuderen. Het lijkt daarmee nog steeds aanlokkelijk 
om met MRI zichtbare materialen voor tandheelkundig gebruik verder te ontwikkelen.  
Een volgend onderwerp van het proefschrift was een aanpak die gebaseerd is op het 
gelijktijdig gebruik van verschillende modaliteiten, zoals CT/MRI. Dergelijke multimodale 
beeldvorming kan complementaire informatie verschaffen, omdat de beperking van de ene 
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techniek gecompenseerd kan worden door de andere. Een gebrek aan geïntegreerde MRI/CT 
machines maakt beeldvorming op dit moment bewerkelijk en belemmert een heldere 
interpretatie van de verkregen data. Aangezien het technisch lastig is om een gecombineerde 
MRI/CT-scanner te produceren, zou voor verdere studies wellicht beter aan een 
gestandaardiseerde en volledig geautomatiseerde beeldverwerkingsmethode gewerkt kunnen 
worden. 
Vervolgens kunnen nog diverse opmerkingen gemaakt worden over de CAs. Verschillende 
typen MRI-CAs warden met succes onderzocht in het proefschrift, desondanks zijn er vele 
mogelijkheden die nog verder uitgezocht dienen te worden. Metalloproteinen (zoals 
hemoglobin en ferritine), die van zichzelf al paramagnetische eigenschappen vertonen, 
zouden beschouwd moeten worden als kandidaten voor de ontwikkeling van een geheel 
nieuwe generatie van veilige MRI signaalstoffen voor biomedische toepassing. Daarnaast 
moet opgemerkt worden dat CAs een significant effect kunnen hebben op de eigenschappen 
van een biomateriaal. Het insluiten van een extra ingrediënt in een calcium fosfaat matrix, zal 
bijvoorbeeld ontegenzeggelijk de kristalvorming beïnvloeden, en dus ook zorgen voor een 
verandering in de klinische hanteerbaarheid van het eindproduct. Er zal waarschijnlijk voor 
elk biomateriaal in botregeneratie en in de tandheelkunde een specifiek geschikt eigen CA 
ontwikkeld moeten worden, dat geen invloed heeft op de uiteindelijk gewenste 
eigenschappen. 
Een laatste overweging is de veiligheid van CAs. Alle CAs die in dit proefschrift zijn gebruikt 
staan bekend als biocompatibel, werden in relatief lage concentratie toegepast, en werden dus 
in het algemeen beschouwd al geschikt voor bot- en tandheelkundige toepassing. Het is echter 
bekend dat bepaalde typen nanopartikels zich kunnen ophopen in specifieke organen (zoals 
milt en lever) in plaats van uitgescheiden te worden door het lichaam. Het bekijken van de 
bio-distributie van CAs en het eventueel voorkomen van ophopingen in een bepaald weefsel 
werd niet bestudeerd, maar is zeker aan te bevelen voor vervolgstudies. Dergelijke informatie 
zal leiden tot een beter begrip van het uiteindelijke lot van CAs wanneer deze vrijkomen uit 
het geïmplanteerde materiaal en antwoorden kunnen geven op belangrijke vragen ten aanzien 
van veiligheid. Een sterk bewijs van biologische veiligheid van de gebruikte materialen zal 
het uiteindelijke klinische gebruik faciliteren en versnellen. 
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